
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="../style.css">
    <title>Document</title>
</head>
<body>

<span class="table_title">False Negatives</span>

<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>generated</th>
      <th>gold</th>
      <th>text</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>26</th>
      <td>RT-PCR<br>β2-microglobulin<br>CYP2J2</td>
      <td>β2mg<br>CYP2J2 mRNA</td>
      <td>Expression of CYP2J2 mRNA was quantified by RT-PCR and results normalized to β2mg and to t = 0.</td>
    </tr>
    <tr>
      <th>1</th>
      <td>vacuum degasser<br>binary pump<br>column oven<br>ESI probe<br>Waters Corporation<br>Micromass Xevo tandem quadrupole mass spectrometric detector<br>autosampler<br>UPLC system<br>Acquity BEH C18 column<br>CYP2C8</td>
      <td>NADP</td>
      <td>Briefly, serial dilutions of the extracts were added to a mixture of regeneration system, NADP Phytofingerprinting was performed on the extracts using a Waters Acquity UPLC system (Waters Corporation, Milford, MA, USA) with an Acquity BEH C18 column (2.1 mm × 100 mm, 1.7 µm particle size) incorporating a binary pump, vacuum degasser, autosampler, column oven, and Micromass Xevo tandem quadrupole mass spectrometric detector (QTOF xevo G2; Waters micromass, Manchester, UK) equipped with ESI probe.</td>
    </tr>
    <tr>
      <th>45</th>
      <td>PEPT1 transporter<br>GSH level<br>H. sabdariffa extract</td>
      <td>PEPT1 transporter<br>GSH</td>
      <td>Two weeks of coadministration of H. sabdariffa extract is sufficient enough to affect the GSH level or the expression of the PEPT1 transporter.</td>
    </tr>
    <tr>
      <th>52</th>
      <td>CYP2C9*2<br>CYP2C9<br>CYP2C9*1<br>CYP2C9*3</td>
      <td>CYP2C9<br>VKORC1<br>CYP2C9*1,*2 and *3 polymorphisms of CYP2C9</td>
      <td>CYP2C9 and VKORC1 genotyping  The CYP2C9*1,*2 and *3 polymorphisms of CYP2C9 were detected by polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP) analysis.</td>
    </tr>
    <tr>
      <th>51</th>
      <td>Tetracarpidium conophorum<br>Musa sapientum<br>Allium sativum</td>
      <td>CYP isoenzymes</td>
      <td>Three of the plants studied did not exhibit inhibitory potential on any of the eight major human CYP isoenzymes used even at the highest dose of the extract, that is, aqueous extracts of Musa sapientum unripe fruits, Tetracarpidium conophorum seeds, and Allium sativum bulbs.</td>
    </tr>
    <tr>
      <th>38</th>
      <td></td>
      <td>GATA-3<br>T cell<br>caspase 3<br>T-box protein expressed in T cells (T-bet)<br>programmed death 1 (PD-1)<br>Forkhead box protein 3 (Foxp3)</td>
      <td>Multiple mechanisms may be involved, including upregulation of transcription factors such as T-box protein expressed in T cells (T-bet) and GATA-3, which modulate the T helper cell balance [169]; downregulation of Bax expression to reduce caspase 3 activity and T cell apoptosis [170]; and reduction of the expression of negative regulators/transcription factors of immune responses, including Forkhead box protein 3 (Foxp3) and programmed death 1 (PD-1) [171].</td>
    </tr>
    <tr>
      <th>8</th>
      <td>Panax ginseng<br>CYP isoforms</td>
      <td>CYP</td>
      <td>Like G. biloba, Panax ginseng appears to have little effect on the activities of the specific CYP isoforms investigated in this study.</td>
    </tr>
    <tr>
      <th>17</th>
      <td>CYP2C19<br>CYP2D6<br>CYP2C9<br>cytochrome P450 enzymes<br>Korean red ginseng extract<br>CYP1A2<br>CYP3A<br>probe substrates</td>
      <td>cytochrome P450 (CYP) enzymes<br>CYP1A2, 2C9, 2C19, 2D6, 3A</td>
      <td>In case of ginseng interactions, it was reported that no herb–drug interaction between single oral dose of Korean red ginseng extract (RGE) (0.5–2.0 g/kg) and the probe substrates for five cytochrome P450 (CYP) enzymes (i.e., CYP1A2, 2C9, 2C19, 2D6, 3A) in mouse [12].</td>
    </tr>
    <tr>
      <th>46</th>
      <td>EJE<br>anthocyanins<br>flavonoids<br>Gliptins<br>dipeptidyl peptidase-4 (DDP-4)</td>
      <td>enzyme dipeptidyl peptidase-4 (DDP-4)</td>
      <td>(EJ) are considered to be functional foods owing to their anti-diabetic Several research groups studying the protective and therapeutic effect of EJE and have identified presence of various classes of bioactive constituents like anthocyanins, flavonoids Gliptins are a class of oral anti-diabetic agents which act by competitively antagonizing the enzyme dipeptidyl peptidase-4 (DDP-4).</td>
    </tr>
    <tr>
      <th>36</th>
      <td>pregnane X receptor</td>
      <td>pregnane‐X‐receptor (PXR)</td>
      <td>These interactions were caused by pregnane‐X‐receptor (PXR) activation.</td>
    </tr>
    <tr>
      <th>0</th>
      <td>cytochrome P450</td>
      <td>cytochrome P450 (CYP450)</td>
      <td>The cytochrome P450 (CYP450) family of enzymes especially plays an important role in the biotransformation of about 70% of xenobiotics and other endogenous substances [14].</td>
    </tr>
    <tr>
      <th>28</th>
      <td>DAS<br>Pgp/MDR1<br>APG</td>
      <td>MDR1<br>Pgp</td>
      <td>The APG-pretreated rats showed significant inhibition of the Pgp/MDR1 protein, that is 65.38% and 69.90% inhibition, respectively, as compared to DAS alone (p < 0.05).</td>
    </tr>
    <tr>
      <th>34</th>
      <td>BCRP/ABCG2<br>intestine<br>DAS<br>APG<br>liver</td>
      <td>ABCG2<br>BCRP</td>
      <td>Hepatic (A) and intestinal (B) BCRP/ABCG2 protein expression in rats after DAS administration with or without APG pretreatment.</td>
    </tr>
    <tr>
      <th>25</th>
      <td>CYP2J2</td>
      <td>CYP2J2 mRNA</td>
      <td>Effect of Samento on CYP2J2 mRNA decay in LS180 cells.</td>
    </tr>
    <tr>
      <th>16</th>
      <td>glucuronidation<br>UGT2B7<br>4-MU<br>Celastrol</td>
      <td>UGT2B7-catalyzed 4-MU glucuronidation</td>
      <td>Inhibition kinetic analysis of celastrol (Cela) towards UGT2B7-catalyzed 4-MU glucuronidation.</td>
    </tr>
    <tr>
      <th>24</th>
      <td>rifampicin<br>pregnane X receptor<br>Samento</td>
      <td>pregnane x receptor (PXR)</td>
      <td>(a) Concentration-dependent effect of Samento and the positive control rifampicin (insert) on pregnane x receptor (PXR) activity.</td>
    </tr>
    <tr>
      <th>9</th>
      <td>Valeriana officinalis<br>CYP3A4</td>
      <td>CYP 3A4</td>
      <td>However, they state that warnings that valerian (Valeriana officinalis) may stimulate CYP 3A4.</td>
    </tr>
    <tr>
      <th>2</th>
      <td>ABCB1<br>p-glycoprotein</td>
      <td>p-glycoprotein (p-gp) encoded by ABCB1</td>
      <td>Previous in vitro studies have reported the inhibitory effect of green tea on p-glycoprotein (p-gp) encoded by ABCB1.</td>
    </tr>
    <tr>
      <th>10</th>
      <td>delirium<br>MAO-inhibitory properties<br>valerian preparation<br>opioids<br>herbal medicines</td>
      <td>MAO</td>
      <td>Given that none of these herbal medicines has been proven to have MAO-inhibitory properties, while induction of delirium, and a positive drug screening on opioids was reported, the assumption of an involvement of the valerian preparation does not seem to be plausible.</td>
    </tr>
    <tr>
      <th>7</th>
      <td>G. biloba</td>
      <td>CYP</td>
      <td>[18] Taken together these findings indicate that herb-drug interactions attributable to G. biloba are not the result of phytochemical-mediated effects on CYP isoforms.</td>
    </tr>
    <tr>
      <th>30</th>
      <td>BCRP/ABCG2<br>APG</td>
      <td>ABCG2<br>BCRP</td>
      <td>The inhibitory potential of APG on BCRP/ABCG2 protein expression was investigated and shown in Figure 5A,B.</td>
    </tr>
    <tr>
      <th>6</th>
      <td>CYP enzymes<br>CYP substrates</td>
      <td>CYP</td>
      <td>Moreover, age-related changes have been observed in the pharmacokinetics of several CYP substrates,[28–30] as well as certain CYP enzymes,[29,30] thus the question remains as to whether such effects may extend to botanical supplements and their effect on drug metabolism in the elderly.</td>
    </tr>
    <tr>
      <th>48</th>
      <td>CYP2C<br>CYP1A<br>CYP3A</td>
      <td>CYP2C-<br>CYP1A-<br>CYP3A-</td>
      <td>Furthermore, CYP1A-, CYP2C- and CYP3A-inducing agents were found in the ethyl acetate extract, but not in the aqueous extract of Danshen [57].</td>
    </tr>
    <tr>
      <th>37</th>
      <td>xenosensor<br>promotor<br>genes<br>PXR<br>xenobiotic receptor<br>PXRRE<br>nucleus</td>
      <td>PXR<br>PXR response elements (PXRRE)</td>
      <td>In the network of genes involved in drug metabolism, the PXR functions as a xenobiotic receptor or “xenosensor,” which, after ligand binding, translocates to the nucleus, where it binds to specific PXR response elements (PXRRE) in the promotor of various genes, modulating their transcription.</td>
    </tr>
    <tr>
      <th>54</th>
      <td>CYP3A4<br>CYP1A1<br>CYP2D6<br>CYP1B1<br>cytochrome P450<br>CYP1A2</td>
      <td>CYPs 1A1, 1A2, 1B1, 3A4 and 2D6<br>cytochrome P450<br>P450 enzymes</td>
      <td>[15] to screen natural products for cytochrome P450 inhibition potential with a particular emphasis on the P450 enzymes, CYPs 1A1, 1A2, 1B1, 3A4 and 2D6.</td>
    </tr>
    <tr>
      <th>47</th>
      <td>ERK pathway<br>stimulation of new vessel formation<br>vasodilation<br>decrease in blood viscosity<br>adipocyte differentiation<br>PI3-K/Akt pathway<br>anthocyanins<br>endothelium-derived relaxant pathways<br>active site<br>reduction of myocardial mass<br>inhibition of calcium influx<br>ACE inhibition<br>cyclooxygenase inhibitory activity</td>
      <td>ACE</td>
      <td>Biological Mechanisms  In vitro and in vivo studies focused on mechanism of action have determined several potential mechanisms of the HS extracts that may explain the hypotensive activity, including (1) vasodilation mediated through endothelium-derived relaxant pathways and inhibition of calcium influx [9, 57], (2) ACE inhibition [9] by the stimulation of new vessel formation and a reduction of myocardial mass [52] or anthocyanins competing with the substrate for the active site [58], (3) decrease in blood viscosity through cyclooxygenase inhibitory activity [44], and (4) inhibition of adipocyte differentiation through the modulation of PI3-K/Akt and ERK pathway [59].</td>
    </tr>
    <tr>
      <th>21</th>
      <td>L-MDR1 cells<br>intracellular calcein fluorescence<br>Banderol<br>human P-glycoprotein (P-gp)<br>Samento</td>
      <td>P-gp<br>P-glycoprotein (P-gp)</td>
      <td>Neither Samento nor Banderol increased intracellular calcein fluorescence in L-MDR1 cells over-expressing human P-glycoprotein (P-gp), indicating lack of P-gp inhibition (data not shown).</td>
    </tr>
    <tr>
      <th>11</th>
      <td>clarithromycin<br>rifampin</td>
      <td>CYP3A</td>
      <td>Subjects also received rifampin (600 mg) and clarithromycin (1000 mg) for 7 days as positive controls for CYP3A induction and inhibition, respectively.</td>
    </tr>
    <tr>
      <th>3</th>
      <td>nuclear receptors<br>P-gp<br>farnesoid X receptor<br>Bsep<br>bile acid receptor<br>pregnane X receptor</td>
      <td>Bsep<br>farnesoid X receptor (FXR, also known as bile acid receptor)<br>P-gp<br>pregnane X receptor (PXR)</td>
      <td>Nuclear receptors, such as farnesoid X receptor (FXR, also known as bile acid receptor) and pregnane X receptor (PXR), are known as major regulators of the expression of Bsep and P-gp, respectively [35].</td>
    </tr>
    <tr>
      <th>32</th>
      <td>DAS<br>BCPR/ABCG2<br>APG-pretreated rats</td>
      <td>BCPR<br>ABCG2</td>
      <td>The APG-pretreated rats showed significant inhibition of the BCPR/ABCG2 protein that is (66.77% and 41.06% inhibition, respectively) as compared to DAS only (p < 0.05).</td>
    </tr>
    <tr>
      <th>44</th>
      <td>4-hydroxy-N-desmethyltamoxifen hydrochloride<br>(E/Z)-endoxifen hydrochloride<br>dextrorphan-d<br>human liver microsomes<br>β-estradiol</td>
      <td>β-estradiol (E2)</td>
      <td>(E/Z)-endoxifen hydrochloride (4-hydroxy-N-desmethyltamoxifen hydrochloride), β-estradiol (E2) and dextrorphan-d Pooled human liver microsomes (HLMs, 50 donors, mixed gender) were purchased from Bioreclamation IVT (Baltimore, USA).</td>
    </tr>
    <tr>
      <th>56</th>
      <td>CYP2C9<br>CYP3A4<br>Curcuminoids</td>
      <td>CY3A4 and 2C9</td>
      <td>Curcuminoids have been shown to inhibit CY3A4 and 2C9 in vitro [230].</td>
    </tr>
    <tr>
      <th>20</th>
      <td>cytochrome P450 enzymes<br>drug transporters</td>
      <td>cytochrome P450 enzymes (CYPs)</td>
      <td>Inhibition of cytochrome P450 enzymes (CYPs) was quantified by commercial kits and inhibition of drug transporters by use of fluorescent probe substrates.</td>
    </tr>
    <tr>
      <th>5</th>
      <td></td>
      <td>P-gP</td>
      <td>In vivo, digoxin was administered intravenously to control rats and citronellal pretreated experimental rats, and in vitro, the transcellular transport of   Single TCM: Single TCM formulations that are capable of inhibiting or downregulating P-gP include Conioselinum anthriscoides “Chuanxiong” (Chuanxiong), Vernonia amygdalina (Biantaobanjiuju), Tapinanthus sessilifolius, Carica papaya (Mugua) and Ginkgo biloba L. (Yinxing).</td>
    </tr>
    <tr>
      <th>19</th>
      <td>hypolipidemic effects<br>insulin tolerance<br>Polymethoxylated flavones<br>glucose levels<br>C. sinensis</td>
      <td>insulin</td>
      <td>Polymethoxylated flavones (PMFs) of C. sinensis have hypolipidemic effects, resulting in a significant reduction of insulin tolerance and glucose levels [61].</td>
    </tr>
    <tr>
      <th>14</th>
      <td>nonspecific substrates<br>UGT<br>compounds</td>
      <td>UGTs<br>UGT isoforms</td>
      <td>Therefore, evaluation of inhibition of compounds towards UGT isoforms was always carried out using recombinant UGTs and nonspecific substrates [19,20,21].</td>
    </tr>
    <tr>
      <th>12</th>
      <td>UGT1A1<br>UGT2B7<br>celastrol</td>
      <td>UGT1A1-mediated 4-MU glucuronidation<br>UGT2B7-catalyzed 4-MU glucuronidation</td>
      <td>Furthermore, inhibition kinetic study (Dixon plot and Lineweaver-Burk plot) demonstrated that celastrol noncompetitively inhibited the UGT1A1-mediated 4-MU glucuronidation, and competitively inhibited UGT2B7-catalyzed 4-MU glucuronidation.</td>
    </tr>
    <tr>
      <th>23</th>
      <td>CYP1A<br>aryl hydrocarbon receptor<br>AhR<br>omeprazole<br>Samento</td>
      <td>CYP1A<br>aryl hydrocarbon receptor (AhR)<br>AhR</td>
      <td>To demonstrate possible influences on aryl hydrocarbon receptor (AhR), another important transcription factor regulating e.g., CYP1A, we also tested whether Samento can activate AhR and found only a minor effect compared to the positive control omeprazole (Figure 4B).</td>
    </tr>
  </tbody>
</table>
<span class="table_title">False Positives</span>

<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>generated</th>
      <th>gold</th>
      <th>text</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>1083</th>
      <td>CYP2C9<br>CYP1A2</td>
      <td></td>
      <td>The metrics used for CYP1A2 and CYP2C9 may be considered as fully validated [28].</td>
    </tr>
    <tr>
      <th>591</th>
      <td>GGT</td>
      <td></td>
      <td>Therefore, we applied this dose of GGT in our study.</td>
    </tr>
    <tr>
      <th>0</th>
      <td>rhabdomyolysis<br>alternative herbal medicine<br>trabectedin<br>heavy toxicity<br>retroperitoneal liposarcoma</td>
      <td></td>
      <td>We describe here the unexpected onset of heavy toxicity including rhabdomyolysis after the fourth course of trabectedin in a patient with retroperitoneal liposarcoma who at the same time was taking an alternative herbal medicine suspected of triggering this adverse event.</td>
    </tr>
    <tr>
      <th>1804</th>
      <td>cancer<br>Picralima nitida<br>Bauhinia monandra<br>peptic ulcer<br>Alstonia boonei<br>diabetes<br>antimalarials<br>hypertension<br>antimicrobials<br>chronic diseases<br>asthma<br>minor ailments</td>
      <td></td>
      <td>Others such as Alstonia boonei, Bauhinia monandra, and Picralima nitida are frequently used in sub‐Saharan Africa and India in the management of chronic diseases such as hypertension, diabetes, asthma, peptic ulcer, and cancer, as antimalarials and antimicrobials and other minor ailments (Mahomoodally, 2013; Ezuruike & Prieto, 2014; Iwu, 2014).</td>
    </tr>
    <tr>
      <th>2025</th>
      <td>Isatis indigotica<br>Radix Isatidis</td>
      <td></td>
      <td>Radix Isatidis (Root of Isatis indigotica Fort., Banlangen).</td>
    </tr>
    <tr>
      <th>1497</th>
      <td>Malus domestica<br>VAEM<br>306ng/mL<br>total mistletoe lectin<br>5mg<br>Lot 7054/0</td>
      <td></td>
      <td>5 mg (VAEM, host tree Malus domestica, Lot 7054/0, total mistletoe lectin concentration 306 ng/mL), and Iscador Qu spec.</td>
    </tr>
    <tr>
      <th>2041</th>
      <td>T47D<br>HES<br>PIP<br>BV<br>TAM<br>MCF7</td>
      <td></td>
      <td>A recent study has shown that the combined use of HES, PIP, and BV with TAM showed an enhanced anti-proliferative effect on MCF7 and T47D and can significantly increase cell apoptosis (Khamis et al., 2018).</td>
    </tr>
    <tr>
      <th>1254</th>
      <td>CYP1A<br>aryl hydrocarbon receptor<br>AhR<br>omeprazole<br>Samento</td>
      <td>CYP1A<br>aryl hydrocarbon receptor (AhR)<br>AhR</td>
      <td>To demonstrate possible influences on aryl hydrocarbon receptor (AhR), another important transcription factor regulating e.g., CYP1A, we also tested whether Samento can activate AhR and found only a minor effect compared to the positive control omeprazole (Figure 4B).</td>
    </tr>
    <tr>
      <th>498</th>
      <td>QC samples<br>standard calibration curves<br>quality control</td>
      <td></td>
      <td>Three concentrations of quality control (QC) samples were prepared at low, medium, and high concentrations in the range of the standard calibration curves.</td>
    </tr>
    <tr>
      <th>1346</th>
      <td>polypropylene cages<br>animals<br>CYP2C8</td>
      <td></td>
      <td>All animals were retained in polypropylene cages: 6 animals were caged (n = 6) per cage with a 12-h light/dark cycle, at 25 °C in humane conditions with free access to food and water and adapted to the living conditions one week prior to experiment The animals were categorized into four groups (n = 6) and fasted for 12 h before the experiment.</td>
    </tr>
    <tr>
      <th>1795</th>
      <td>endogenous peaks</td>
      <td></td>
      <td>No endogenous peaks were identified in the extracted ion chromatograms that would cause interference with drug quantitation.</td>
    </tr>
    <tr>
      <th>67</th>
      <td>South Korean population</td>
      <td></td>
      <td>In South Korean population reported a range from 29% to 83% [5].</td>
    </tr>
    <tr>
      <th>1950</th>
      <td>ascorbic acid<br>free radical 2,2-diphenyl-1-picrylhydrazyl (DPPH)</td>
      <td></td>
      <td>100 µL of various concentrations of the extracts, and the ascorbic acid control, in methanol, were added to 100 µL of a 0.02% (w/v) stock solution of the free radical 2,2-diphenyl-1-picrylhydrazyl (DPPH) in methanol.</td>
    </tr>
    <tr>
      <th>1310</th>
      <td>CYP2C8</td>
      <td></td>
      <td>Table 1  The major ingredients of woohwangchengonsimwon suspension (Kwang-Dong Pharmaceutical Company, Seoul, Korea) Ingredients\tQuantity in 30 ml (mg) Bovis Calculus\t14 Dioscoreae Rhizoma\t282 Glycyrrhizae Radix et Rhizoma\t202 Ginseng Radix\t97 Typhae Pollen\t100 Massa Medicata Fermentata\t100 Glycine Semen Germinatum\t70 Cinnamomi cortex\t70 Paeoniae Radix\t60 Liriopis Tuber\t60 Scutellariae Radix\t60 Angelicae Gigantis Radix\t60 Saposhnikoviae Radix\t60 Atractylodis Rhizoma Alba\t60 Bupleuri Radix\t50 Platycodonis Radix\t50 Armeniacae Semen\t50 Poria Sclerotium\t50 Cnidii Rhizoma\t50 Civet\t15 Antelopis Cornu\t35 Borneolum*\t41 Ampelopsis Radis\t30 Zingiberis Rhizoma\t30 Open in a separate window *Borneolum included 38.58 mg of borneol and isoborneol.</td>
    </tr>
    <tr>
      <th>1849</th>
      <td>sexual dysfunction<br>Transition to menopause<br>cognitive declines<br>mood disorders<br>weight gain<br>night sweats<br>hot flashes<br>sleep disturbances</td>
      <td></td>
      <td>2020; 81:XXX–XXX) Transition to menopause is associated with a period of increased risk for problematic symptoms, including hot flashes, night sweats, sleep disturbances, sexual dysfunction, mood disorders, weight gain, and cognitive declines.</td>
    </tr>
    <tr>
      <th>1352</th>
      <td>Group IV<br>APG</td>
      <td></td>
      <td>on the 7th day, 2 h after APG 40 mg/kg administration, and Group IV was administered with APG 40 mg/kg for 7 days.</td>
    </tr>
    <tr>
      <th>1712</th>
      <td>competitive inhibition<br>mixed-inhibition<br>noncompetitive inhibition</td>
      <td></td>
      <td>The competitive, noncompetitive and mixed‐inhibition models (Equations 1–3, respectively) were considered.</td>
    </tr>
    <tr>
      <th>677</th>
      <td>dizziness</td>
      <td></td>
      <td>Precisely, only 3 participants complained of very light dizziness.</td>
    </tr>
    <tr>
      <th>1615</th>
      <td>recovery<br>precision<br>matrix effect<br>U.S. Food and Drug Administration (USFDA)<br>selectivity<br>bioanalytical method validation<br>accuracy<br>dilution integrity<br>linearity<br>stability</td>
      <td></td>
      <td>The method was fully validated in compliance with the U.S. Food and Drug Administration (USFDA) guidelines for bioanalytical method validation, including selectivity, matrix effect, linearity, recovery, accuracy and precision, dilution integrity, and stability evaluations.</td>
    </tr>
    <tr>
      <th>9</th>
      <td>co-morbidity<br>drugs</td>
      <td></td>
      <td>Due to the absence of co-morbidity, the patient had not received any other drugs during treatment with trabectedin.</td>
    </tr>
    <tr>
      <th>322</th>
      <td>whole blood<br>QIAamp DNA Blood Mini Kit<br>DNA</td>
      <td></td>
      <td>DNA was isolated from the 200 µL of whole blood samples using a QIAamp DNA Blood Mini Kit (Qiagen, Germantown, MD, USA).</td>
    </tr>
    <tr>
      <th>207</th>
      <td>Penicillin-streptomycin<br>Sodium Pyruvate<br>Dulbecco’s Modified Eagle Medium<br>HEPES<br>Trypsin EDTA<br>Minimal Essential Medium<br>Hanks balanced salt solution</td>
      <td></td>
      <td>Dulbecco’s Modified Eagle Medium (DMEM), Minimal Essential Medium (MEM), Hanks balanced salt solution (HBSS), HEPES, Trypsin EDTA, Penicillin-streptomycin, and Sodium Pyruvate were from GIBCO BRL (Invitrogen Corp., Grand Island, NY, USA).</td>
    </tr>
    <tr>
      <th>917</th>
      <td>CYP2C19<br>CYP2D6<br>CYP2C9<br>cytochrome P450 enzymes<br>Korean red ginseng extract<br>CYP1A2<br>CYP3A<br>probe substrates</td>
      <td>cytochrome P450 (CYP) enzymes<br>CYP1A2, 2C9, 2C19, 2D6, 3A</td>
      <td>In case of ginseng interactions, it was reported that no herb–drug interaction between single oral dose of Korean red ginseng extract (RGE) (0.5–2.0 g/kg) and the probe substrates for five cytochrome P450 (CYP) enzymes (i.e., CYP1A2, 2C9, 2C19, 2D6, 3A) in mouse [12].</td>
    </tr>
    <tr>
      <th>345</th>
      <td>Subject baseline characteristics<br>AUC</td>
      <td></td>
      <td>Relationship between the catechin AUC Abbreviations: AUC Subject baseline characteristics at the start of the study Note: Data are presented as mean ± SD for continuous variables and as ratios for categorical variables.</td>
    </tr>
    <tr>
      <th>2016</th>
      <td>co-administration<br>BIO<br>pop-PK model<br>herb<br>pharmacokinetics<br>CYP2C8<br>OS<br>pharmacodynamic evaluation<br>metabolic clearance</td>
      <td></td>
      <td>As shown in Table 1, after co-administration with RS, BIO of OS increased by 62% without change in its absorption rate (k  The developed pop-PK model lets us have an interpretation on the contradictory phenomena that co-administration of RS would increase both the elimination rate and systemic exposure (AUC The pop-PK model could separately estimate the metabolic clearance (CL  A platform including a six-dimension in-vitro screening, an in-vivo pharmacokinetics in rats and an ex-vivo pharmacodynamic evaluation, has been developed and successfully applied to find RS as a potential herb that would influence the co-administrated OS in rats.</td>
    </tr>
    <tr>
      <th>1655</th>
      <td>warfarin<br>Lycium barbarum L.</td>
      <td></td>
      <td>The interaction study of warfarin and Lycium barbarum L.  Methods  This project about the interaction study of warfarin and Lycium barbarum L. is approved by Fujian Medical University Union Hospital ethics committee (NO: 2015KY002).</td>
    </tr>
    <tr>
      <th>961</th>
      <td>glutathione peroxidase (GPx)<br>oxidative stress<br>catalase (CAT)<br>PCOS<br>superoxide dismutase (SOD)<br>malondialdehyde (MDA)</td>
      <td></td>
      <td>Oxidative stress is dramatically increased in PCOS patients, when oxidant/antioxidant status is measured by circulating serum markers, including catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), and malondialdehyde (MDA) [3].</td>
    </tr>
    <tr>
      <th>1269</th>
      <td>cyclosporine A<br>rifampicin</td>
      <td></td>
      <td>Results for the positive controls rifampicin and cyclosporine A were published previously [25].</td>
    </tr>
    <tr>
      <th>1530</th>
      <td>anaesthetized</td>
      <td></td>
      <td>The animals were anaesthetized before blood collection process.</td>
    </tr>
    <tr>
      <th>168</th>
      <td>American College of Obstetrics and Gynecology<br>vasomotor symptoms of menopause<br>black cohosh</td>
      <td></td>
      <td>The American College of Obstetrics and Gynecology included black cohosh as a possible remedy for the vasomotor symptoms of menopause [15].</td>
    </tr>
    <tr>
      <th>1169</th>
      <td>Cochrane Database of Systematic Reviews</td>
      <td></td>
      <td>2012), Cochrane Database of Systematic Reviews (2005–Dec.</td>
    </tr>
    <tr>
      <th>2000</th>
      <td>enzymes<br>cells<br>influenza viruses<br>microsomes</td>
      <td></td>
      <td>In our current study, a screening platform based on microsomes, enzymes, cells and influenza viruses have for the first time been developed and utilized to screen potential interaction between OS and anti-influenza herb/herbal components.</td>
    </tr>
    <tr>
      <th>1548</th>
      <td>Student’s paired t-test</td>
      <td></td>
      <td>Statistical analysis of results obtained from clinical study was performed using Student’s paired t-test.</td>
    </tr>
    <tr>
      <th>1208</th>
      <td>Table 1</td>
      <td></td>
      <td>A summary of the background characteristics of the interviewed patients is given in Table 1.</td>
    </tr>
    <tr>
      <th>1342</th>
      <td>DAS<br>APG</td>
      <td></td>
      <td>The purpose of the current study was to determine whether or not APG has a pharmacokinetic interaction with DAS, and if so, how they would interact.</td>
    </tr>
    <tr>
      <th>1636</th>
      <td>INR<br>patient<br>warfarin<br>attendance of appointments<br>medication</td>
      <td></td>
      <td>The patient was compliant regarding the attendance of appointments and in taking the medication, and maintained a therapeutic INR (1.7–2.5) on a maintenance daily dose of 1.875 mg warfarin with monthly INR monitoring.</td>
    </tr>
    <tr>
      <th>2360</th>
      <td>allicin<br>allyl thiosulfinates<br>allyl<br>sulfur compounds</td>
      <td></td>
      <td>It is composed of a large number of sulfur compounds, with suspected bioactive compounds called allyl thiosulfinates (mainly allicin) [65].</td>
    </tr>
    <tr>
      <th>1490</th>
      <td>hormonal therapy<br>early stage<br>estrogen receptor (ER)<br>metastatic ER-positive breast cancer<br>breast tumors</td>
      <td>estrogen receptor (ER)</td>
      <td>Approximately 70–80% of all breast tumors are estrogen receptor (ER) positive [2], and hormonal therapy plays therefore an important role in the therapy of early stage and metastatic ER-positive breast cancer.</td>
    </tr>
    <tr>
      <th>1194</th>
      <td>Xiao-yao-san<br>dizziness<br>CBZ<br>nausea<br>major depression<br>skin rash<br>bipolar disorder<br>blurred vision</td>
      <td></td>
      <td>In a randomized double-blinded control trial, Xiao-yao-san increased the incidence of CBZ-related side effects including dizziness, blurred vision, skin rash, and nausea in patients with major depression or bipolar disorder.</td>
    </tr>
    <tr>
      <th>1315</th>
      <td>Foster City, CA<br>Analyst software<br>Applied Biosystems</td>
      <td></td>
      <td>The analytical data were processed using Analyst software (version 1.4, Applied Biosystems, Foster City, CA).</td>
    </tr>
    <tr>
      <th>1833</th>
      <td>Tetracarpidium conophorum<br>Musa sapientum<br>Allium sativum</td>
      <td>CYP isoenzymes</td>
      <td>Three of the plants studied did not exhibit inhibitory potential on any of the eight major human CYP isoenzymes used even at the highest dose of the extract, that is, aqueous extracts of Musa sapientum unripe fruits, Tetracarpidium conophorum seeds, and Allium sativum bulbs.</td>
    </tr>
    <tr>
      <th>1892</th>
      <td>CYP2C8</td>
      <td></td>
      <td>Case Report: Fatigue and Bleeding in a Polymedicated Patient Using Several Herbal Supplementations, Detected with g-Nomic® Software Abel Saldarreaga Marin, 1 Marc Cendros, 2 Carlos J Ciudad, 3 and Ana Sabater 2 Author information Article notes Copyright and License information PMC Disclaimer Go to: Abstract  This was a case report of severe fatigue and bleeding in a 65-year-old man with ischemic heart disease who was wearing a stent and taking multiple medications for hypertension and diabetes.</td>
    </tr>
    <tr>
      <th>11</th>
      <td>ancillary medications<br>narrow therapeutic index<br>oncology practice<br>cancer patients<br>combinations<br>chemotherapeutic drugs<br>prolonged life expectancy</td>
      <td></td>
      <td>As known, cancer patients are likely to experience drug interactions due to the increased number and types of chemotherapeutic drugs, their combinations in oncology practice and their narrow therapeutic index, the achievement of a prolonged life expectancy, and the common use of a broad range of ancillary medications to prevent and/or treat cancer-related syndromes and treatment-induced toxicity [8].</td>
    </tr>
    <tr>
      <th>1112</th>
      <td>CYP2C9<br>echinacea</td>
      <td></td>
      <td>However, an in vivo study indicated that echinacea did not significantly affect the metabolism of drugs metabolized by CYP2C9 [47].</td>
    </tr>
    <tr>
      <th>741</th>
      <td>radiotherapy<br>temozolomide<br>Karnofsky performance status scale<br>neurological deficiencies</td>
      <td></td>
      <td>The patient had a Karnofsky performance status scale of 90% after resection without neurological deficiencies and was referred to our department for further treatment with radiotherapy and temozolomide (TEM).</td>
    </tr>
    <tr>
      <th>1305</th>
      <td>woohwangcheongsimwon suspension<br>bupropion</td>
      <td></td>
      <td>Drug interactions may occur between woohwangcheongsimwon suspension and bupropion.</td>
    </tr>
    <tr>
      <th>2316</th>
      <td>cannabis preparations</td>
      <td></td>
      <td>Cannabis preparations are emerging as a promising option for co-treatment of inflammatory diseases.</td>
    </tr>
    <tr>
      <th>1743</th>
      <td>VKOR<br>Gegen<br>Danshen<br>TM</td>
      <td>VKOR<br>TM</td>
      <td>We also monitored the effects of Danshen/Gegen on the activities and mRNA and protein expression levels of VKOR and TM (for pharmacodynamic analysis).</td>
    </tr>
    <tr>
      <th>1709</th>
      <td>FRE<br>GRT</td>
      <td></td>
      <td>Go to: 2.</td>
    </tr>
    <tr>
      <th>80</th>
      <td>traditional hypoglycemic herbs<br>rs1142345</td>
      <td></td>
      <td>Therefore, rs1142345 was associated with the clinical effect of traditional hypoglycemic herbs.</td>
    </tr>
    <tr>
      <th>481</th>
      <td>centelloid<br>CAW-R61J</td>
      <td></td>
      <td>Based on the centelloid content of CAW-R61J, we expect similar plasma concentrations for these compounds in our clinical studies using this extract.</td>
    </tr>
    <tr>
      <th>171</th>
      <td>liver</td>
      <td></td>
      <td>This case culminated in liver failure despite discontinuation of the herbal supplement [4].</td>
    </tr>
    <tr>
      <th>2240</th>
      <td>SJW<br>serotonergic effects</td>
      <td></td>
      <td>Apart from CYP/P-gp induction, SJW mediates interactions through its serotonergic effects.</td>
    </tr>
    <tr>
      <th>1669</th>
      <td>HDL-C<br>total cholesterol<br>cholesterol<br>triglycerides<br>cholesterol RCT interventions<br>LDL-C</td>
      <td></td>
      <td>Table 5  Cholesterol RCT interventions and effects of cholesterol RCT interventions on total cholesterol, HDL-C, LDL-C, and triglycerides.</td>
    </tr>
    <tr>
      <th>1938</th>
      <td>liquor<br>type 1 Whatman filter paper</td>
      <td></td>
      <td>The resulting liquor was suction-filtered through type 1 Whatman filter paper and stored in a sealed darkened glass container.</td>
    </tr>
    <tr>
      <th>82</th>
      <td>extensive metabolizer<br>AUC<br>concentration-time curve<br>poor metabolizer</td>
      <td></td>
      <td>AUC: concentration-time curve; EMs: extensive metabolizer; PM: poor metabolizer.</td>
    </tr>
    <tr>
      <th>1704</th>
      <td>physiologically‐based pharmacokinetic (PBPK)<br>herb–drug interactions<br>modelling and simulation<br>drug metabolism</td>
      <td></td>
      <td>Keywords: drug metabolism, herb–drug interactions, modelling and simulation, physiologically‐based pharmacokinetic (PBPK) What is already known about this subject      Physiologically‐based pharmacokinetic (PBPK) modelling approaches combined with in vitro to in vivo extrapolation techniques have been extensively used for predicting clinically meaningful pharmacokinetic drug interactions.</td>
    </tr>
    <tr>
      <th>2372</th>
      <td>systems biology<br>herbal interventions<br>chemical and pharmacological data<br>system-to-system methodology</td>
      <td></td>
      <td>System-to-system or systems biology methodology is a more appropriate model for the evaluation of more complex interactions but its use is often limited by the availability of the relevant chemical and pharmacological data, especially in complex herbal interventions.</td>
    </tr>
    <tr>
      <th>1048</th>
      <td>CD4+ T-cell</td>
      <td></td>
      <td>The median CD4+ T-cell count was 498 (range, 244 to 962) cells/mm3.</td>
    </tr>
    <tr>
      <th>1360</th>
      <td>Research Ethics Committee of King Saud University College of Pharmacy Riyadh<br>KSU-SE-21-58</td>
      <td></td>
      <td>The research was approved by the Research Ethics Committee of King Saud University College of Pharmacy Riyadh, Saudi Arabia (KSU-SE-21-58).</td>
    </tr>
    <tr>
      <th>1576</th>
      <td>Eugenia jambolana</td>
      <td></td>
      <td>Dried seed of Eugenia jambolana were powdered and used for preparation of aqueous extract by using the double maceration technique.</td>
    </tr>
    <tr>
      <th>2104</th>
      <td>K Tissue distribution profiles<br>tissue distribution coefficients<br>CIP<br>PCE<br>tissue to plasma distribution coefficients</td>
      <td></td>
      <td>PCE significantly increased the tissue to plasma distribution coefficients (K  Tissue distribution profiles of ciprofloxacin (CIP) after intravenous administration of CIP in the absence (A) and presence (B) of PCE to rats, as well as the tissue to plasma distribution coefficients [K  The tissue distribution curves of GA in normal rats after intragastric administration of PCE in the absence and presence of CIP are displayed in Figures 7A,B, respectively.</td>
    </tr>
    <tr>
      <th>1574</th>
      <td>concomitant treatments<br>diabetic patient</td>
      <td></td>
      <td>The present work was carried out to check the safety and efficacy of one of the probable concomitant treatments that a diabetic patient is likely to undertake during the course of his treatment.</td>
    </tr>
    <tr>
      <th>390</th>
      <td>half-life<br>t Experimental values</td>
      <td></td>
      <td>The half-life (t Experimental values are expressed as mean ± SD.</td>
    </tr>
    <tr>
      <th>1915</th>
      <td>herb-drug use<br>oncology and urology clinics<br>awareness<br>Kingston<br>cancer patients<br>health care professionals<br>Jamaican prescription drug users<br>University Hospital of the West Indies</td>
      <td></td>
      <td>A survey of cancer patients attending the oncology and urology clinics at the University Hospital of the West Indies in Kingston, and two earlier surveys of Jamaican prescription drug users identified high levels of herb-drug use (80% [4] 80% [5] and 81% [6], respectively), while awareness of such herb-drug use amongst health care professionals was low across all four surveys (13% [5], 15% [4], 18% [6] and 19% [3], respectively).</td>
    </tr>
    <tr>
      <th>2088</th>
      <td>GA<br>PCA</td>
      <td></td>
      <td>Consequently, GA and PCA were chosen as PCE tracer components in the pharmacokinetic- and tissue distribution-based HDIs studies.</td>
    </tr>
    <tr>
      <th>1583</th>
      <td>SITA<br>PRM</td>
      <td></td>
      <td>Mass chromatograms of SITA and PRM (Peak for SITA at 0.642min, PRM at 0.482 min).</td>
    </tr>
    <tr>
      <th>523</th>
      <td>analytical process<br>QC sample<br>standard curve sample<br>FDA<br>ICH<br>accuracy<br>Guideline of Bioanalytical method validation<br>analytical instrument<br>EMA<br>CYP2C8<br>biological sample</td>
      <td></td>
      <td>Owing to slight variations in the analytical process (e.g., changes in recovery during preparation of a biological sample and variability in the performance of the analytical instrument), there may be cases where the response of a QC sample is higher than that of a standard curve sample, but the inter- and intra-day accuracy in Table 2 were within the acceptance criteria for accuracy (i.e., 85~115%) according to the Guideline of Bioanalytical method validation from FDA, EMA, and ICH [37].</td>
    </tr>
    <tr>
      <th>2352</th>
      <td>MDPI</td>
      <td></td>
      <td>Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</td>
    </tr>
    <tr>
      <th>126</th>
      <td>Oat3<br>Oat1</td>
      <td></td>
      <td>Further, unique substrates that interact with Oat1, but not with Oat3 (and vice-versa) have been identified [7].</td>
    </tr>
    <tr>
      <th>1517</th>
      <td>quinidine<br>CYP2D6</td>
      <td>CYP2D6</td>
      <td>Dextromethorphan in vitro inhibition profiles of CYP2D6 by reference inhibitor: Quinidine (0.1-1-2-5-10-100 μM).</td>
    </tr>
    <tr>
      <th>879</th>
      <td>causal relationship with the test substance<br>date of onset and disappearance<br>adverse reactions<br>treatment of adverse reactions<br>measures taken in relation to the test substance<br>name of the drug other than the test substance<br>degree and result of adverse reaction</td>
      <td></td>
      <td>During the investigation of adverse reactions, the date of onset and disappearance, the degree and result of the adverse reaction, the measures are taken in relation to the test substance and the causal relationship with the test substance, the name of the drug other than the test substance, and treatment of adverse reactions were included.</td>
    </tr>
    <tr>
      <th>832</th>
      <td>myocardial biopsy<br>LBA<br>detection of autoimmune diseases<br>studies of imaging<br>cardiac catheterization</td>
      <td></td>
      <td>Uma investigação ampla foi realizada, incluindo LBA, estudos de imagem, detecção de doenças autoimunes, cateterismo cardíaco direito e biópsia miocárdica.</td>
    </tr>
    <tr>
      <th>484</th>
      <td>phase II drug-metabolizing enzymes<br>CA derivatives</td>
      <td></td>
      <td>It will also be important to examine possible interactions of CA derivatives with phase II drug-metabolizing enzymes.</td>
    </tr>
    <tr>
      <th>906</th>
      <td>glucuronidation<br>serotonin<br>UGT1A6</td>
      <td>UGT1A6</td>
      <td>For example, 120-fold variability of UGT1A6 expression in human liver might result in 13-fold variablity in serotonin glucuronidation [24].</td>
    </tr>
    <tr>
      <th>974</th>
      <td>polymethoxylated flavonoids (PMF)<br>hesperidin<br>terpenoids (limonene and linalool)<br>cytoprotective effects<br>Citrus Sinensis<br>OS<br>Rutaceae</td>
      <td></td>
      <td>Citrus Sinensis (L.) Osbeck from Rutaceae family mainly contains hesperidin, polymethoxylated flavonoids (PMF), and terpenoids (limonene and linalool), and these phenolic bioactive compounds indicate considerable cytoprotective effects against OS [18].</td>
    </tr>
    <tr>
      <th>1600</th>
      <td>indomethacin<br>A. officinarum</td>
      <td></td>
      <td>Our results first clarified that oral administration of A. officinarum produced significant alterations in the pharmacokinetic parameters of indomethacin.</td>
    </tr>
    <tr>
      <th>1245</th>
      <td>cytochrome P450 enzymes<br>drug transporters</td>
      <td>cytochrome P450 enzymes (CYPs)</td>
      <td>Inhibition of cytochrome P450 enzymes (CYPs) was quantified by commercial kits and inhibition of drug transporters by use of fluorescent probe substrates.</td>
    </tr>
    <tr>
      <th>1940</th>
      <td>chromatographic methods</td>
      <td></td>
      <td>The following chromatographic methods were employed.</td>
    </tr>
    <tr>
      <th>1239</th>
      <td>conceived<br>experiments<br>designed</td>
      <td></td>
      <td>conceived and designed the whole experiments.</td>
    </tr>
    <tr>
      <th>393</th>
      <td>plasma samples<br>rats<br>selectivity</td>
      <td></td>
      <td>In the present study, the selectivity was examined using independent plasma samples from six different rats.</td>
    </tr>
    <tr>
      <th>2223</th>
      <td>ginseng<br>phytochemicals<br>CYP3A4<br>midazolam</td>
      <td>CYP3A4</td>
      <td>The inhibitory and inductive effect of the different phytochemicals in ginseng on CYP3A4 is demonstrated through the observed changes in the AUC and other pharmacokinetic parameters of midazolam in these human studies [27, 88].</td>
    </tr>
    <tr>
      <th>1278</th>
      <td>T. Rützert<br>P388/dx<br>HEK-OATP1B3<br>D. Ballinari<br>Z. Dvorak<br>HEK-OATP1B1<br>D. Theile<br>A. Fautsch<br>S. Rosenzweig<br>C. Mueller<br>MDCKII-BCRP<br>P388<br>D. Keppler<br>A. H. Schinkel<br>J. Kocher</td>
      <td></td>
      <td>Thanks to J. Kocher, S. Rosenzweig, C. Mueller, A. Fautsch, and T. Rützert for excellent technical assistance, to D. Ballinari (Pharmacia & Upjohn, Milano, Italy) for providing P388 and P388/dx cells, to A. H. Schinkel (The Netherlands Cancer Institute, Amsterdam, The Netherlands) for providing MDCKII-BCRP cells, to D. Keppler (German Cancer Research Centre, Heidelberg, Germany) for providing HEK-OATP1B1 and HEK-OATP1B3 cell lines, to Z. Dvorak (Palycký University, Olomouc, Czech Republic) for providing the AZ-AhR cells, and to D. Theile for careful proofreading of the manuscript.</td>
    </tr>
    <tr>
      <th>818</th>
      <td>valerian</td>
      <td></td>
      <td>In summary, it can be concluded that warnings regarding a specific risk of interactions of valerian are without any recent evidence.</td>
    </tr>
    <tr>
      <th>696</th>
      <td>PR interval<br>corrected QT interval (QTc)<br>QRS duration</td>
      <td></td>
      <td>On serial electrocardiograms the PR interval, QRS duration and corrected QT interval (QTc) were similar in both arms (S2 Table).</td>
    </tr>
    <tr>
      <th>1748</th>
      <td>The Plant List<br>diclofenac sodium<br>naringin<br>Racemic warfarin</td>
      <td></td>
      <td>The plant names in current study were used according to the latest revision in “The Plant List” ( Racemic warfarin, diclofenac sodium and naringin (internal standards) were purchased from Sigma-Aldrich (St. Louis, MO, USA).</td>
    </tr>
    <tr>
      <th>686</th>
      <td>PLOS ONE policies</td>
      <td></td>
      <td>This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.</td>
    </tr>
    <tr>
      <th>1359</th>
      <td>authors</td>
      <td></td>
      <td>All authors have read and agreed to the published version of the manuscript.</td>
    </tr>
    <tr>
      <th>1275</th>
      <td>data</td>
      <td></td>
      <td>Data were evaluated as described previously [28].</td>
    </tr>
    <tr>
      <th>1381</th>
      <td>muscle strength<br>SC extract</td>
      <td></td>
      <td>Our first hypothesis is that the supplementation of SC extract in humans can increase muscle strength.</td>
    </tr>
    <tr>
      <th>104</th>
      <td>HDI<br>DDI studies<br>herbal medicinal remedies</td>
      <td></td>
      <td>With the tremendous surge in the acceptance of and public interest in herbal medicinal remedies, researchers are adopting the guidelines and opinions proposed for DDI studies to study HDI.</td>
    </tr>
    <tr>
      <th>1050</th>
      <td>Darunavir</td>
      <td></td>
      <td>Darunavir pharmacokinetics.</td>
    </tr>
    <tr>
      <th>1577</th>
      <td>filtrate<br>extract</td>
      <td></td>
      <td>After seven days, the extract was filtered and the filtrate was stored in refrigerator until next processing.</td>
    </tr>
    <tr>
      <th>1058</th>
      <td>antiretroviral agents<br>clinical pharmacokinetic interactions<br>botanicals</td>
      <td></td>
      <td>In spite of this, studies of clinical pharmacokinetic interactions between antiretroviral agents and botanicals are scarce in the literature.</td>
    </tr>
    <tr>
      <th>2288</th>
      <td>sildenafil<br>Epimedium sagittatum</td>
      <td></td>
      <td>The AUC data showed statistically significant differences between group 1 and 2 and between groups 2 and 3 possibly suggest the herb-drug interaction between Epimedium sagittatum extract and sildenafil.</td>
    </tr>
    <tr>
      <th>1954</th>
      <td>pharmacokinetic data<br>area under the plasma concentration-time curve<br>curcumin<br>area under the first moment of plasma drug concentration-time curve</td>
      <td></td>
      <td>The pharmacokinetic data revealed that curcumin-treated animals had significantly (p ≤ 0.05) higher area under the plasma concentration-time curve and area under the first moment of plasma drug concentration-time curve.</td>
    </tr>
    <tr>
      <th>2135</th>
      <td>exercise time<br>Total Energy Expenditure<br>PLC<br>YM</td>
      <td></td>
      <td>Total Energy Expenditure (TEE) was neither significantly affected by the treatment (YM vs. PLC) nor the exercise time (Figure 3).</td>
    </tr>
    <tr>
      <th>1820</th>
      <td>Merck<br>HPLC-grade acetonitrile<br>Acetic acid</td>
      <td></td>
      <td>Acetic acid and HPLC‐grade acetonitrile were purchased from Merck (LiChrosolv GG, Darmstadt, Germany).</td>
    </tr>
    <tr>
      <th>987</th>
      <td>total flavonoids<br>anhydrous sodium sulfate<br>Clevenger type apparatus<br>methanolic extract<br>dark yellow oil<br>hydrodistillation<br>Na Total flavonoids<br>Folin-Ciocalteau reagent</td>
      <td></td>
      <td>One mL of methanolic extract (5 mg/mL in acetone-water solution) was mixed with 200 µL of Folin-Ciocalteau reagent and 1 mL of 2% Na Total flavonoids were determined using the AlCl The herbal mixture powder (120 g) was exposed to hydrodistillation using a Clevenger type apparatus for about 4 h. Then, the obtained dark yellow oil was dried over anhydrous sodium sulfate, measured, and stored in a dark glass at 4 °C for further analyses.</td>
    </tr>
    <tr>
      <th>405</th>
      <td>TCM formulations<br>digoxin</td>
      <td></td>
      <td>Based on our analysis of the literature, the mechanism of interaction between TCM formulations and digoxin is as follows: A.</td>
    </tr>
    <tr>
      <th>107</th>
      <td>herbals<br>intermediary metabolites<br>conventional medications</td>
      <td></td>
      <td>The TDI effects of these herbals is felt when patients chronically use them because sufficient intermediary metabolites may be generated and this can be deleterious to consumers concomitantly taking conventional medications, as stated earlier.</td>
    </tr>
    <tr>
      <th>1757</th>
      <td>warfarin<br>plasma concentration<br>DFG-warfarin combination<br>PT time</td>
      <td></td>
      <td>The results of our previous study showed that the administration of a DFG-warfarin combination led to a reduction in the warfarin plasma concentration and PT time of rats [23, 32].</td>
    </tr>
    <tr>
      <th>2095</th>
      <td>CIP<br>GA<br>PCA</td>
      <td></td>
      <td>The supernate was utilized for the quantification of GA, PCA, and CIP.</td>
    </tr>
    <tr>
      <th>1438</th>
      <td>Lingzhi<br>Yunzhi<br>meta-analysis<br>cancer treatment<br>systematic reviews</td>
      <td></td>
      <td>Although systematic reviews and meta-analysis of Lingzhi and Yunzhi as an adjunct for cancer treatment have been performed [8–10], these reviews mostly focused on clinical outcomes with no mechanistic explanations for the potential beneficial or harmful interactions.</td>
    </tr>
    <tr>
      <th>1511</th>
      <td>intermediate metabolizers<br>poor metabolizers<br>extensive metabolizers<br>ultra-rapid metabolizers<br>enzyme phenotypes</td>
      <td></td>
      <td>Based on genotype combinations encoding for varying enzyme phenotypes, patients have been classified as poor, intermediate, extensive, or ultra-rapid metabolizers [32, 33].</td>
    </tr>
    <tr>
      <th>825</th>
      <td>radiological abnormalities<br>LVEF<br>venlafaxine</td>
      <td></td>
      <td>After venlafaxine discontinuation, there was rapid improvement, with regression of the radiological abnormalities and normalization of the LVEF.</td>
    </tr>
    <tr>
      <th>1909</th>
      <td>plasma concentrations<br>Cmax<br>Trough<br>echinacea alkamide tetraene</td>
      <td></td>
      <td>Trough plasma concentrations of the major echinacea alkamide tetraene ranged from 1 to 23 ng ml−1, and the Cmax was found to range from 13 to 65 ng ml−1.</td>
    </tr>
    <tr>
      <th>1116</th>
      <td>studies</td>
      <td></td>
      <td>However, no studies were reported these data.</td>
    </tr>
    <tr>
      <th>2066</th>
      <td>glutathione<br>sGPT<br>TBARS<br>sGOT<br>liver transaminases<br>DDB<br>TAM-intoxicated liver injury<br>antioxidant enzymes</td>
      <td></td>
      <td>DDB is found to alleviate the oxidative stress status of TAM-intoxicated liver injury in rats, with the study reporting a significant increase in antioxidant enzymes, a significant decrease in the activity of sGPT and sGOT, reduction of glutathione concomitant, and a significant reduction of TBARS and liver transaminases (El-Beshbishy, 2005b).</td>
    </tr>
    <tr>
      <th>483</th>
      <td>CAW-R61J compounds<br>P450</td>
      <td>P450</td>
      <td>Ultimately, the clinical relevance of the weak P450 inhibition seen in this study will depend on the IC50 values of the as yet unknown inhibitory CAW-R61J compounds and their in vivo concentration achieved in humans.</td>
    </tr>
    <tr>
      <th>1257</th>
      <td>drug metabolizing enzymes<br>drug transporters<br>Banderol<br>Samento</td>
      <td></td>
      <td>This study, therefore, scrutinized in vitro whether Samento and Banderol can inhibit the activity or induce the expression of important drug metabolizing enzymes and drug transporters.</td>
    </tr>
    <tr>
      <th>2336</th>
      <td>CYP2C9<br>CYP3A4<br>Curcuminoids</td>
      <td>CY3A4 and 2C9</td>
      <td>Curcuminoids have been shown to inhibit CY3A4 and 2C9 in vitro [230].</td>
    </tr>
    <tr>
      <th>1314</th>
      <td>TurboIonSpray</td>
      <td></td>
      <td>The TurboIonSpray interface was operated in positive ion mode at 5500 V and 500°C.</td>
    </tr>
    <tr>
      <th>2331</th>
      <td>HILI</td>
      <td></td>
      <td>HILI could occur more frequently in these groups because of the combination of risk factors.</td>
    </tr>
    <tr>
      <th>253</th>
      <td>FRE<br>GRT</td>
      <td></td>
      <td>2).</td>
    </tr>
    <tr>
      <th>408</th>
      <td>Li Xin</td>
      <td></td>
      <td>Li Xin et al.</td>
    </tr>
    <tr>
      <th>1753</th>
      <td>P-value</td>
      <td></td>
      <td>*P < 0.05; **P < 0.01; ***P < 0.001, compared with the vehicle control group.</td>
    </tr>
    <tr>
      <th>2368</th>
      <td>antidiabetics<br>Lycium</td>
      <td></td>
      <td>Evidence supporting the interaction between Lycium and antidiabetics is experimental only.</td>
    </tr>
    <tr>
      <th>1900</th>
      <td>CYP2C9*2<br>CYP2C9<br>CYP2C9*1<br>CYP2C9*3</td>
      <td>CYP2C9<br>VKORC1<br>CYP2C9*1,*2 and *3 polymorphisms of CYP2C9</td>
      <td>CYP2C9 and VKORC1 genotyping  The CYP2C9*1,*2 and *3 polymorphisms of CYP2C9 were detected by polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP) analysis.</td>
    </tr>
    <tr>
      <th>1726</th>
      <td>Schisandra lignans<br>midazolam<br>tacrolimus<br>PBPK models</td>
      <td></td>
      <td>PBPK simulations were also carried out to evaluate the capability of PBPK models of Schisandra lignans in predicting the extent of interactions with midazolam and tacrolimus with trial designs as detailed in Table 3.</td>
    </tr>
    <tr>
      <th>426</th>
      <td>TCM formulations<br>digoxin</td>
      <td></td>
      <td>Therefore, the interactions between TCM formulations and digoxin are difficult to elucidate, and they are easily ignored by physicians.</td>
    </tr>
    <tr>
      <th>1528</th>
      <td>captopril<br>CYP2C8</td>
      <td></td>
      <td>daily for two weeks at morning and a single captopril dose (4.5 mg/200 g BW; p.o.)</td>
    </tr>
    <tr>
      <th>1609</th>
      <td>rats<br>model group<br>M-AOE group</td>
      <td></td>
      <td>And other experiments were divided into 2 groups: model group and M-AOE group, with six rats in each group.</td>
    </tr>
    <tr>
      <th>1782</th>
      <td>liver cytochrome P450<br>beta-naphthoflavone<br>Zhen Zhang<br>enzyme-linked immunosorbent assay<br>cyclophosphamide<br>vitamin K epoxide reductase<br>Zhu Zu<br>Beikang Ge<br>thrombomodulin<br>phenobarbital<br>vitamin K<br>Danshen–Gegen Formula<br>salvianolic acid B</td>
      <td>thrombomodulin<br>liver cytochrome P450<br>vitamin K<br>vitamin K epoxide reductase</td>
      <td>liver cytochrome P450 vitamin K epoxide reductase vitamin K vitamin K thrombomodulin Danshen–Gegen Formula salvianolic acid B phenobarbital beta-naphthoflavone cyclophosphamide enzyme-linked immunosorbent assay Beikang Ge and Zhen Zhang contributed equally to this work BKG, ZZh and ZZu conceived and designed the study.</td>
    </tr>
    <tr>
      <th>1019</th>
      <td>insulin<br>serotonin receptors<br>pancreatic β cells<br>FBS</td>
      <td>insulin<br>pancreatic β cells<br>serotonin receptors</td>
      <td>demonstrated that ginger could decrease the FBS level by the mechanism of serotonin receptors which activate pancreatic β cells to release insulin [56].</td>
    </tr>
    <tr>
      <th>230</th>
      <td>anti-diabetic<br>obesity<br>rooibos extracts<br>diabetes<br>anti-obesity<br>cardio-protective effects</td>
      <td></td>
      <td>The anti-diabetic [9,10], anti-obesity [11], and cardio-protective effects [12,13,14] of rooibos extracts are of specific relevance given the global increase in the prevalence of diabetes and obesity [15,16,17].</td>
    </tr>
    <tr>
      <th>819</th>
      <td>conflict of interests</td>
      <td></td>
      <td>The authors declare that there is no conflict of interests regarding the publication of this paper.</td>
    </tr>
    <tr>
      <th>2270</th>
      <td>serum creatinine</td>
      <td></td>
      <td>At that time the serum creatinine level was 74.27 µmol/L and was stable.</td>
    </tr>
    <tr>
      <th>41</th>
      <td>levodopa<br>carbidopa</td>
      <td></td>
      <td>The clinical pharmacist recommended dose increases of carbidopa-levodopa to help control his tremors still present early in the morning (Figure 1).</td>
    </tr>
    <tr>
      <th>850</th>
      <td>herb extract complex (RHC)<br>red ginseng</td>
      <td></td>
      <td>This study aims to confirm the safety of red ginseng and herb extract complex (RHC), which are used to relieve menopausal symptoms.</td>
    </tr>
    <tr>
      <th>1793</th>
      <td>analyte<br>human plasma</td>
      <td></td>
      <td>The extraction recovery from human plasma was considered acceptable with a mean recovery of greater than 88% for each analyte.</td>
    </tr>
    <tr>
      <th>894</th>
      <td>RHC<br>large-scale menopausal subjects</td>
      <td></td>
      <td>However, further research is needed on the safety of RHC intake for a long period in large-scale menopausal subjects.</td>
    </tr>
    <tr>
      <th>1533</th>
      <td>captopril</td>
      <td></td>
      <td>The within-run accuracy and precision of captopril analysis ranged from 1.56% to 14.38% (Table 3).</td>
    </tr>
    <tr>
      <th>1761</th>
      <td>Gegen<br>DFG</td>
      <td></td>
      <td>Taken together with the results of the current study, it seems clear that these effects could be attributed to the Gegen present in DFG.</td>
    </tr>
    <tr>
      <th>144</th>
      <td>PCR<br>human genomic DNA</td>
      <td></td>
      <td>Briefly, PCR was performed in a final reaction volume of 50 μl, which included 20 μl 2.5 × HotMasterMix (Eppendorf, Westbury, NY, USA), approximately 250 ng of human genomic DNA and the primer pairs (0.25 μM).</td>
    </tr>
    <tr>
      <th>1034</th>
      <td>darunavir-ritonavir<br>HIV strains<br>darunavir</td>
      <td></td>
      <td>Thus, at the approved dosage of darunavir-ritonavir, darunavir concentrations at the end of the dosing interval remain well above the concentration needed to inhibit replication of HIV strains (20; V. Sekar, S. Spinosa-Guzman, E. Lefebvre, and R. Hoetelmans, presented at the 16th International AIDS Conference, 2006).</td>
    </tr>
    <tr>
      <th>623</th>
      <td>St. John’s wort<br>area-under-the-curve<br>CYP2C8</td>
      <td></td>
      <td>[17] The single-time point phenotypic ratio approach confirmed what other investigators observed with St. John’s wort when more conventional “area-under-the-curve” methods were utilized to determine midazolam clearance.</td>
    </tr>
    <tr>
      <th>629</th>
      <td>anticoagulant therapy</td>
      <td></td>
      <td>[11,12] Such an interaction is particularly relevant to elderly patients on anticoagulant therapy.</td>
    </tr>
    <tr>
      <th>671</th>
      <td>quinine sulphate tablets<br>G. kola<br>heparinised tubes<br>Venous blood samples</td>
      <td></td>
      <td>Sample collection  Venous blood samples (5ml) was collected into heparinised tubes at time zero (just before the administration of quinine sulphate tablets)) and at 1, 2, 3,4, 6, 8, 12, 24, 36 and 48 h after each participant received quinine alone or concurrently with the scheduled dose of G. kola.</td>
    </tr>
    <tr>
      <th>1276</th>
      <td>Banderol<br>Samento</td>
      <td></td>
      <td>IC In conclusion, Samento and Banderol exhibit a completely different in vitro profile as perpetrators in herb–drug interactions.</td>
    </tr>
    <tr>
      <th>373</th>
      <td>liver samples<br>tissue lysis buffer</td>
      <td></td>
      <td>Briefly, total protein was obtained by homogenizing 100 mg of liver samples with equal volume of a tissue lysis buffer.</td>
    </tr>
    <tr>
      <th>699</th>
      <td>P-value<br>LDL<br>HDL</td>
      <td></td>
      <td>Abbreviations: HDL (high density lipoprotein); LDL (low density lipoprotein) *P-value for interaction effect of groups over time.</td>
    </tr>
    <tr>
      <th>1100</th>
      <td>composition<br>extraction and formulation method<br>bioanalytical data</td>
      <td></td>
      <td>Extraction and formulation method, composition, and bioanalytical data regarding the herbal preparations from the included RCTs are summarized Table 2.</td>
    </tr>
    <tr>
      <th>769</th>
      <td>warfarin</td>
      <td></td>
      <td>Pharmacokinetic–pharmacodynamic modelling  The population PKPD parameter estimates for warfarin are presented in the Table 3.</td>
    </tr>
    <tr>
      <th>1376</th>
      <td>SC extract<br>quadriceps muscle strength<br>lactate</td>
      <td></td>
      <td>The purpose of this study was to evaluate the effect of SC extract supplementation on quadriceps muscle strength (QMS) and lactate at rest in adult women.</td>
    </tr>
    <tr>
      <th>128</th>
      <td>transporter families<br>OATs</td>
      <td></td>
      <td>For the most part these latter two transporter families and the OATs have fairly distinct substrate interactions; however, the possibility that they also may contribute to the overall clinical pharmacokinetic profile of Danshen components in vivo needs to be considered until investigated directly.</td>
    </tr>
    <tr>
      <th>760</th>
      <td>CYP2C8</td>
      <td></td>
      <td>The half-life was calculated as ln 2/kel, the apparent clearance (CL/F) as dose/AUC0−∞ and the apparent volume of distribution (V/F) as CL/kel.</td>
    </tr>
    <tr>
      <th>54</th>
      <td>Met/Met<br>COMT</td>
      <td></td>
      <td>Interestingly, the patient’s PGx results (Table 1) reported a genotype for COMT Met/Met, therefore higher levels of dopamine in his synapses would be expected.</td>
    </tr>
    <tr>
      <th>501</th>
      <td>berberine</td>
      <td></td>
      <td>Then, 150 μL acetonitrile containing 1 ng/mL berberine (IS) was added to the reconstituted standard curves.</td>
    </tr>
    <tr>
      <th>1667</th>
      <td>antioxidant activity<br>HS varieties</td>
      <td></td>
      <td>The HS varieties with deeper red calyxes exhibited greater antioxidant activity as compared to lighter red or white varieties [44, 45].</td>
    </tr>
    <tr>
      <th>2131</th>
      <td>scale</td>
      <td></td>
      <td>The scale was anchored at each end with the labels “not at all” (0 mm) and “extremely” (100 mm).</td>
    </tr>
    <tr>
      <th>708</th>
      <td>project number<br>educational status<br>age<br>institutional ethics committee<br>marital status<br>ethics code<br>occupational status<br>patients' demographic information<br>sex<br>university research affairs</td>
      <td></td>
      <td>After obtaining institutional ethics committee approval (project number and ethics code: 294155) from the university research affairs, patients' demographic information (sex, age, educational status, occupational status, and marital status) were collected from patients' hospital records or by direct interviewing of patients and filled in a specially designed form for this study.</td>
    </tr>
    <tr>
      <th>926</th>
      <td>valsartan<br>RGE<br>Rc</td>
      <td></td>
      <td>The results revealed that the repeated administration of RGE and high dose of Rc did not significantly induce herb–drug interactions involving valsartan (Figure 5 and Figure 8).</td>
    </tr>
    <tr>
      <th>2403</th>
      <td>abemaciclib<br>quality of life<br>patients' outcomes<br>adherence<br>diarrhea<br>dose reductions</td>
      <td></td>
      <td>These may favor the occurrence of abemaciclib-related diarrhea, causing dose reductions and poor adherence and eventually negatively influencing patients' outcomes and quality of life.</td>
    </tr>
    <tr>
      <th>2301</th>
      <td>complementary and alternative therapy<br>species<br>geographical area<br>supplement</td>
      <td></td>
      <td>Most surveys on complementary and alternative therapy or supplement use by those patients did not ask for the species used [4,19,29] or were conducted outside of the geographical area of this review [30,31,32], or both [33,34].</td>
    </tr>
    <tr>
      <th>1370</th>
      <td>herb-mediated changes<br>clinical relevance<br>CYP2C8</td>
      <td></td>
      <td>If so, herb-mediated changes in CYP activity may take on greater clinical relevance in this population.</td>
    </tr>
    <tr>
      <th>568</th>
      <td>Hyptis suaveolens<br>Boerhavia diffusa<br>Myrothamnus flabellifolius<br>CYP2B6<br>Launaea taraxacilla</td>
      <td>CYP2B6</td>
      <td>The study showed that Launaea taraxacifolia Hyptis suaveolens, Boerhavia diffusa and Myrothamnus flabellifolius extracts caused a concentration-dependent inhibition in CYP2B6.</td>
    </tr>
    <tr>
      <th>1011</th>
      <td>insulin<br>HOMA-IR<br>FBS</td>
      <td></td>
      <td>Moreover, the binary comparison indicated no significant difference in the FBS level (p = 0.212) in group 2, the insulin level (p = 0.842) in group 3, and the HOMA-IR level (p = 0.403) in group 3 compared to group 1.</td>
    </tr>
    <tr>
      <th>1745</th>
      <td>herbalist<br>thin layer chromatography<br>Chinese Pharmacopoeia 2005</td>
      <td></td>
      <td>The raw herbs were morphologically authenticated by an in-house herbalist and chemically by the thin layer chromatography in accordance with the Chinese Pharmacopoeia 2005 [36].</td>
    </tr>
    <tr>
      <th>1293</th>
      <td>p-value</td>
      <td></td>
      <td>* p < 0.05, ** p < 0.01.</td>
    </tr>
    <tr>
      <th>396</th>
      <td>AC</td>
      <td></td>
      <td>Linearity for AC was obtained over the concentration range of 1–500 ng/mL.</td>
    </tr>
    <tr>
      <th>1086</th>
      <td>warfarin<br>pharmacodynamic (PD)<br>herbal medicines<br>pharmacokinetic (PK)</td>
      <td></td>
      <td>The aim of this study was to systematically review data regarding pharmacokinetic (PK)-pharmacodynamic (PD) parameters from randomized controlled trials relating to interactions between herbal medicines and warfarin.</td>
    </tr>
    <tr>
      <th>1543</th>
      <td>water<br>food<br>laboratory rodent chow<br>Shanghai, China</td>
      <td></td>
      <td>Water and food (laboratory rodent chow, Shanghai, China) were allowed ad libitum.</td>
    </tr>
    <tr>
      <th>1067</th>
      <td>Ginkgo biloba</td>
      <td></td>
      <td>Ginkgo biloba extract is a popular herbal remedy used for a variety of disorders.</td>
    </tr>
    <tr>
      <th>1105</th>
      <td>risk of bias</td>
      <td></td>
      <td>marked circle, Unclear risk of bias; Minus (-) marked circle, High risk of bias.</td>
    </tr>
    <tr>
      <th>464</th>
      <td>Ring et al., 1996<br>Suzuki et al., 2002<br>Thu et al., 2017<br>VandenBrink et al., 2011<br>Emoto et al., 2003<br>Walsky et al., 2006<br>Zhao et al., 2012<br>CYP2C8</td>
      <td></td>
      <td>3; Table 8) in a manner consistent with the literature (Ring et al., 1996; Suzuki et al., 2002; Emoto et al., 2003; Walsky et al., 2006; VandenBrink et al., 2011; Zhao et al., 2012; Thu et al., 2017).</td>
    </tr>
    <tr>
      <th>995</th>
      <td>calibration curve<br>standard<br>1,1′,3,3′-tetramethoxypropane</td>
      <td></td>
      <td>A 1,1′,3,3′-tetramethoxypropane was used to construct the calibration curve as the standard [32] (reference value: 0.54–1.32 pg/mL).</td>
    </tr>
    <tr>
      <th>1064</th>
      <td>EGb 761®<br>CYP enzymes<br>metabolic drug–drug interactions</td>
      <td></td>
      <td>EGb 761® has no relevant effect on the in vivo activity of the major CYP enzymes in humans and therefore has no relevant potential to cause respective metabolic drug–drug interactions.</td>
    </tr>
    <tr>
      <th>1121</th>
      <td>pathologic inhibitors of coagulation<br>disseminated intravascular coagulation (DIC)<br>vitamin K malabsorption<br>super-warfarin exposure<br>warfarin</td>
      <td></td>
      <td>Other diagnostic considerations in a patient presenting with coagulopathy of unknown origin include warfarin or super-warfarin exposure, disseminated intravascular coagulation (DIC), vitamin K malabsorption, and pathologic inhibitors of coagulation (6).</td>
    </tr>
    <tr>
      <th>1675</th>
      <td>hypertensive patients<br>total cholesterol<br>HS</td>
      <td></td>
      <td>One brief 15 day study reported a significant increase in total cholesterol among hypertensive patients administered HS [18].</td>
    </tr>
    <tr>
      <th>1127</th>
      <td>blood pressure<br>pulse<br>oxygen saturation</td>
      <td></td>
      <td>Vital signs (blood pressure, pulse, oxygen saturation) were obtained on every study day.</td>
    </tr>
    <tr>
      <th>1126</th>
      <td>WSU Institutional Review Board</td>
      <td></td>
      <td>The WSU Institutional Review Board reviewed and approved the study protocol and consent form prior to subject enrollment.</td>
    </tr>
    <tr>
      <th>2231</th>
      <td>bromazepam<br>kava</td>
      <td></td>
      <td>A study in 18 health volunteers did not show any clinically relevant interaction between kava and bromazepam [104].</td>
    </tr>
    <tr>
      <th>268</th>
      <td>maximum plasma concentration (Cmax)<br>area under the plasma concentration–time curve from time zero to infinity (AUC0–∞)<br>elimination half-life (t1/2)<br>docetaxel</td>
      <td></td>
      <td>The following pharmacokinetic parameters of docetaxel were calculated: area under the plasma concentration–time curve from time zero to infinity (AUC0–∞), elimination half-life (t1/2) and maximum plasma concentration (Cmax).</td>
    </tr>
    <tr>
      <th>1781</th>
      <td>CYP2C8</td>
      <td></td>
      <td>All of these factors could therefore be considered as potential explanations for the discrepancies observed between the in vitro and in vivo results.</td>
    </tr>
    <tr>
      <th>785</th>
      <td>elderly</td>
      <td></td>
      <td>It therefore was recommended that they should be avoided in the elderly [10, 12].</td>
    </tr>
    <tr>
      <th>1569</th>
      <td>EJE<br>anthocyanins<br>flavonoids<br>Gliptins<br>dipeptidyl peptidase-4 (DDP-4)</td>
      <td>enzyme dipeptidyl peptidase-4 (DDP-4)</td>
      <td>(EJ) are considered to be functional foods owing to their anti-diabetic Several research groups studying the protective and therapeutic effect of EJE and have identified presence of various classes of bioactive constituents like anthocyanins, flavonoids Gliptins are a class of oral anti-diabetic agents which act by competitively antagonizing the enzyme dipeptidyl peptidase-4 (DDP-4).</td>
    </tr>
    <tr>
      <th>2401</th>
      <td>clinical study</td>
      <td></td>
      <td>Therefore, the clinical study was conducted to confirm the in vitro results.</td>
    </tr>
    <tr>
      <th>929</th>
      <td>Rb2<br>tri-glycosylated PPD-type ginsenosides<br>Rb1<br>plasma concentration<br>Rc</td>
      <td></td>
      <td>The plasma concentration was ranged from 7.8 μM to 34.1 μM but unbound fraction of tri-glycosylated PPD-type ginsenosides (Rb1, Rb2, and Rc) was very low (0.1–0.2% in rat plasma, 0.4–0.5% in rat liver; Figure 9B).</td>
    </tr>
    <tr>
      <th>1114</th>
      <td>CYP enzyme activity<br>gingko</td>
      <td></td>
      <td>Another in vivo study reported that gingko induced CYP enzyme activity in a dose-dependent manner, but did not cause hepatic damage [48].</td>
    </tr>
    <tr>
      <th>240</th>
      <td>FRE<br>CYP3A4<br>CYP2C9<br>GRT<br>CYP2C8</td>
      <td>CYP2C9<br>CYP3A4<br>CYP2C8</td>
      <td>GRT and FRE inhibited the reaction rate of CYP2C8, CYP2C9, and CYP3A4 as measured over 30 min (Figure 2a–c).</td>
    </tr>
    <tr>
      <th>255</th>
      <td>statistically significant</td>
      <td></td>
      <td>This result was statistically not significant.</td>
    </tr>
    <tr>
      <th>448</th>
      <td>DMSO</td>
      <td></td>
      <td>DMSO was added to the CAW-R61J dosing solutions to 0.1% (v/v) such that all treatment conditions contained 0.1% DMSO.</td>
    </tr>
    <tr>
      <th>1893</th>
      <td>drug interactions</td>
      <td></td>
      <td>Drug interactions can be considered illnesses by themselves.</td>
    </tr>
    <tr>
      <th>543</th>
      <td>ART<br>quality of life</td>
      <td></td>
      <td>However, attention has now shifted from reduction in mortality to improvement of the quality of life for people taking ART [1,2].</td>
    </tr>
    <tr>
      <th>32</th>
      <td>nicotine dependence<br>spinal stenosis<br>chronic neck pain<br>alcohol dependence<br>mild kidney disease<br>frequent falls<br>chronic back pain<br>chronic shoulder pain<br>vitamin D deficiency</td>
      <td></td>
      <td>In addition to PD, the patient’s past medical history includes spinal stenosis, vitamin D deficiency, frequent falls, a history of nicotine and alcohol dependence, mild kidney disease, and chronic neck, back, and shoulder pain.</td>
    </tr>
    <tr>
      <th>1308</th>
      <td>aqueous suspension<br>Korean Pharmaceutical Codex</td>
      <td></td>
      <td>It has been officially listed in the Korean Pharmaceutical Codex for a long time and an aqueous suspension has recently been developed for convenient administration [1].</td>
    </tr>
    <tr>
      <th>1651</th>
      <td>warfarin<br>prosthetic heart values<br>Gouqizi</td>
      <td></td>
      <td>However, a daily Gouqizi dose of 6 g (dosing recommended by Chinese Pharmacopoeia) for 3 days did not enhance the effects of warfarin in three patients with prosthetic heart values who were concomitantly taking warfarin.</td>
    </tr>
    <tr>
      <th>634</th>
      <td>warfarin<br>CYP2C9<br>ginseng<br>S-warfarin</td>
      <td>CYP2C9</td>
      <td>[62] CYP2C9 is the principal isoform involved in the biotransformation of warfarin (more particularly the active enantiomer, S-warfarin) and the aforementioned reports hint strongly at a ginseng-mediated induction of this enzyme.</td>
    </tr>
    <tr>
      <th>20</th>
      <td>medicinal cannabis</td>
      <td></td>
      <td>This case report highlights the complexity associated with medicinal cannabis and the health risks associated with its use.</td>
    </tr>
    <tr>
      <th>1221</th>
      <td>herbal medicines</td>
      <td></td>
      <td>Healthcare practitioners who are aware of their patients' use of herbal medicines and its identity can more easily monitor them for any possible interactions using available information, such as that presented in Tables 3, 4.</td>
    </tr>
    <tr>
      <th>2305</th>
      <td>USA<br>plants<br>studies<br>Canada</td>
      <td></td>
      <td>Thus, two studies from Canada and the USA were screened to find plants that patients might use.</td>
    </tr>
    <tr>
      <th>1708</th>
      <td>herb–drug interactions</td>
      <td></td>
      <td>21 Clearly, a reliable and systematic approach to predict these herb–drug interactions is needed.</td>
    </tr>
    <tr>
      <th>1391</th>
      <td>SC extract<br>placebo</td>
      <td></td>
      <td>The mean SC extract supplementation and placebo compliance were 97.3% (90.2−100%) in the SC group and 95.8% (86.7–100%) in the placebo group.</td>
    </tr>
    <tr>
      <th>789</th>
      <td>clinical relevance</td>
      <td></td>
      <td>These limitations do not allow valid extrapolations with respect to a clinical relevance of the results.</td>
    </tr>
    <tr>
      <th>227</th>
      <td>CYP3A4<br>CYP2C9<br>thiazolidinediones (TZDs)<br>atorvastatin<br>sulfonylureas<br>Cytochrome P450 enzymes<br>CYP2C8</td>
      <td>Cytochrome P450 enzymes<br>CYP2C9<br>CYP3A4<br>CYP2C8</td>
      <td>Cytochrome P450 enzymes, CYP2C8, CYP2C9, and CYP3A4, are important in the metabolism of hypoglycemic drugs, such as thiazolidinediones (TZDs) and sulfonylureas, and hypocholesterolemic drugs, such as atorvastatin.</td>
    </tr>
    <tr>
      <th>2344</th>
      <td>individual susceptibility</td>
      <td></td>
      <td>The clinical significance of this phenomenon depends on individual susceptibility.</td>
    </tr>
    <tr>
      <th>2399</th>
      <td>activation</td>
      <td></td>
      <td>The activation was highest at 25 μg/ml concentration.</td>
    </tr>
    <tr>
      <th>2293</th>
      <td>Maxim extract</td>
      <td></td>
      <td>Maxim extract are available from the authors.</td>
    </tr>
    <tr>
      <th>2267</th>
      <td>drugs with a narrow therapeutic window</td>
      <td></td>
      <td>This is especially important for drugs with a narrow therapeutic window.</td>
    </tr>
    <tr>
      <th>1133</th>
      <td>SAS<br>terminal elimination rate constant</td>
      <td></td>
      <td>The terminal elimination rate constant (λ All statistical analyses were conducted using SAS (v. 9.2; SAS Institute).</td>
    </tr>
    <tr>
      <th>138</th>
      <td>7α<br>6β<br>7β<br>6α</td>
      <td></td>
      <td>Four of these metabolites (6α, 6β, 7α and 7β positions) have been identified in urine, which represented 1, 20, 6 and 14% of urinary recovered dose 96 h after dose, respectively (Oida et al., 1985).</td>
    </tr>
    <tr>
      <th>1903</th>
      <td>warfarin<br>herbal medicines</td>
      <td></td>
      <td>All subjects completed the study and no adverse events related to either of the herbal medicines or warfarin were reported.</td>
    </tr>
    <tr>
      <th>200</th>
      <td>diabetes<br>efficacy</td>
      <td></td>
      <td>People with diabetes receiving this combination should be closely monitored to evaluate possible signs of reduced efficacy.</td>
    </tr>
    <tr>
      <th>1063</th>
      <td>E. purpurea</td>
      <td></td>
      <td>We found, however, that E. purpurea was well tolerated, with no evident safety issue of concern.</td>
    </tr>
    <tr>
      <th>1243</th>
      <td>pharmacological safety<br>herbal medicines</td>
      <td></td>
      <td>However, there is hardly any data on the pharmacological safety of these two herbal medicines.</td>
    </tr>
    <tr>
      <th>1313</th>
      <td>safety monitoring</td>
      <td></td>
      <td>Safety monitoring was performed throughout the study.</td>
    </tr>
    <tr>
      <th>839</th>
      <td>renais<br>sedimento urinário<br>hepáticos<br>proteínas do complemento</td>
      <td></td>
      <td>Os parâmetros renais e hepáticos, as proteínas do complemento e o sedimento urinário estavam todos normais.</td>
    </tr>
    <tr>
      <th>1719</th>
      <td>log P<br>tissue composition<br>K p</td>
      <td></td>
      <td>Inter‐correlation between tissue composition and log P also had a significant impact on the estimation of K p (tissue‐to‐plasma partition coefficients).</td>
    </tr>
    <tr>
      <th>783</th>
      <td>Valeriana officinalis<br>CYP3A4</td>
      <td>CYP 3A4</td>
      <td>However, they state that warnings that valerian (Valeriana officinalis) may stimulate CYP 3A4.</td>
    </tr>
    <tr>
      <th>142</th>
      <td>polymerase chain reaction-RFLP<br>CYP2C9*3<br>CYP2C9<br>CYP2C9*2</td>
      <td>CYP2C9*3<br>CYP2C9*2</td>
      <td>Detection of the CYP2C9*2 and CYP2C9*3 alleles were carried out using a polymerase chain reaction based restriction fragment length polymorphism (polymerase chain reaction-RFLP) analysis.</td>
    </tr>
    <tr>
      <th>1118</th>
      <td>activated partial thromboplastin time<br>prothrombin time<br>international normalized ratio</td>
      <td></td>
      <td>At the time of admission to ED, she had a prothrombin time (PT) of more than 37 seconds, activated partial thromboplastin time (aPTT) more than 70 seconds, and international normalized ratio (INR) greater than seven.</td>
    </tr>
    <tr>
      <th>2345</th>
      <td>adverse effects<br>plants<br>natural</td>
      <td></td>
      <td>It is important to make patients aware of the fact that plants can cause adverse effects and are not safe in every situation by being “natural”.</td>
    </tr>
    <tr>
      <th>2370</th>
      <td>antidiabetics<br>Lycium</td>
      <td></td>
      <td>Findings such as these suggest that Lycium may have an additive effect when used in combination with conventional antidiabetics [86].</td>
    </tr>
    <tr>
      <th>773</th>
      <td>warfarin<br>cranberry juice</td>
      <td></td>
      <td>(2007) concluded that there were no pharmacodynamic interactions between warfarin and cranberry juice, but they employed a low dose of warfarin (10 mg), which made this end point difficult to assess.</td>
    </tr>
    <tr>
      <th>1612</th>
      <td>bile</td>
      <td></td>
      <td>The bile was collected during 0–1 h, 1–2 h, 2–3 h, 3–4 h, 4–5 h, 5–6 h and 6–7 h after dosing.</td>
    </tr>
    <tr>
      <th>93</th>
      <td>cytochrome P450</td>
      <td>cytochrome P450 (CYP450)</td>
      <td>The cytochrome P450 (CYP450) family of enzymes especially plays an important role in the biotransformation of about 70% of xenobiotics and other endogenous substances [14].</td>
    </tr>
    <tr>
      <th>1390</th>
      <td>plasma samples</td>
      <td></td>
      <td>Plasma samples were obtained by centrifugation and stored at −80 °C.</td>
    </tr>
    <tr>
      <th>704</th>
      <td>Chronic kidney disease</td>
      <td></td>
      <td>Chronic kidney disease (CKD) is a global public health problem with an increasing incidence and a lot of economic burden for treatment.</td>
    </tr>
    <tr>
      <th>1156</th>
      <td>Traditional Chinese medicine<br>other herbs/botanicals<br>food<br>dietary supplements</td>
      <td></td>
      <td>Traditional Chinese medicine accounted for most of the interactions (n = 17), followed by food (n = 10), dietary supplements (n = 3), and other herbs/botanicals (n = 3).</td>
    </tr>
    <tr>
      <th>1165</th>
      <td>healthcare professionals<br>CBZ<br>decision making<br>systematic review</td>
      <td></td>
      <td>In view of all the constraints of the existing literature, a comprehensive systematic review focusing on CBZ and overcoming the mentioned hurdles is warranted for healthcare professionals to make proper decisions.</td>
    </tr>
    <tr>
      <th>1693</th>
      <td>hepatotoxicity<br>kidney function<br>liver function<br>HS</td>
      <td></td>
      <td>Studies demonstrate that HS consumption does not adversely effect liver and kidney function at lower doses, but may be hepatotoxic at extremely high doses.</td>
    </tr>
    <tr>
      <th>1897</th>
      <td>warfarin<br>echinacea<br>policosanol</td>
      <td></td>
      <td>Therefore, two commonly used herbal medicines, echinacea and policosanol were investigated for their potential to interact with warfarin.</td>
    </tr>
    <tr>
      <th>1358</th>
      <td>K.M.A.</td>
      <td></td>
      <td>; supervision, K.M.A.</td>
    </tr>
    <tr>
      <th>1022</th>
      <td>hypolipidemic effects<br>insulin tolerance<br>Polymethoxylated flavones<br>glucose levels<br>C. sinensis</td>
      <td>insulin</td>
      <td>Polymethoxylated flavones (PMFs) of C. sinensis have hypolipidemic effects, resulting in a significant reduction of insulin tolerance and glucose levels [61].</td>
    </tr>
    <tr>
      <th>2342</th>
      <td>ASA<br>MTX</td>
      <td></td>
      <td>With MTX doses between 7.5 and 15 mg weekly, this effect is moderate (AUC +28% with ASA, less for the others), and there is inter-individual variability.</td>
    </tr>
    <tr>
      <th>1542</th>
      <td>Eng et al.</td>
      <td></td>
      <td>2016; Eng et al.</td>
    </tr>
    <tr>
      <th>1732</th>
      <td>anti-cancer activity<br>S. sphenanthera</td>
      <td></td>
      <td>Constituents of S. sphenanthera extract also exhibited anti‐cancer activity, although with evidence strictly limited to in vitro data in different cancer cell lines.</td>
    </tr>
    <tr>
      <th>2251</th>
      <td>echinacea<br>kratom<br>St. John’s wort<br>hydroxycut<br>piperine<br>celery<br>rhodiola<br>moringa<br>valerian<br>terminalia/commiphora ayurvedic mixture<br>ginkgo<br>ginseng<br>kava</td>
      <td></td>
      <td>This review identified 13 herbal products - celery, echinacea, ginkgo, ginseng, hydroxycut, kava, kratom, moringa, piperine, rhodiola, St. John’s wort, terminalia/commiphora ayurvedic mixture and valerian – all of which have shown interactions with specific neuropsychiatric drugs.</td>
    </tr>
    <tr>
      <th>665</th>
      <td>subject<br>quinine sulphate<br>overnight fast<br>600 mg<br>group<br>oral dose</td>
      <td></td>
      <td>In the first phase, after an overnight fast, each subject in the respective groups received a single oral dose of 600 mg quinine sulphate tablets (Maderich Ltd, Surrey, England).</td>
    </tr>
    <tr>
      <th>2409</th>
      <td>fatigue<br>diet<br>loose stools</td>
      <td></td>
      <td>Moreover, the reckless pieces of information about possible effects of diet, such as fatigue and loose stools, elicited confusion in the patient.</td>
    </tr>
    <tr>
      <th>585</th>
      <td>author</td>
      <td></td>
      <td>All authors reviewed the final manuscript.</td>
    </tr>
    <tr>
      <th>1845</th>
      <td>Limca<br>allopathic medicines<br>polyherbal formulation<br>menopause symptoms</td>
      <td></td>
      <td>Ltd., Varanasi, India) is a patented polyherbal formulation developed to manage menopause symptoms that can be taken along with other allopathic medicines.</td>
    </tr>
    <tr>
      <th>1521</th>
      <td>captopril<br>pharmacokinetic interactions<br>H. sabdariffa</td>
      <td></td>
      <td>To our knowledge, there is no available information regarding pharmacokinetic interactions between captopril and H. sabdariffa.</td>
    </tr>
    <tr>
      <th>518</th>
      <td>fimasartan-amide<br>fimasartan<br>chromatograms<br>amlodipine<br>hydrochlorothiazide</td>
      <td></td>
      <td>Figure 2 shows the chromatograms of the blank matrix and those of fimasartan, fimasartan-amide, amlodipine, and hydrochlorothiazide spiked at the LLOQ or rat plasma samples 1 h after oral administration of fimasartan, amlodipine, and hydrochlorothiazide.</td>
    </tr>
    <tr>
      <th>1508</th>
      <td>endoxifen<br>VAEM<br>CYP2C8</td>
      <td></td>
      <td>Significances are given relative to the VAEM untreated values (*p < 0.05, **p < 0.01, ***p < 0.001) VAEM, as well as endoxifen, showed a concentration-dependent inhibition of proliferation (Fig.</td>
    </tr>
    <tr>
      <th>542</th>
      <td>HAART</td>
      <td></td>
      <td>However, there are several challenges associated with the chronic nature of HAART administration.</td>
    </tr>
    <tr>
      <th>1482</th>
      <td>FRE<br>GRT</td>
      <td></td>
      <td>a.</td>
    </tr>
    <tr>
      <th>2310</th>
      <td>hepatotoxic herbs</td>
      <td></td>
      <td>Many potentially hepatotoxic herbs are not studied extensively enough to determine a safe daily dose.</td>
    </tr>
    <tr>
      <th>620</th>
      <td>FRE<br>GRT<br>CYP2C8</td>
      <td></td>
      <td>Table I  Pre- and Postsupplementation Phenotypic Ratios (means, 95% confidence intervals) Phenotypic Ratio (CYP)\tSupplement\tPresupplementation (mean and 95% CI)\tPostsupplementation.</td>
    </tr>
    <tr>
      <th>2063</th>
      <td>Jiawei Xiaoyao San<br>Chinese herbal formula</td>
      <td></td>
      <td>Jiawei Xiaoyao San (JWXYS) is a very common Chinese herbal formula used by the Chinese for thousands of years (Chen et al., 2014).</td>
    </tr>
    <tr>
      <th>1592</th>
      <td>BUN<br>EJE<br>EJE + SITA<br>CYP2C8</td>
      <td></td>
      <td>Treatment with EJE and EJE + SITA significantly (p < 0.001) reduced the elevated levels of BUN (Fig.</td>
    </tr>
    <tr>
      <th>1331</th>
      <td>DAS<br>Pgp/MDR1<br>APG</td>
      <td>MDR1<br>Pgp</td>
      <td>The APG-pretreated rats showed significant inhibition of the Pgp/MDR1 protein, that is 65.38% and 69.90% inhibition, respectively, as compared to DAS alone (p < 0.05).</td>
    </tr>
    <tr>
      <th>1193</th>
      <td>alcohol</td>
      <td></td>
      <td>Caution should also be paid for beverage containing alcohol.</td>
    </tr>
    <tr>
      <th>1354</th>
      <td>electrospray ionization</td>
      <td></td>
      <td>Electrospray ionization was used to ionize samples in a positive direction.</td>
    </tr>
    <tr>
      <th>2309</th>
      <td>Aloe vera</td>
      <td></td>
      <td>A Spanish study reports Aloe vera [37].</td>
    </tr>
    <tr>
      <th>2185</th>
      <td>water<br>food</td>
      <td></td>
      <td>Food and water were supplied ad libitum.</td>
    </tr>
    <tr>
      <th>1961</th>
      <td>antihistamines<br>glucocorticoids<br>rash</td>
      <td></td>
      <td>In our patient, the rash was refractory to glucocorticoids and only resolved once her exposure to the extract ceased, although antihistamines were helpful to reduce pruritis.</td>
    </tr>
    <tr>
      <th>1224</th>
      <td>herbs</td>
      <td></td>
      <td>Herbs have been used for primary health care for thousands of years before the advent of modern medicines.</td>
    </tr>
    <tr>
      <th>1589</th>
      <td>six rats</td>
      <td></td>
      <td>Values expressed as mean ± SEM of six rats.</td>
    </tr>
    <tr>
      <th>1984</th>
      <td>anti-influenza herbs<br>herbal components<br>metabolism<br>absorption<br>P-gp<br>S4</td>
      <td></td>
      <td>S4, the P The above in-vitro experiments suggested that there should be some potential HDI between OS and these anti-influenza herbs/herbal components during absorption and metabolism.</td>
    </tr>
    <tr>
      <th>1216</th>
      <td>pharmacokinetic parameters<br>modulators<br>substrates<br>drug interactions<br>drugs</td>
      <td></td>
      <td>An analysis of the drugs commonly prescribed to patients with diabetes show that most of these are substrates or modulators of known pharmacokinetic parameters commonly implicated in drug interactions.</td>
    </tr>
    <tr>
      <th>1301</th>
      <td>CYP2J2</td>
      <td>CYP2J2 mRNA</td>
      <td>Effect of Samento on CYP2J2 mRNA decay in LS180 cells.</td>
    </tr>
    <tr>
      <th>60</th>
      <td>Katie Meyer</td>
      <td></td>
      <td>The authors want to thank Katie Meyer for her assistance.</td>
    </tr>
    <tr>
      <th>456</th>
      <td>CYP2C8</td>
      <td></td>
      <td>All curve fitting was carried out using Prism 8.0.2 (GraphPad Software, San Diego, CA).</td>
    </tr>
    <tr>
      <th>261</th>
      <td>NCI CTCAE<br>grade 3<br>version 3.0<br>grade 4<br>docetaxel<br>E. purpurea</td>
      <td></td>
      <td>The secondary objective was to assess the effect of E. purpurea supplementation on safety parameters, such as grade 3 and 4 toxicities induced by docetaxel [according to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE, version 3.0)].</td>
    </tr>
    <tr>
      <th>176</th>
      <td>Naranjo</td>
      <td></td>
      <td>Naranjo [8] Causality Scale for Adverse Drug Reactions.</td>
    </tr>
    <tr>
      <th>291</th>
      <td>alkylamides<br>gene reporter assay<br>CYP3A4<br>E. purpurea extracts</td>
      <td>CYP3A4</td>
      <td>In LS180 cells, our group has shown significant induction of CYP3A4 by isolated alkylamides and E. purpurea extracts using a gene reporter assay, which is a reliable method to assess the CYP3A4 induction potential of compounds [23].</td>
    </tr>
    <tr>
      <th>1325</th>
      <td>CYP2B6<br>woohwangcheongsimwon suspension<br>bupropion<br>pharmacokinetics</td>
      <td>CYP2B6</td>
      <td>Go to: Discussion  In this study, we examined the CYP2B6 inhibitory effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion.</td>
    </tr>
    <tr>
      <th>1715</th>
      <td>competitive inhibition<br>noncompetitive inhibition</td>
      <td></td>
      <td>Theoretically, the discrimination between competitive and noncompetitive inhibitions is not critical when concentrations of substrates are much lower than their K m values, which is often the case in the clinical setting.</td>
    </tr>
    <tr>
      <th>267</th>
      <td>plasma</td>
      <td></td>
      <td>Subsequently, plasma was separated and stored at −20°C until analysis.</td>
    </tr>
    <tr>
      <th>1625</th>
      <td>gastric injury<br>metabolites<br>A. officinarum<br>indomethacin<br>pharmacokinetics</td>
      <td></td>
      <td>Therefore, the protective effect of A. officinarum on indomethacin-induced gastric injury might also be through the changes of pharmacokinetics for indomethacin and its metabolites to exert.</td>
    </tr>
    <tr>
      <th>223</th>
      <td>P-gp<br>L. pumila<br>calcein-AM<br>digoxin</td>
      <td>P-gp</td>
      <td>IC Next, we determined the inhibition of P-gp by the extract of L. pumila and the constituents by using the two widely used probes calcein-AM and digoxin (Rautio et al., 2006).</td>
    </tr>
    <tr>
      <th>1399</th>
      <td>herbal medicine<br>anti-depressant effects<br>St. John's wort<br>bioavailability<br>drugs<br>efficacy</td>
      <td></td>
      <td>The first clinically relevant reports of preparations of St. John's wort (SJW), a herbal medicine with anti‐depressant effects, interacting with other drugs, altering their bioavailability and efficacy, were published about 20 years ago.</td>
    </tr>
    <tr>
      <th>630</th>
      <td>platelet activating factor<br>ginkgolides</td>
      <td>platelet activating factor</td>
      <td>This interaction appears attributable to the inhibition of platelet activating factor by various ginkgolides.</td>
    </tr>
    <tr>
      <th>245</th>
      <td>sulfaphenazole<br>CYP3A4<br>quercetin<br>CYP2C9<br>ketoconazole<br>CYP2C8</td>
      <td>CYP2C9<br>CYP3A4<br>CYP2C8</td>
      <td>quercetin (positive CYP2C8 inhibitor), sulfaphenazole (positive CYP2C9 inhibitor), and ketoconazole (positive CYP3A4 inhibitor).</td>
    </tr>
    <tr>
      <th>1106</th>
      <td>CONSORT statements<br>reporting percentage</td>
      <td></td>
      <td>Based on the two CONSORT statements, the reporting percentage for each of the articles ranged from 36.5% to 61.5% and the mean percentage for all articles was 45.6%.</td>
    </tr>
    <tr>
      <th>556</th>
      <td>herbal medicines</td>
      <td></td>
      <td>Although effective in the treatment of some diseases, the mechanisms of action for most herbal medicines remain largely unknown.</td>
    </tr>
    <tr>
      <th>367</th>
      <td>Mrp2<br>MTX<br>red ginseng</td>
      <td>Mrp2</td>
      <td>Therefore, in conclusion, this study showed that the herb–drug interactions between red ginseng and MTX occurred via Mrp2 regulation changes in rats, but clinical significance thereof should be determined with follow-up studies.</td>
    </tr>
    <tr>
      <th>1180</th>
      <td>databases</td>
      <td></td>
      <td>In order to achieve a comprehensive literature search, a total of eleven databases were searched.</td>
    </tr>
    <tr>
      <th>325</th>
      <td>single-nucleotide polymorphisms (SNPs)<br>C1236T<br>G2677A<br>ABCB1<br>G2677T<br>C3435T</td>
      <td></td>
      <td>The identification of genotyping was performed for 4 single-nucleotide polymorphisms (SNPs) in ABCB1, namely C3435T (rs1045642), C1236T (rs1128503), G2677A (rs2032582), and G2677T (rs2032582).</td>
    </tr>
    <tr>
      <th>1005</th>
      <td>group 1<br>herbal mixture<br>group 3<br>CC<br>group 2<br>participants</td>
      <td></td>
      <td>Then, 75 participants were randomly allocated into 3 groups including group 1: CC (n = 25); group 2: herbal mixture (n = 25); and group 3: CC with herbal mixture (n = 25).</td>
    </tr>
    <tr>
      <th>1551</th>
      <td>H.O.<br>T.O.<br>Y.O.<br>S.M.<br>K.S.<br>E.H.<br>R.T.</td>
      <td></td>
      <td>S.M., Y.O., R.T., E.H., T.O., H.O., and K.S.</td>
    </tr>
    <tr>
      <th>2167</th>
      <td>fat-loss outcomes<br>exercise training<br>physically active<br>females<br>BF%<br>YM<br>CYP2C8</td>
      <td></td>
      <td>The BF% data indicated all females who took part were at the lower BF% percentile, indicating that they were physically active, with higher  Although the positive effects of YM on fat-loss outcomes during exercise are found only in single trials, future research could test the longitudinal YM effectiveness, especially when combining regular exercise training with YM treatment.</td>
    </tr>
    <tr>
      <th>1524</th>
      <td>plasma sample<br>ammonia solution<br>plasma<br>2-4-dibromoacetophenone</td>
      <td></td>
      <td>For derivatization of plasma captopril, a plasma sample (180 µL) was first mixed with 20 µL of 520 ppm 2-4-dibromoacetophenone stock solution and 20 µL of 5% ammonia solution, vortexed for 30 seconds, and incubated at room temperature for 30 min.</td>
    </tr>
    <tr>
      <th>1406</th>
      <td>Whitten, Myers, Hawrelak, & Wohlmuth, 2006<br>Soleymani, Bahramsoltani, Rahimi, & Abdollahi, 2017<br>Gurley, Fifer, & Gardner, 2012<br>Chrubasik‐Hausmann, Vlachojannis, & McLachlan, 2019<br>Izzo, 2004<br>Borrelli & Izzo, 2009</td>
      <td></td>
      <td>The most important information has been comprehensively summarized (Borrelli & Izzo, 2009; Chrubasik‐Hausmann, Vlachojannis, & McLachlan, 2019; Gurley, Fifer, & Gardner, 2012; Izzo, 2004; Soleymani, Bahramsoltani, Rahimi, & Abdollahi, 2017; Whitten, Myers, Hawrelak, & Wohlmuth, 2006).</td>
    </tr>
    <tr>
      <th>955</th>
      <td>drug interactions<br>efficacy<br>herbal products<br>safety</td>
      <td></td>
      <td>Therefore, herbal products must be assessed for their efficacy and safety, including their potential for interactions with other drugs [14].</td>
    </tr>
    <tr>
      <th>803</th>
      <td>valerian preparations<br>drugs</td>
      <td></td>
      <td>A possible pharmacodynamic interaction of valerian preparations with other drugs is supported only by two case reports.</td>
    </tr>
    <tr>
      <th>535</th>
      <td>amlodipine<br>hydrochlorothiazide<br>fimasartan<br>CYP2C8</td>
      <td></td>
      <td>We also used the same MRM condition as previously published reports [39,40] and the product ion mass spectra from fimasartan, amlodipine, and hydrochlorothiazide showed different mass fragmentation patterns (Figure 1).</td>
    </tr>
    <tr>
      <th>1373</th>
      <td>botanical supplements<br>elderly<br>prescription medications</td>
      <td></td>
      <td>Concomitant ingestion of botanical supplements with prescription medications, therefore, should be strongly discouraged in the elderly.</td>
    </tr>
    <tr>
      <th>2125</th>
      <td>manufacturer<br>publisher<br>product</td>
      <td></td>
      <td>Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</td>
    </tr>
    <tr>
      <th>1981</th>
      <td>RLM<br>hCE1<br>ten marker components</td>
      <td></td>
      <td>Results from RLM and hCE1 showed a similar trend for the ten marker components (Figs.</td>
    </tr>
    <tr>
      <th>574</th>
      <td>room temperature<br>purified water<br>72 h<br>material<br>solid residue<br>supernatant</td>
      <td></td>
      <td>The material was allowed to extract for 72 h at room temperature during which supernatant was decanted every 24 h and the solid residue reconstituted in the same volume of purified water for the extraction process to be repeated.</td>
    </tr>
    <tr>
      <th>1150</th>
      <td>rabbits<br>gliclazide<br>curcumin<br>normal rats<br>blood glucose</td>
      <td></td>
      <td>However, multiple-dose combination of curcumin with gliclazide produced significantly greater reduction in percent blood glucose reduction at 3-, 4-, 6-, 8-, 10-, and 12-hour intervals after treatment in normal rats and rabbits when compared with gliclazide control.</td>
    </tr>
    <tr>
      <th>534</th>
      <td>fimasartan</td>
      <td></td>
      <td>These results suggest that fimasartan is an attractive candidate for the treatment of hypertension and suggest the increasing use of fimasartan monotherapy and combination therapy.</td>
    </tr>
    <tr>
      <th>2265</th>
      <td>calcineurin inhibitors<br>Sirolimus</td>
      <td></td>
      <td>Sirolimus displays a synergistic action with calcineurin inhibitors and a distinctive mechanism of action from calcineurin inhibitors, which are indispensable immunosuppressive agents in kidney transplantation.</td>
    </tr>
    <tr>
      <th>1697</th>
      <td>electrolyte levels<br>HS extracts</td>
      <td></td>
      <td>In addition, electrolyte levels generally are not effected by ingesting HS extracts despite its diuretic effects.</td>
    </tr>
    <tr>
      <th>755</th>
      <td>International normalized ratio<br>warfarin</td>
      <td></td>
      <td>International normalized ratio  International normalized ratio was measured at each blood sampling time before and after warfarin dosing using a BFT II analyser.</td>
    </tr>
    <tr>
      <th>1204</th>
      <td>healthcare professionals<br>herbal medicines<br>patients</td>
      <td></td>
      <td>In identifying these possible interactions, we have highlighted the need for healthcare professionals to promote a proactive monitoring of patients' use of herbal medicines.</td>
    </tr>
    <tr>
      <th>70</th>
      <td>HDIs</td>
      <td></td>
      <td>To date an increasing number of studies in evaluating HDIs have been reported [11].</td>
    </tr>
    <tr>
      <th>1170</th>
      <td>pharmacokinetic parameters<br>oral bioavailability<br>CBZ<br>honey</td>
      <td></td>
      <td>Although honey was shown to decrease the oral bioavailability of CBZ in rabbits, it had no effect on the pharmacokinetic parameters of CBZ in human [63–65].</td>
    </tr>
    <tr>
      <th>1393</th>
      <td>BMI<br>height<br>weight</td>
      <td></td>
      <td>There were no significant differences between the groups for height, weight, or BMI at baseline (Table 1).</td>
    </tr>
    <tr>
      <th>1774</th>
      <td>CYP2C<br>CYP1A<br>CYP3A</td>
      <td>CYP2C-<br>CYP1A-<br>CYP3A-</td>
      <td>Furthermore, CYP1A-, CYP2C- and CYP3A-inducing agents were found in the ethyl acetate extract, but not in the aqueous extract of Danshen [57].</td>
    </tr>
    <tr>
      <th>1322</th>
      <td>blood pressure<br>heart rate<br>body temperature</td>
      <td></td>
      <td>No clinically significant alterations in blood pressure, heart rate or body temperature were observed.</td>
    </tr>
    <tr>
      <th>1294</th>
      <td>reporter gene assays</td>
      <td></td>
      <td>Results of the reporter gene assays.</td>
    </tr>
    <tr>
      <th>1978</th>
      <td>OS<br>rat plasma</td>
      <td></td>
      <td>The incubation system for rat plasma contains 1 μg/mL of OS and 10% rat plasma since the super-fast reaction rate of 100% rat plasma resulted in no discrimination for nearly all the studied herb/herbal components.</td>
    </tr>
    <tr>
      <th>359</th>
      <td>nuclear receptors<br>P-gp<br>farnesoid X receptor<br>Bsep<br>bile acid receptor<br>pregnane X receptor</td>
      <td>Bsep<br>farnesoid X receptor (FXR, also known as bile acid receptor)<br>P-gp<br>pregnane X receptor (PXR)</td>
      <td>Nuclear receptors, such as farnesoid X receptor (FXR, also known as bile acid receptor) and pregnane X receptor (PXR), are known as major regulators of the expression of Bsep and P-gp, respectively [35].</td>
    </tr>
    <tr>
      <th>849</th>
      <td>financial support</td>
      <td></td>
      <td>Apoio financeiro: Nenhum.</td>
    </tr>
    <tr>
      <th>236</th>
      <td>CYP2C9<br>CYP3A4<br>flavonoids<br>CYP2C8</td>
      <td>CYP2C9<br>CYP3A4<br>CYP2C8</td>
      <td>Flavonoids, common in the diet, are responsible for the modulation of the clinically relevant CYP2C8, CYP2C9, and CYP3A4 enzymes [31].</td>
    </tr>
    <tr>
      <th>1369</th>
      <td>cytochrome P-450</td>
      <td></td>
      <td>Phytochemical-mediated modulation of cytochrome P-450 (CYP) activity may underlie many herb-drug interactions.</td>
    </tr>
    <tr>
      <th>639</th>
      <td>plasma quinine<br>HPLC<br>3-hydroxyquinine</td>
      <td></td>
      <td>Blood samples were collected and analyzed for plasma quinine and its metabolite, (3-hydroxyquinine) using a validated HPLC method.</td>
    </tr>
    <tr>
      <th>2366</th>
      <td>gymnema tea<br>metformin</td>
      <td></td>
      <td>These findings suggest further research in individuals with diabetes is required to determine the effect of the combination of gymnema tea and metformin on blood sugar levels.</td>
    </tr>
    <tr>
      <th>1678</th>
      <td>RCT<br>study design</td>
      <td></td>
      <td>More specifically, most studies did not make clear the type of RCT being conducted and in many cases there were study design problems.</td>
    </tr>
    <tr>
      <th>793</th>
      <td>CYP2E1<br>CYP3A4<br>CYP2D6<br>CYP1A2<br>CYP2C8</td>
      <td></td>
      <td>Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined.</td>
    </tr>
    <tr>
      <th>2120</th>
      <td>Scientific Research Project of Tianjin Municipal Education Commission<br>National Administration of Traditional Chinese Medicine<br>National Science and Technology Major Project of China<br>Youth Qihuang Scholars Support Project</td>
      <td></td>
      <td>The study was funded by the Scientific Research Project of Tianjin Municipal Education Commission (2021ZD017 and 2021ZD030), and the National Science and Technology Major Project of China under Grant number (2018ZX09734-002), Youth Qihuang Scholars Support Project of the National Administration of Traditional Chinese Medicine.</td>
    </tr>
    <tr>
      <th>2317</th>
      <td>CYP2C8</td>
      <td></td>
      <td>This is debated, and there are hints to possible beneficial effects [135].</td>
    </tr>
    <tr>
      <th>805</th>
      <td>delirium<br>MAO-inhibitory properties<br>valerian preparation<br>opioids<br>herbal medicines</td>
      <td>MAO</td>
      <td>Given that none of these herbal medicines has been proven to have MAO-inhibitory properties, while induction of delirium, and a positive drug screening on opioids was reported, the assumption of an involvement of the valerian preparation does not seem to be plausible.</td>
    </tr>
    <tr>
      <th>2297</th>
      <td>analgetic drugs<br>non-pharmacological treatments</td>
      <td></td>
      <td>Though non-pharmacological treatments are the main therapy for these patients, application of analgetic drugs is common, often over years.</td>
    </tr>
    <tr>
      <th>153</th>
      <td>Epstein Barr virus<br>acute cytomegalovirus</td>
      <td></td>
      <td>Serological titers for acute cytomegalovirus (CMV) and Epstein Barr virus (EBV) were negative.</td>
    </tr>
    <tr>
      <th>1972</th>
      <td>PBS<br>dichlorvos</td>
      <td></td>
      <td>The reaction was terminated by adding 5 μL of 8 mg/mL dichlorvos and then mixed with 600 μL PBS.</td>
    </tr>
    <tr>
      <th>811</th>
      <td>metabolism of extract components<br>in vivo bioavailability</td>
      <td></td>
      <td>Especially the open questions of in vivo bioavailability and of the metabolism of extract components relevant for in vitro effects often prevent reliable extrapolations from in vitro to in vivo data.</td>
    </tr>
    <tr>
      <th>2274</th>
      <td>MK</td>
      <td></td>
      <td>Author contributions: MK drafted the initial and final versions of the manuscript.</td>
    </tr>
    <tr>
      <th>272</th>
      <td>Cmax<br>cycle 1<br>AUC0–∞<br>cycle 2<br>t1/2<br>docetaxel<br>E. purpurea</td>
      <td></td>
      <td>Statistical analysis  For each patient, the values of AUC0–∞, t1/2 and Cmax of docetaxel in cycle 1 (before E. purpurea) were compared with values obtained in cycle 2 (after E. purpurea).</td>
    </tr>
    <tr>
      <th>1212</th>
      <td>traditional use<br>diabetes management<br>12 identified plants<br>pharmacological evidence</td>
      <td></td>
      <td>For all of the 12 identified plants, pharmacological evidence validating their traditional use in diabetes management have been published.</td>
    </tr>
    <tr>
      <th>2033</th>
      <td>natural products<br>TAM</td>
      <td></td>
      <td>Conclusion: There is evidence for potential interactions of various natural products with TAM in pre-clinical studies, although the relevant clinical evidence is still lacking.</td>
    </tr>
    <tr>
      <th>44</th>
      <td>pain models<br>inhalation<br>healthy subjects<br>oral<br>routes of administration<br>sources of the product<br>patients</td>
      <td></td>
      <td>Numerous factors can explain discrepancies between study results such as pain models, healthy subjects vs. patients, routes of administration (inhalation vs. oral), and sources of the product [19,20,21].</td>
    </tr>
    <tr>
      <th>972</th>
      <td>insulin<br>blood glucose</td>
      <td></td>
      <td>Furthermore, it decreases insulin and blood glucose markedly [17].</td>
    </tr>
    <tr>
      <th>1880</th>
      <td>MenoAct851<br>placebo</td>
      <td></td>
      <td>The selected volunteers were randomized to placebo (inert substitute for a treatment or intervention) or MenoAct851 formulation (500 mg BID for 14 days in double-blind fashion) groups.</td>
    </tr>
    <tr>
      <th>1108</th>
      <td>warfarin<br>herbal medicines</td>
      <td></td>
      <td>All included studies investigated the PD interactions of warfarin with herbal medicines, but different parameters were used in each study.</td>
    </tr>
    <tr>
      <th>554</th>
      <td>medicinal plants<br>developing countries</td>
      <td></td>
      <td>There is substantial evidence supporting the potential of medicinal plants in combating diseases, especially in developing countries [12,13,14,15].</td>
    </tr>
    <tr>
      <th>428</th>
      <td>herb-drug interactions<br>CYP2C8</td>
      <td></td>
      <td>Many view these medicines as benign because they are of natural origin; however, because their constituents may be metabolized through the same enzymatic pathways as pharmaceutical agents, there is a potential for herb-drug interactions.</td>
    </tr>
    <tr>
      <th>1397</th>
      <td>oxidative metabolism<br>lactate</td>
      <td></td>
      <td>have shown the association between high lactate production and reduced oxidative metabolism [47].</td>
    </tr>
    <tr>
      <th>242</th>
      <td>CYP2C9<br>CYP3A4<br>polyphenols<br>ASP</td>
      <td>CYP2C9<br>CYP3A4</td>
      <td>GRT containing higher levels of polyphenols, in particular ASP (12.78% compared to 0.36%), demonstrated a more potent inhibition of CYP3A4 activity than FRE with IC CYP2C9 plays a role in the oxidation of xenobiotic and endogenous compounds and is responsible for the metabolism of 15%–20% of drugs undergoing phase I metabolism [52,53].</td>
    </tr>
    <tr>
      <th>627</th>
      <td>St. John’s wort</td>
      <td></td>
      <td>[54] Thus, a potential interaction may exist between these agents and St. John’s wort.</td>
    </tr>
    <tr>
      <th>164</th>
      <td>Clinicopathological features</td>
      <td></td>
      <td>The clinicopathological features of Case 1 are illustrated in Tables 1, 2, and 3.</td>
    </tr>
    <tr>
      <th>1349</th>
      <td>DAS<br>Group I<br>Group II</td>
      <td></td>
      <td>Group I and II were orally administered with normal saline for 7 days and Group II was orally administered DAS (25 mg/kg) on the 7th day.</td>
    </tr>
    <tr>
      <th>379</th>
      <td>et al.<br>Bautista</td>
      <td></td>
      <td>2016; Bautista et al.</td>
    </tr>
    <tr>
      <th>2208</th>
      <td>CYP450 family<br>celery<br>phytoestrogens<br>DMEs</td>
      <td>CYP450 family<br>DMEs</td>
      <td>Phytoestrogens and other bioactive components of celery can interact with the DMEs, including those in the CYP450 family.</td>
    </tr>
    <tr>
      <th>2384</th>
      <td>Asafetida</td>
      <td></td>
      <td>Asafetida has been used as a folk medication for various ailments including flatulence, cough, asthma, bronchitis, hysteria, and convulsions (Eigner and Scholz, 1999).</td>
    </tr>
    <tr>
      <th>1896</th>
      <td>PGPM-14-963-g0003</td>
      <td></td>
      <td>Object name is PGPM-14-963-g0003.jpg Figure 3  Drug interactions and drug – lifestyle reported by the personalized prescription software.</td>
    </tr>
    <tr>
      <th>1875</th>
      <td>planning to conceive<br>serum human chorionic gonadotropin<br>breastfeeding<br>pregnant<br>female volunteers</td>
      <td></td>
      <td>Female volunteers were excluded if they were pregnant (positive test for serum human chorionic gonadotropin at screening or check-in), breastfeeding, or planning to conceive a child within 30 days of treatment cessation.</td>
    </tr>
    <tr>
      <th>617</th>
      <td>ultraviolet absorption spectra<br>retention times</td>
      <td></td>
      <td>Peaks were assigned by a comparison of retention times and ultraviolet absorption spectra.</td>
    </tr>
    <tr>
      <th>688</th>
      <td>TCAM<br>ART initiation<br>adults<br>KwaZulu-Natal<br>HIV positive individuals</td>
      <td></td>
      <td>More than 50% of adults in KwaZulu-Natal attending public sector facilities for ART initiation disclose using TCAM [10], and similar levels of TCAM use by HIV positive individuals may occur worldwide [11].</td>
    </tr>
    <tr>
      <th>434</th>
      <td>drug-metabolizing enzymes<br>CAW</td>
      <td></td>
      <td>None of the aforementioned studies investigated the effects on drug-metabolizing enzymes of the type of extract (CAW) used in our preclinical studies and in our current phase I (NCT03929250, NCT03937908) and proposed phase II clinical trials investigating CAW as a botanical drug for cognitive decline.</td>
    </tr>
    <tr>
      <th>902</th>
      <td>Dixon plot<br>competitive inhibition<br>Lineweaver-Burk plot</td>
      <td></td>
      <td>When the intersection is in the second quadrant and vertical axis for Dixon and Lineweaver-Burk plots respectively, the inhibition type is competitive.</td>
    </tr>
    <tr>
      <th>297</th>
      <td>P-gp<br>zosuquidar<br>docetaxel<br>R101933</td>
      <td>P-gp</td>
      <td>For example, the potent P-gp inhibitors R101933 [27, 28] and zosuquidar [29] did not significantly alter plasma levels of docetaxel in cancer patients.</td>
    </tr>
    <tr>
      <th>949</th>
      <td>FRE<br>pharmacokinetic parameters<br>valsartan<br>area under the curve (AUC)<br>GRT<br>CYP2C8</td>
      <td></td>
      <td>AUC: area under the plasma concentration-time curve from 0 to 48 h C Pharmacokinetic parameters of valsartan and Rc following intravenous injection of valsartan at a dose of 1 mg/kg in rats.</td>
    </tr>
    <tr>
      <th>1791</th>
      <td>hormone therapy<br>ginkgo biloba</td>
      <td></td>
      <td>There was no difference in the toxicity profile of hormone therapy with ginkgo biloba use in women with early stage breast cancer.</td>
    </tr>
    <tr>
      <th>1865</th>
      <td>immunologic disease<br>endocrine disease<br>neurologic disease<br>hematologic disease<br>renal disease<br>cardiovascular disease<br>pulmonary disease<br>gastrointestinal disease<br>hepatic disease<br>dermatologic disease</td>
      <td></td>
      <td>Volunteers were excluded if they had any clinically significant history or presence of a cardiovascular, pulmonary, hepatic, renal, hematologic, gastrointestinal, endocrine, immunologic, dermatologic, or neurologic disease/disorder.</td>
    </tr>
    <tr>
      <th>1336</th>
      <td>DAS<br>BCPR/ABCG2<br>APG-pretreated rats</td>
      <td>BCPR<br>ABCG2</td>
      <td>The APG-pretreated rats showed significant inhibition of the BCPR/ABCG2 protein that is (66.77% and 41.06% inhibition, respectively) as compared to DAS only (p < 0.05).</td>
    </tr>
    <tr>
      <th>1889</th>
      <td>simvastatin</td>
      <td></td>
      <td>(B) Plasma obtained from the volunteer received single oral dose of 40 mg simvastatin.</td>
    </tr>
    <tr>
      <th>244</th>
      <td>distilled water</td>
      <td></td>
      <td>Stock solutions (10 mg/mL) were prepared by diluting the extracts and compounds in distilled water.</td>
    </tr>
    <tr>
      <th>1516</th>
      <td>Figure S2</td>
      <td></td>
      <td>(PDF 36 kb) Figure S2.</td>
    </tr>
    <tr>
      <th>886</th>
      <td>characteristics<br>demographic information</td>
      <td></td>
      <td>The examination of demographic information and characteristics before consumption showed no statistically significant difference between the intake groups.</td>
    </tr>
    <tr>
      <th>2376</th>
      <td>synergism<br>adverse reactions<br>drug effects<br>interactions<br>therapeutic benefits</td>
      <td></td>
      <td>Conversely, it is important to keep in mind that these interactions may also present therapeutic benefits as a result of synergism which may lead to enhanced drug effects or reduced adverse reactions.</td>
    </tr>
    <tr>
      <th>1110</th>
      <td>herb-warfarin interaction</td>
      <td></td>
      <td>These relevant case reports indicated a potential herb-warfarin interaction, but it was difficult to identify a causal relationship.</td>
    </tr>
    <tr>
      <th>1232</th>
      <td>liver drug enzymes</td>
      <td></td>
      <td>Liver drug enzymes are the common sites of drug interaction in human.</td>
    </tr>
    <tr>
      <th>490</th>
      <td>chronic kidney disease<br>hypertension<br>fimasartan</td>
      <td></td>
      <td>Based on these clinical outcomes, fimasartan can be recommended for patients with hypertension and chronic kidney disease [4,14].</td>
    </tr>
    <tr>
      <th>1328</th>
      <td>pomegranate<br>grapefruit<br>statins</td>
      <td></td>
      <td>The herbal reaction toward different types of statins is varied so that grapefruit or pomegranate was interacted with only some types of statins, but not with all statin types.</td>
    </tr>
    <tr>
      <th>2100</th>
      <td>CIP<br>GA<br>PCE<br>PCA</td>
      <td></td>
      <td>After co-administration of CIP and PCE, the PK changes of GA and PCA are displayed in Figures 3, 4, respectively.</td>
    </tr>
    <tr>
      <th>2300</th>
      <td>prevalence</td>
      <td></td>
      <td>They found a prevalence of 56.6%.</td>
    </tr>
    <tr>
      <th>595</th>
      <td>GGT<br>AAP</td>
      <td></td>
      <td>Therefore, two simulation scenarios were used to evaluate the magnitude of any interaction, (AAP 1000 mg once daily + GGT 7680 mg once daily) and (AAP 1000 mg × 4 times daily + GGT 7680 mg once daily) in a week.</td>
    </tr>
    <tr>
      <th>96</th>
      <td>K A<br>non-targeted approach<br>linear regression analysis</td>
      <td></td>
      <td>Linear regression analysis of the time course was used to determine the K A non-targeted approach was used in order to provide information about all possible metabolites present in the analysed samples.</td>
    </tr>
    <tr>
      <th>2339</th>
      <td>ASA<br>Willow bark extract<br>platelet aggregation</td>
      <td></td>
      <td>Willow bark extract showed a smaller effect on platelet aggregation in humans than ASA [234].</td>
    </tr>
    <tr>
      <th>365</th>
      <td>MTX<br>red ginseng</td>
      <td></td>
      <td>Therefore, the use of MTX and red ginseng alone or in combination is highly plausible for treatment of rheumatoid arthritis.</td>
    </tr>
    <tr>
      <th>1842</th>
      <td>aqueous extract<br>Allium sativum</td>
      <td></td>
      <td>In this study, aqueous extract of oven‐dried Allium sativum bulbs was used.</td>
    </tr>
    <tr>
      <th>600</th>
      <td>J.-w.C.<br>L.T.N.<br>Q.T.T.<br>H.-y.Y.<br>H.-m.B.</td>
      <td></td>
      <td>; performing modeling, Q.T.T., H.-m.B., L.T.N., J.-w.C., and H.-y.Y.</td>
    </tr>
    <tr>
      <th>844</th>
      <td>exclusão de outras possíveis causas<br>investigação exaustiva<br>hígida<br>35 anos de idade<br>paciente</td>
      <td></td>
      <td>O caso ocorreu em uma paciente previamente hígida de 35 anos de idade que foi submetida a investigação exaustiva após a exclusão de outras possíveis causas.</td>
    </tr>
    <tr>
      <th>157</th>
      <td>plasma cell rich interface hepatitis<br>portal tracts<br>periportal hepatocyte apoptosis<br>cholangiolar proliferation<br>histology<br>chronic hepatitis<br>liver</td>
      <td></td>
      <td>At this time, the liver histology demonstrated chronic hepatitis with fibroinflammatory expansion of portal tracts by moderate plasma cell rich interface hepatitis, rare periportal hepatocyte apoptosis, and mild cholangiolar proliferation (Figures 1(a) and 1(b)).</td>
    </tr>
    <tr>
      <th>2242</th>
      <td>SJW<br>CYP3A4<br>midazolam</td>
      <td>CYP3A4</td>
      <td>investigated the ability of SJW to interact with CYP3A4 in a 2-way, open-label crossover study of 21 healthy subjects using midazolam as the probe substrate.</td>
    </tr>
    <tr>
      <th>1477</th>
      <td>Yunzhi<br>cytotoxic and tumor-infiltrating lymphocytes<br>suppressor T cells<br>lipid peroxide levels<br>superoxide dismutase (SOD)</td>
      <td></td>
      <td>Yunzhi could also enhance the cytotoxicity of anticancer drugs via other mechanisms, such as direct increase in the activity of cytotoxic and tumor-infiltrating lymphocytes, decrease in the activity of suppressor T cells [38, 70], and decrease and increase in superoxide dismutase (SOD) and lipid peroxide levels, respectively, in cancer cells [131].</td>
    </tr>
    <tr>
      <th>2233</th>
      <td>circulation<br>diabetes<br>Kratom<br>diarrhea<br>concentration<br>alertness<br>libido</td>
      <td></td>
      <td>Kratom is also used as complementary medicine to manage diabetes, diarrhea, improve circulation, enhance alertness and concentration, and increase libido [111-114].</td>
    </tr>
    <tr>
      <th>300</th>
      <td>advanced cancer<br>tumour progression</td>
      <td></td>
      <td>Considering the risk of tumour progression, randomization was not in the interest of patients with advanced cancer.</td>
    </tr>
    <tr>
      <th>899</th>
      <td>nonspecific substrates<br>UGT<br>compounds</td>
      <td>UGTs<br>UGT isoforms</td>
      <td>Therefore, evaluation of inhibition of compounds towards UGT isoforms was always carried out using recombinant UGTs and nonspecific substrates [19,20,21].</td>
    </tr>
    <tr>
      <th>1103</th>
      <td>attrition<br>trials</td>
      <td></td>
      <td>For incomplete outcome data, seven trials [21–24, 26, 28, 29] reported detailed information regarding attrition by describing the number and reasons for withdrawal.</td>
    </tr>
    <tr>
      <th>1590</th>
      <td>diabetic control group<br>normal group</td>
      <td></td>
      <td>*significantly different from normal group, # significantly different from diabetic control group at p < 0.001.</td>
    </tr>
    <tr>
      <th>1138</th>
      <td>intestinal<br>glucuronidation<br>silibinin–raloxifene interaction<br>Silibinin</td>
      <td></td>
      <td>Silibinin was selected as a model herbal product perpetrator based on well‐characterized composition, availability of human pharmacokinetic data, and in vitro inhibitory potency (K Because standard approaches to evaluate herb–drug interactions mediated via inhibition of intestinal glucuronidation in humans have not been described, two different modeling platforms were used to predict the likelihood and magnitude of the silibinin–raloxifene interaction.</td>
    </tr>
    <tr>
      <th>1209</th>
      <td>age group<br>type-2 diabetes</td>
      <td></td>
      <td>This is possibly because the highest number of patients with type-2 diabetes fell within that age group.</td>
    </tr>
    <tr>
      <th>172</th>
      <td>immune mechanism<br>autoimmune response<br>host cellular protein<br>hapten</td>
      <td></td>
      <td>The immune mechanism is precipitated by a drug or a metabolite acting as a hapten covalently binding to host cellular protein, converting into an immunogen [24] and thereby eliciting an autoimmune response.</td>
    </tr>
    <tr>
      <th>1927</th>
      <td>phytochemicals<br>CYP1A2</td>
      <td>CYP1A2</td>
      <td>Key phytochemicals were individually assessed for their impact on CYP1A2 activity.</td>
    </tr>
    <tr>
      <th>2326</th>
      <td>ginseng</td>
      <td></td>
      <td>The term “ginseng” can be used for several drugs.</td>
    </tr>
    <tr>
      <th>88</th>
      <td>Sasanemasa<br>Akoko<br>Lifui<br>Faangum<br>Sesemasa</td>
      <td></td>
      <td>Local names for this shrub include Faangum in Cameroon, Sasanemasa/Sesemasa or Esisimansa in Ghana, Lifui in Togo, and Akoko in Nigeria.</td>
    </tr>
    <tr>
      <th>1914</th>
      <td>discrepancy</td>
      <td></td>
      <td>The reason for the discrepancy with previous studies remains unclear.</td>
    </tr>
    <tr>
      <th>757</th>
      <td>standard human plasma<br>known factor activity<br>clotting time</td>
      <td></td>
      <td>Percentage factor activity for each sample was obtained from a standard curve constructed using different dilutions of standard human plasma of known factor activity and clotting time.</td>
    </tr>
    <tr>
      <th>185</th>
      <td>in vivo distribution studies<br>pharmacokinetic features</td>
      <td></td>
      <td>In vivo distribution studies are crucial in drug research as they can be performed to demonstrate the pharmacokinetic features of a drug [21, 22].</td>
    </tr>
    <tr>
      <th>632</th>
      <td>Panax ginseng<br>CYP isoforms</td>
      <td>CYP</td>
      <td>Like G. biloba, Panax ginseng appears to have little effect on the activities of the specific CYP isoforms investigated in this study.</td>
    </tr>
    <tr>
      <th>740</th>
      <td>Roozbeh et al.</td>
      <td></td>
      <td>[27] In the study performed by Roozbeh et al.</td>
    </tr>
    <tr>
      <th>2226</th>
      <td>ginseng<br>manic psychosis</td>
      <td></td>
      <td>Chronic use of ginseng on its own has been associated with manic psychosis [90].</td>
    </tr>
    <tr>
      <th>86</th>
      <td>conventional therapeutic drugs<br>herbal remedies</td>
      <td></td>
      <td>With the boom in conventional therapeutic drugs, the utilization of herbal remedies sometimes in combination with other medications has increased tremendously over the last decade [1,2].</td>
    </tr>
    <tr>
      <th>1766</th>
      <td>human<br>rats<br>CYP2C8</td>
      <td></td>
      <td>Although these isoforms are expressed in several different species, a high degree of similarity in their gene sequences between rats and human may not automatically result in similar levels of catalytic specificity and activity.</td>
    </tr>
    <tr>
      <th>2092</th>
      <td>ATP-binding cassette transporters<br>CIP</td>
      <td></td>
      <td>CIP is a known substrate of the ATP-binding cassette transporters, which have been implicated in its intestinal secretion, biliary excretion and secretion into breast milk (Vance-Bryan et al., 1990; Merino et al., 2006; Ando et al., 2007; Mulgaonkar et al., 2012).</td>
    </tr>
    <tr>
      <th>56</th>
      <td>PD<br>hallucinations<br>patients</td>
      <td></td>
      <td>Additionally, a previous study evaluated patients with PD and their subsequent reactions to cannabis use, reporting that one out of five patients experienced hallucinations [12].</td>
    </tr>
    <tr>
      <th>599</th>
      <td>Y.C.P.</td>
      <td></td>
      <td>and Y.C.P.</td>
    </tr>
    <tr>
      <th>463</th>
      <td>CYP2C8</td>
      <td></td>
      <td>; data not shown).</td>
    </tr>
    <tr>
      <th>382</th>
      <td>AC<br>DST</td>
      <td></td>
      <td>However, it is unknown whether there is an interaction between AC and DST.</td>
    </tr>
    <tr>
      <th>1886</th>
      <td>SD<br>mean</td>
      <td></td>
      <td>Values are expressed as mean (SD).</td>
    </tr>
    <tr>
      <th>18</th>
      <td>transport mechanisms<br>death receptor</td>
      <td></td>
      <td>Moreover, as the patient took a commercial preparation of chokeberry juice which did not provide information on the amounts of its compounds, it cannot be excluded that other interactions might have occurred such as the inhibition of transport mechanisms, the activation of the death receptor and other unknown mechanisms.</td>
    </tr>
    <tr>
      <th>331</th>
      <td>adverse events</td>
      <td></td>
      <td>Sixteen subjects reported 27 adverse events.</td>
    </tr>
    <tr>
      <th>1905</th>
      <td>Platelet aggregation<br>Adenosine diphosphate<br>Open in a separate window<br>Collagen</td>
      <td></td>
      <td>Table 3  Platelet aggregation (Ohms) after 2 weeks of echinacea and policosanol pre-treatment (n= 12) \tControl\tPolicosanol treatment\tEchinacea treatment Agonist\tMean (95% CI)\tMean (95% CI)\tGeometric mean ratio to control (90% CI)\tMean (95% CI)\tGeometric mean ratio to control (90% CI) ADP*\t7.8 (5.5, 10.0)\t6.8 (4.9, 8.8)\t0.92 (0.64, 1.30)\t7.5 (4.1, 10.8)\t0.84 (0.59, 1.19) Arachidonic acid\t11.0 (9.6, 12.5)\t11.2 (9.4, 12.9)\t1.00 (0.82, 1.23)\t12.1 (9.3, 15.0)\t1.06 (0.86, 1.30) Collagen\t13.0 (11.5, 14.6)\t14.9 (12.6, 17.2)\t1.13 (0.93, 1.37)\t15.8 (12.2, 19.5)\t1.17 (0.97, 1.42) Open in a separate window *Adenosine diphosphate.</td>
    </tr>
    <tr>
      <th>837</th>
      <td>venlafaxina<br>CYP2D6</td>
      <td></td>
      <td>A administração circunstancial de inibidores da isoenzima CYP2D6 e a presença de um fenótipo de metabolização lenta de CYP2D6 podem ter resultado na acumulação tóxica da venlafaxina e na manifestação clínica subsequente.</td>
    </tr>
    <tr>
      <th>908</th>
      <td>CYP2C8</td>
      <td></td>
      <td>Additionally, it can metabolize many drugs including clofibric acid and valproic acid [25].</td>
    </tr>
    <tr>
      <th>449</th>
      <td>Plates</td>
      <td></td>
      <td>Plates were thawed at ambient temperature.</td>
    </tr>
    <tr>
      <th>1041</th>
      <td>clinical interview<br>HIV-1 RNA load<br>chemistry<br>CD4+ T-cell count<br>physical examination<br>blood counts</td>
      <td></td>
      <td>Safety was evaluated by clinical interview and physical examination and by laboratory assessment (blood counts, chemistry, CD4+ T-cell count, and HIV-1 RNA load) on days 0, 14, and 28.</td>
    </tr>
    <tr>
      <th>1928</th>
      <td>IC<br>in vitro CYP assays<br>CYP2C8</td>
      <td></td>
      <td>The IC It was not possible to determine the IC In vitro CYP assays offer an accurate, and relatively inexpensive, first stage assessment tool for gauging the potential for herb-drug interactions.</td>
    </tr>
    <tr>
      <th>111</th>
      <td>vacuum degasser<br>binary pump<br>column oven<br>ESI probe<br>Waters Corporation<br>Micromass Xevo tandem quadrupole mass spectrometric detector<br>autosampler<br>UPLC system<br>Acquity BEH C18 column<br>CYP2C8</td>
      <td>NADP</td>
      <td>Briefly, serial dilutions of the extracts were added to a mixture of regeneration system, NADP Phytofingerprinting was performed on the extracts using a Waters Acquity UPLC system (Waters Corporation, Milford, MA, USA) with an Acquity BEH C18 column (2.1 mm × 100 mm, 1.7 µm particle size) incorporating a binary pump, vacuum degasser, autosampler, column oven, and Micromass Xevo tandem quadrupole mass spectrometric detector (QTOF xevo G2; Waters micromass, Manchester, UK) equipped with ESI probe.</td>
    </tr>
    <tr>
      <th>378</th>
      <td>ginsenosides</td>
      <td></td>
      <td>Contents of ginsenosides in RGE.</td>
    </tr>
    <tr>
      <th>1047</th>
      <td>pharmacokinetic parameters</td>
      <td></td>
      <td>Pharmacokinetic parameters were natural log transformed before analysis, and confidence intervals for means (and for the difference between two means) were constructed on the natural log scale based on an analysis of variance model with treatment as a fixed effect.</td>
    </tr>
    <tr>
      <th>2052</th>
      <td>Evn-50<br>cell growth<br>ethyl acetate extract of Vitex negundo L.<br>apoptosis<br>cell viability<br>TAM resistance<br>TAM<br>TAM-resistant cell line MCF-7 tam-R</td>
      <td></td>
      <td>In a study involving TAM-resistant cell line MCF-7 tam-R, while 10 Evn-50 is an ethyl acetate extract of Vitex negundo L. When used in combination with TAM to treat TAM-resistant MCF-7/TAM-R cells, it significantly reduces cell viability, inhibits cell growth, induces apoptosis, and reverses TAM resistance of MCF-7/TAM-R cells (Hu et al., 2012).</td>
    </tr>
    <tr>
      <th>787</th>
      <td>valeriana<br>valerian</td>
      <td></td>
      <td>A search with the search terms (valerian or valeriana) was conducted in the databases MEDLINE and TOXLIT, via DIMDI (Cologne, Germany).</td>
    </tr>
    <tr>
      <th>304</th>
      <td>ethyl acetate<br>ethyl gallate<br>plasma<br>ascorbic acid-EDTA solution</td>
      <td></td>
      <td>Briefly, 1 mL of ethyl acetate was added to 100 µL plasma and ascorbic acid-EDTA solution 10:1 (v/v) mixture with 10 µL ethyl gallate (1 µg/mL) as internal standard and vortexed for 15 minutes and centrifuged at 4,500 rpm for 20 minutes.</td>
    </tr>
    <tr>
      <th>282</th>
      <td>roots<br>total amount of extract<br>aerial parts<br>E. purpurea</td>
      <td></td>
      <td>Our commercial product was only labelled to contain 95% aerial parts and 5% roots of E. purpurea, and no information was provided about the total amount of extract used.</td>
    </tr>
    <tr>
      <th>1071</th>
      <td>5-OH-OME<br>DEX<br>DOR<br>OME<br>MID</td>
      <td></td>
      <td>Precipitation was done the same way without an internal standard for OME, 5-OH-OME, DEX, DOR), and MID assays, respectively.</td>
    </tr>
    <tr>
      <th>363</th>
      <td>red ginseng products<br>rheumatoid arthritis</td>
      <td></td>
      <td>In particular, the beneficial effects of red ginseng products for reducing the symptoms of rheumatoid arthritis have been proven in animals and humans [24,25,26,27,36].</td>
    </tr>
    <tr>
      <th>1531</th>
      <td>body fluid<br>saline solution</td>
      <td></td>
      <td>The loss of body fluid was compensated by administrating 1.0 mL saline solution (p.o.)</td>
    </tr>
    <tr>
      <th>63</th>
      <td>CAM<br>2009-2010<br>cancer patients<br>China</td>
      <td></td>
      <td>In China, 93.4% of cancer patients reported having used CAM in 2009-2010 [4].</td>
    </tr>
    <tr>
      <th>2332</th>
      <td>atorvastatin<br>water<br>green tea</td>
      <td></td>
      <td>applied atorvastatin in rats after 3 weeks of drinking green tea or water.</td>
    </tr>
    <tr>
      <th>2047</th>
      <td>T-47D<br>MCF-7<br>TAM</td>
      <td></td>
      <td>When combined with TAM, it exhibits a significant synergistic inhibitory effect on MCF-7 and T-47D cell growth (Cho et al., 2010).</td>
    </tr>
    <tr>
      <th>1913</th>
      <td>(S)-warfarin</td>
      <td></td>
      <td>Interestingly, this effect on the pharmacokinetics of (S)-warfarin was not associated with a significant effect on warfarin pharmacodynamics.</td>
    </tr>
    <tr>
      <th>1135</th>
      <td>herb–drug interactions<br>ADME processes<br>herbal products</td>
      <td></td>
      <td>This limitation applies particularly to the prediction of herb–drug interactions, as herbal products are typically mixtures of multiple constituents that can alter ADME processes via multiple mechanisms.</td>
    </tr>
    <tr>
      <th>2290</th>
      <td>et Zucc.</td>
      <td></td>
      <td>et Zucc.)</td>
    </tr>
    <tr>
      <th>423</th>
      <td>TCM formulations<br>digoxin</td>
      <td></td>
      <td>Although a lot of experience has been accumulated in the clinical application of digoxin over the years, limited research has been conducted on its possible interactions with TCM formulations.</td>
    </tr>
    <tr>
      <th>1959</th>
      <td>rashes<br>Lomatium</td>
      <td></td>
      <td>The naturopathic literature from which most information about rashes caused by Lomatium is drawn do not indicate a well-studied treatment of the rash aside from supportive care and cessation of Lomatium ingestion.</td>
    </tr>
    <tr>
      <th>770</th>
      <td>warfarin<br>AUC<br>cranberry juice</td>
      <td></td>
      <td>(2007) also investigated the effect of pretreatment with cranberry juice for 5 days on warfarin pharmacokinetics and found no clinically significant change in the AUC of S-warfarin.</td>
    </tr>
    <tr>
      <th>1734</th>
      <td>Ginkgo biloba<br>antiplatelet agents</td>
      <td></td>
      <td>Ginkgo biloba is available as an over-the-counter drug and reported to cause haemorrhage when coadministered with other antiplatelet agents.</td>
    </tr>
    <tr>
      <th>506</th>
      <td>DMSO<br>amlodipine<br>hydrochlorothiazide<br>fimasartan</td>
      <td></td>
      <td>Each rat in the combination group received a mixture of fimasartan (3 mg/kg), amlodipine (5 mg/kg), and hydrochlorothiazide (5 mg/kg) dissolved in saline containing 10% DMSO.</td>
    </tr>
    <tr>
      <th>2318</th>
      <td>pulverized dried bulbs<br>Allicin<br>Allium sativum</td>
      <td></td>
      <td>The European pharmacopoeia monographs pulverized dried bulbs of Allium sativum containing at least 0.45% allicin [154].</td>
    </tr>
    <tr>
      <th>340</th>
      <td>ABCB1<br>GTC<br>digoxin</td>
      <td></td>
      <td>To identify the effect of ABCB1 genotype on the pharmacokinetic alteration of digoxin by GTC, we compared the percentage changes from Day 1 (digoxin alone treatment) of AUC This study investigated the effect of GTC on the pharmacokinetics of digoxin.</td>
    </tr>
    <tr>
      <th>1581</th>
      <td>pGP<br>CYP3A4</td>
      <td></td>
      <td>3a and b).</td>
    </tr>
    <tr>
      <th>609</th>
      <td>herbal supplement usage<br>65 years of age<br>patients<br>prescription medications<br>individuals</td>
      <td></td>
      <td>[1–3,8,9] Still other surveys indicate that herbal supplement usage is prevalent among patients taking prescription medications,[10–12] with many individuals greater than 65 years of age.</td>
    </tr>
    <tr>
      <th>1412</th>
      <td>hyperforin<br>flavonoids<br>SJW extracts<br>hypericin<br>isolated constituents<br>depression</td>
      <td></td>
      <td>SJW extracts as well as isolated constituents (hyperforin, hypericin, or flavonoids) have been investigated in vitro and in vivo for their interactions with a variety of potentially relevant targets for depression.</td>
    </tr>
    <tr>
      <th>814</th>
      <td>Office of Dietary Supplements<br>NIH<br>valerian<br>HMPC monograph</td>
      <td></td>
      <td>That therapeutic safety regarding interactions is high in valerian and is mentioned in the respective monograph of the HMPC [18] and also in a fact sheet of the Office of Dietary Supplements at the NIH [32].</td>
    </tr>
    <tr>
      <th>2090</th>
      <td>CIP<br>urine</td>
      <td></td>
      <td>Approximately 60% of CIP is excreted in unchanged form into the urine (Vance-Bryan et al., 1990).</td>
    </tr>
    <tr>
      <th>2128</th>
      <td>relative humidity<br>barometric pressure<br>air temperature</td>
      <td></td>
      <td>All tests were performed at similar laboratory environmental conditions controlling for air temperature, barometric pressure, and relative humidity.</td>
    </tr>
    <tr>
      <th>1020</th>
      <td>phenolic phytochemicals<br>spearmint</td>
      <td></td>
      <td>showed that phenolic phytochemicals of spearmint possessed hypoglycemic, and antioxidant attributes [57].</td>
    </tr>
    <tr>
      <th>1362</th>
      <td>average<br>SD</td>
      <td></td>
      <td>All results are presented as the average ± SD.</td>
    </tr>
    <tr>
      <th>2285</th>
      <td>S. D.<br>n<br>mean</td>
      <td></td>
      <td>Data are expressed as mean ± S. D. (n = 6).</td>
    </tr>
    <tr>
      <th>1657</th>
      <td>blood pressure<br>HS extract</td>
      <td></td>
      <td>Animal studies have consistently shown that consumption of HS extract reduces blood pressure in a dose dependent manner.</td>
    </tr>
    <tr>
      <th>187</th>
      <td>puerarin<br>rat tissue homogenate<br>formic acid</td>
      <td></td>
      <td>Thereafter, 50 μL of the IS solution (puerarin, 20 ng/mL in methanol) and 50 μL of 2% formic acid were added to 100 μL of the rat tissue homogenate.</td>
    </tr>
    <tr>
      <th>1302</th>
      <td>RT-PCR<br>β2-microglobulin<br>CYP2J2</td>
      <td>β2mg<br>CYP2J2 mRNA</td>
      <td>Expression of CYP2J2 mRNA was quantified by RT-PCR and results normalized to β2mg and to t = 0.</td>
    </tr>
    <tr>
      <th>1731</th>
      <td>Schisandra lignans</td>
      <td></td>
      <td>Another limitation of the current study is the reliance on the assumption that Schisandra lignans are solely responsible for the interactions with CYP substrates.</td>
    </tr>
    <tr>
      <th>2146</th>
      <td>hypocholesterolemic properties<br>quinic acid<br>triterpenic saponins<br>dihydrocaffeolquinic acids<br>caffeine<br>mono-caffeolquinic acids<br>minerals<br>central nervous system<br>adrengenic effects<br>chlorogenic acids<br>vitamins<br>anti-lipolytic<br>caffeic acid</td>
      <td></td>
      <td>The metabolic effects include adrengenic effects and stimulated central nervous system associated with caffeine, anti-lipolytic, and hypocholesterolemic properties in chlorogenic acids (mono- and di-caffeolquinic acids) hydroxycinnamic acids (caffeic acid, quinic acid) and triterpenic saponins, and other minerals and vitamins [5].</td>
    </tr>
    <tr>
      <th>94</th>
      <td>Cassia abbreviata<br>CYP2C19<br>CYP2C9<br>CYP1A2<br>Newbouldia laevis</td>
      <td>CYP2C19<br>CYP2C9<br>CYP1A2</td>
      <td>This study concentrated on investigating the effects of potential interaction between extracts from Newbouldia laevis and Cassia abbreviata on CYP1A2, CYP2C9, and CYP2C19 activities.</td>
    </tr>
    <tr>
      <th>350</th>
      <td>ginsenosides<br>RGE<br>rats<br>plasma concentrations</td>
      <td></td>
      <td>After RGE was orally administered to rats at single or multiple doses for 1 or 2 weeks, the plasma concentrations of ginsenosides were also monitored.</td>
    </tr>
    <tr>
      <th>2348</th>
      <td>HMP<br>Germany<br>Valerian<br>Garcia-Alvarez</td>
      <td></td>
      <td>Valerian, for example, is marketed in Germany, mainly as HMP, and, thus, possibly a great proportion of consumption was not included in the survey by Garcia-Alvarez [7].</td>
    </tr>
    <tr>
      <th>2294</th>
      <td>European regulatory environment<br>Bilia and Céu Costas review</td>
      <td></td>
      <td>A more detailed description of the regulatory environment in Europe, as well as its practical effects, can be found in the Bilia and Céu Costas review [13].</td>
    </tr>
    <tr>
      <th>820</th>
      <td>clarithromycin<br>rifampin</td>
      <td>CYP3A</td>
      <td>Subjects also received rifampin (600 mg) and clarithromycin (1000 mg) for 7 days as positive controls for CYP3A induction and inhibition, respectively.</td>
    </tr>
    <tr>
      <th>1861</th>
      <td>IC50<br>SRM Institute of Science and Technology<br>SRM Medical College Hospital and Research Centre<br>CYP2C8</td>
      <td></td>
      <td>The following formula determines the half-maximal inhibitory concentration (IC SRM Medical College Hospital and Research Centre and SRM Institute of Science and Technology, Kattankulathur ethics committees approved the protocol (approval No.</td>
    </tr>
    <tr>
      <th>1237</th>
      <td>aspirin<br>P-g-binding site</td>
      <td></td>
      <td>The present work provides an insight into the mechanism exploration governing HDI between aspirin and PNS.</td>
    </tr>
    <tr>
      <th>2283</th>
      <td>sirolimus<br>parsley juice</td>
      <td></td>
      <td>In this patient, we reported the possible effect of parsley juice on the level of sirolimus.</td>
    </tr>
    <tr>
      <th>1027</th>
      <td>proliferative and secretory phases<br>hormonal factors<br>PCOS women<br>lipid profile<br>sexual hormones</td>
      <td>sexual hormones</td>
      <td>We recommend that further research should be undertaken regarding the effects of herbal mixtures on hormonal factors of PCOS women such as sexual hormones in both proliferative and secretory phases, and lipid profile in a longer follow-up.</td>
    </tr>
    <tr>
      <th>1364</th>
      <td>BCRP/ABCG2<br>intestine<br>DAS<br>APG<br>liver</td>
      <td>ABCG2<br>BCRP</td>
      <td>Hepatic (A) and intestinal (B) BCRP/ABCG2 protein expression in rats after DAS administration with or without APG pretreatment.</td>
    </tr>
    <tr>
      <th>436</th>
      <td>transporter function<br>nuclear receptor agonists<br>hepatocytes</td>
      <td></td>
      <td>Hepatocytes cultured in this format are responsive to nuclear receptor agonists and maintain important transporter function necessary for proper drug disposition (Yang et al., 2016).</td>
    </tr>
    <tr>
      <th>905</th>
      <td>celastrol</td>
      <td></td>
      <td>The second plot (Figure 3C) using slope (obtained from Lineweaver-Burk plot) vs. celastrol concentration showed that the inhibition kinetic parameter (Ki) was 0.49 μM.</td>
    </tr>
    <tr>
      <th>1203</th>
      <td>herbal medicines</td>
      <td></td>
      <td>Fifty percent of the informants used herbal medicines alongside their prescription drugs.</td>
    </tr>
    <tr>
      <th>177</th>
      <td>published cases<br>hepatotoxicity<br>case studies<br>black cohosh</td>
      <td></td>
      <td>Similarities and differences among current case studies and published cases of black cohosh hepatotoxicity.</td>
    </tr>
    <tr>
      <th>1894</th>
      <td>lifestyle<br>medication</td>
      <td></td>
      <td>Actions and Outcome  After evaluating the possible interactions between medication and lifestyle, some measures were taken to avoid those interactions.</td>
    </tr>
    <tr>
      <th>545</th>
      <td>EFV<br>liver damage<br>nausea<br>dyslipidemia<br>fever<br>vomiting<br>headache<br>NVP<br>diarrhoea</td>
      <td></td>
      <td>EFV and NVP have been associated with a number of side effects including liver damage, nausea, vomiting, fever, diarrhoea, dyslipidemia and headache [10].</td>
    </tr>
    <tr>
      <th>51</th>
      <td>dopamine<br>CB1Rs<br>inhibitory neurotransmitter<br>presynaptic neurons</td>
      <td>CB1Rs</td>
      <td>When CB1Rs on presynaptic neurons are activated, inhibitory neurotransmitter levels are reduced and dopamine levels increase [5,24,25].</td>
    </tr>
    <tr>
      <th>1207</th>
      <td>significant relationship</td>
      <td></td>
      <td>A significant relationship between variables was identified if p < 0.05.</td>
    </tr>
    <tr>
      <th>687</th>
      <td>S. frutescens</td>
      <td></td>
      <td>In Stage 2 77 additional participants were randomized to either 1,200 mg S. frutescens or placebo.</td>
    </tr>
    <tr>
      <th>2008</th>
      <td>rat plasma<br>hCE1<br>inhibition activities<br>hydrolase<br>herbal components</td>
      <td>hCE1</td>
      <td>The hydrolase activities in rat plasma may be originated from more than one kind of enzymes (not only hCE1) and the inhibition activities of these herbal components to each kind of hydrolysis enzymes are different.</td>
    </tr>
    <tr>
      <th>333</th>
      <td>EC<br>pharmacokinetics<br>ECG<br>EGC<br>digoxin<br>EGCG<br>GTC</td>
      <td></td>
      <td>Compared to the single administration of digoxin (Day 1), the concomitant administration of digoxin and GTC was associated with a significant reduction in systemic exposure of digoxin (Day 15): AUC The concentration–time profiles of EC, EGC, ECG, and EGCG and the pharmacokinetics parameters are presented in Figure 4 and Table 3.</td>
    </tr>
    <tr>
      <th>182</th>
      <td>Relinquing® granule<br>LVFX<br>Polygonum capitatum</td>
      <td></td>
      <td>For patients with urinary system infection, Relinqing® granule from Polygonum capitatum is usually combined with LVFX.</td>
    </tr>
    <tr>
      <th>557</th>
      <td>intestinal absorption<br>test compound<br>soluble extract<br>bioavailability<br>herbal extracts<br>GI tract<br>plasma concentrations</td>
      <td></td>
      <td>Since the intestinal absorption and plasma concentrations of each test compound are not known, and with the knowledge that herbal extracts have different bioavailability [28], the estimated bioavailable concentration was calculated using the % yield to give the soluble extract available in the GI tract.</td>
    </tr>
    <tr>
      <th>5</th>
      <td>abdominal mass</td>
      <td></td>
      <td>In May 2009 he underwent surgical removal of the abdominal mass achieving a complete margin negative (R0) resection.</td>
    </tr>
    <tr>
      <th>258</th>
      <td>alkylamides<br>caffeic acid derivatives<br>ethanolic liquid extracts</td>
      <td></td>
      <td>Of these components, caffeic acid derivatives and the more bioavailable alkylamides are found in ethanolic liquid extracts for medicinal use [8].</td>
    </tr>
    <tr>
      <th>2268</th>
      <td>sirolimus<br>tacrolimus</td>
      <td></td>
      <td>The patient received tacrolimus-based immunosuppression until April 2016, and then the treatment was switched from tacrolimus to sirolimus due to evident tremors.</td>
    </tr>
    <tr>
      <th>377</th>
      <td>Red ginseng extract</td>
      <td></td>
      <td>Sample Availability: Red ginseng extract are available from the authors.</td>
    </tr>
    <tr>
      <th>1999</th>
      <td>S8</td>
      <td></td>
      <td>S8).</td>
    </tr>
    <tr>
      <th>294</th>
      <td>E. purpurea<br>docetaxel<br>dexamethasone</td>
      <td></td>
      <td>Besides the dosing regimen and content of the applied E. purpurea product, docetaxel pretreatment with dexamethasone may also have contributed to the lack of a significant effect of E. purpurea on the pharmacokinetics of docetaxel.</td>
    </tr>
    <tr>
      <th>473</th>
      <td>S.D.</td>
      <td></td>
      <td>Data shown are the means ± S.D.</td>
    </tr>
    <tr>
      <th>486</th>
      <td>DDI potential<br>combination drugs<br>tolerability<br>safety</td>
      <td></td>
      <td>Therefore, the tolerability and safety of combination drugs were evaluated in the context of their DDI potential.</td>
    </tr>
    <tr>
      <th>1630</th>
      <td>indomethacin<br>S-AOE<br>model group<br>M-AOE</td>
      <td></td>
      <td>In our study, the changing trends in the plasma concentration-time curves of indomethacin in S-AOE and M-AOE groups were similar to those in model group shown in Fig.</td>
    </tr>
    <tr>
      <th>1717</th>
      <td>neutral compounds<br>Partition coefficients</td>
      <td></td>
      <td>8 Partition coefficients (log P) of neutral compounds are generally the most influential parameter dictating the extent of distribution to different tissues.</td>
    </tr>
    <tr>
      <th>1952</th>
      <td>H. verticillata<br>phytochemicals</td>
      <td></td>
      <td>Structures of phytochemicals identified in the aqueous extract of H. verticillata (aerial, dried).</td>
    </tr>
    <tr>
      <th>1990</th>
      <td>RS<br>OS<br>OSA<br>CYP2C8</td>
      <td></td>
      <td>The results suggested that co-administration with RS could significantly increase the systemic exposure of OS and decrease that of OSA (Fig.</td>
    </tr>
    <tr>
      <th>343</th>
      <td>GTC<br>digoxin</td>
      <td></td>
      <td>Surprisingly, the coadministration of GTC reduced the systemic exposure of digoxin in this study.</td>
    </tr>
    <tr>
      <th>2174</th>
      <td>R.A.</td>
      <td></td>
      <td>R.A. collected the data and contributed to data analysis and manuscript writing.</td>
    </tr>
    <tr>
      <th>830</th>
      <td>cardiopulmonary toxicity<br>venlafaxine</td>
      <td></td>
      <td>The present case details the occurrence of cardiopulmonary toxicity, which was probably associated with venlafaxine.</td>
    </tr>
    <tr>
      <th>146</th>
      <td>grapefruit<br>gliclazide<br>caffeine-containing beverages</td>
      <td></td>
      <td>All participants were asked not to drink caffeine-containing beverages and to refrain from grapefruit from the day before until 2 days after taking gliclazide.</td>
    </tr>
    <tr>
      <th>1740</th>
      <td>VKOR<br>Western blot<br>microsomes<br>Real Time-Polymerase Chain Reaction<br>CYP<br>TM</td>
      <td>TM<br>VKOR<br>CYP</td>
      <td>Microsomes incubation, Real Time-Polymerase Chain Reaction and Western blot was applied respectively to study the activity, mRNA expression and protein expression of CYP, VKOR and TM.</td>
    </tr>
    <tr>
      <th>2159</th>
      <td>active ingredients<br>bioavailability<br>YM capsules</td>
      <td></td>
      <td>However, further research is required to assess active ingredients of YM capsules and analyze their bioavailability following ingestion.</td>
    </tr>
    <tr>
      <th>941</th>
      <td>ginsenosides<br>Rb2<br>PPT<br>PPD<br>rat plasma<br>Rb1<br>Rd<br>Rc</td>
      <td></td>
      <td>Plasma concentration-time profiles of the ginsenosides (A) Rb1, (B) Rb2, (C) Rc, (D) Rd, (E) PPD, and (F) PPT in the rat plasma after 1-week repeated administration of red ginseng extract (RGE).</td>
    </tr>
    <tr>
      <th>165</th>
      <td>right upper quadrant abdominal pain<br>lower extremity edema<br>fatigue</td>
      <td></td>
      <td>Although she was initially asymptomatic, she developed right upper quadrant abdominal pain, fatigue, and lower extremity edema by the time of her presentation.</td>
    </tr>
    <tr>
      <th>199</th>
      <td>KY</td>
      <td></td>
      <td>KY[2017]073).</td>
    </tr>
    <tr>
      <th>68</th>
      <td>therapeutic indices<br>drugs</td>
      <td></td>
      <td>An important fact is that most of these affected drugs have very narrow therapeutic indices.</td>
    </tr>
    <tr>
      <th>510</th>
      <td>jejunal segments<br>pre-warmed saline</td>
      <td></td>
      <td>The jejunal segments were then isolated and rinsed using pre-warmed saline.</td>
    </tr>
    <tr>
      <th>614</th>
      <td>CYP enzymes<br>CYP substrates</td>
      <td>CYP</td>
      <td>Moreover, age-related changes have been observed in the pharmacokinetics of several CYP substrates,[28–30] as well as certain CYP enzymes,[29,30] thus the question remains as to whether such effects may extend to botanical supplements and their effect on drug metabolism in the elderly.</td>
    </tr>
    <tr>
      <th>1487</th>
      <td>side effects of conventional cancer therapy<br>complementary and alternative treatment options<br>breast cancer</td>
      <td></td>
      <td>Women diagnosed with breast cancer frequently seek complementary and alternative (CAM) treatment options that can help to cope with their disease and the side effects of conventional cancer therapy.</td>
    </tr>
    <tr>
      <th>734</th>
      <td>common cold<br>anticough syrups<br>respiratory problems<br>Iranian borage<br>E. amoenum<br>formulated herbal products</td>
      <td></td>
      <td>[2526] Iranian borage (E. amoenum) as unformulated and anticough syrups as formulated herbal products were the most used ones in our study population, while common cold and respiratory problems were determined to be the main indications for this trend.</td>
    </tr>
    <tr>
      <th>1836</th>
      <td>type of the extract<br>assay method<br>extraction procedure<br>enzyme sources<br>CYP isoenzymes<br>concentration<br>Allium sativum</td>
      <td>CYP isoenzymes</td>
      <td>Though we did not report any inhibition of CYP isoenzymes by Allium sativum, the discrepancies in these reports and ours may be due to the extraction procedure, assay method, concentration and type of the extract used and enzyme sources.</td>
    </tr>
    <tr>
      <th>1174</th>
      <td>CBZ<br>children with epilepsy<br>folinic acid<br>rats<br>nicotinamide</td>
      <td></td>
      <td>As regards the dietary supplement-CBZ interactions, folinic acid did not alter the plasma level of CBZ in rats [61] while nicotinamide increased CBZ plasma level and decreased its clearance in two children with epilepsy [70].</td>
    </tr>
    <tr>
      <th>731</th>
      <td>middle-aged (50–64) patients<br>trend<br>study</td>
      <td></td>
      <td>'s study,[25] which reported that the trend was more prevalent among middle-aged (50–64) patients compared to other age groups.</td>
    </tr>
    <tr>
      <th>2354</th>
      <td>herbal components<br>drug molecules<br>Herb–drug interactions (HDI)</td>
      <td></td>
      <td>Herb–drug interactions (HDI) may affect clinical safety and efficacy via additive/synergistic or antagonistic interactions among the herbal components and drug molecules.</td>
    </tr>
    <tr>
      <th>2012</th>
      <td>HDI relevancy<br>absolute z-score<br>OS<br>herb/herbal component</td>
      <td></td>
      <td>After such a normalization, the absolute z-score of an herb/herbal component effect on OS would be proportional to its level of HDI relevancy with OS.</td>
    </tr>
    <tr>
      <th>1230</th>
      <td>BNPP<br>PNS</td>
      <td></td>
      <td>There was no significant difference between BNPP (68 µg/mL) and PNS (150 µg/mL).</td>
    </tr>
    <tr>
      <th>388</th>
      <td>liver microsomes<br>CYP2C8</td>
      <td></td>
      <td>The maximum plasma concentration (C Rat liver microsomes were used to determine the metabolic rate of AC.</td>
    </tr>
    <tr>
      <th>59</th>
      <td>CYP2D6</td>
      <td></td>
      <td>Given this patient’s genetic results, guidelines, and current pain status, the clinical pharmacist suggested morphine as an alternative, as it does not utilize CYP2D6 for metabolism [34].</td>
    </tr>
    <tr>
      <th>2271</th>
      <td>adverse effects<br>herb<br>drug</td>
      <td></td>
      <td>Contrary to this safety perception, herb–drug interactions could lead to serious adverse effects.</td>
    </tr>
    <tr>
      <th>1800</th>
      <td>Potential for clinically important<br>Mangifera indica<br>herbal medicines<br>dietary supplements</td>
      <td></td>
      <td>Increasing use of medicinal herbs as nutritional supplements and traditional medicines for the treatment of diabetes, hypertension, hyperlipidemia, and malaria fever with conventional drugs poses possibilities of herb–drug interactions ( In vitro inhibition of eight major   Mangifera indica moderately inhibited  Potential for clinically important     Funding information  This research did not receive any specific grant from funding agencies in the public, commercial, or not‐for‐profit sectors Management of chronic diseases is burdensome to patients (Eton et al., 2013; Ørtenblad, Meillier, & Jønsson, 2017) who tend to seek alternative remedies to conventional medications that may supposedly provide cure or offer safe use (Yarney et al., 2013; Joeliantina, Agil, Qomaruddin, Jonosewojo, & Kusnanto, 2016) This self‐medication practice is common among chronically ill patients or patients with terminal diseases (Bodenheimer, Lorig, Holman, & Grumbach, 2002; Hasan, Ahmed, Bukhari, & Loon, 2009), and the major culprit in this group of patients are dietary supplements and herbal medicines (Gardiner, Graham, Legedza, Eisenberg, & Phillips, 2006; Gardiner, Phillips, & Shaughnessy, 2008).</td>
    </tr>
    <tr>
      <th>2391</th>
      <td>HPLC grade solvents<br>General-purpose reagents</td>
      <td></td>
      <td>General-purpose reagents (GPR) were used for extraction processes, while HPLC grade solvents were used for HPLC determinations.</td>
    </tr>
    <tr>
      <th>369</th>
      <td>total RNA<br>GE healthcare Korea<br>Seoul, Korea<br>Nano Vue Plus</td>
      <td></td>
      <td>The concentration of total RNA was determined by Nano Vue Plus (GE healthcare Korea, Seoul, Korea).</td>
    </tr>
    <tr>
      <th>2030</th>
      <td>natural products<br>clinical breast cancer patients<br>drug interactions</td>
      <td></td>
      <td>30%–70% of clinical breast cancer patients use natural products, which may increase the likelihood of drug interactions.</td>
    </tr>
    <tr>
      <th>1503</th>
      <td>4-hydroxy-N-desmethyltamoxifen hydrochloride<br>(E/Z)-endoxifen hydrochloride<br>dextrorphan-d<br>human liver microsomes<br>β-estradiol</td>
      <td>β-estradiol (E2)</td>
      <td>(E/Z)-endoxifen hydrochloride (4-hydroxy-N-desmethyltamoxifen hydrochloride), β-estradiol (E2) and dextrorphan-d Pooled human liver microsomes (HLMs, 50 donors, mixed gender) were purchased from Bioreclamation IVT (Baltimore, USA).</td>
    </tr>
    <tr>
      <th>194</th>
      <td>integrities<br>calibration curve</td>
      <td></td>
      <td>The diluted samples were analyzed using a calibration curve to derive their integrities, which were within the acceptable limit of ±15%.</td>
    </tr>
    <tr>
      <th>392</th>
      <td>acetonitrile</td>
      <td></td>
      <td>The highest recovery was obtained using acetonitrile as a protein precipitant.</td>
    </tr>
    <tr>
      <th>2387</th>
      <td>CYP2D6<br>CYP3A</td>
      <td></td>
      <td>So, DEX has been used as a common probe for both CYP3A and CYP2D6 activities (Spanakis et al., 2009; Yu and Haining, 2001), as well as in vivo in several studies (Ducharme et al., 1996; Funck-Brentano et al., 2005; Jones et al., 1996).</td>
    </tr>
    <tr>
      <th>1974</th>
      <td>inferior vena<br>antiviral activity<br>rats<br>blood</td>
      <td></td>
      <td>At 30 min following the 8PM dose on Day 5, the rats were anesthetized and about 10 mL of blood were collected from rats’ inferior vena for determination of antiviral activity.</td>
    </tr>
    <tr>
      <th>237</th>
      <td>DMSO<br>acetonitrile<br>methanol</td>
      <td></td>
      <td>The organic solvents such as methanol, acetonitrile and DMSO showed no inhibitory effects on the respective enzymes (Supplementary Materials, Figure S1a–c).</td>
    </tr>
    <tr>
      <th>2132</th>
      <td>PLC<br>CHO<br>YM</td>
      <td></td>
      <td>However, the total AUC for CHO was lower in YM than PLC (13.3 vs. 15.00, p < 0.001).</td>
    </tr>
    <tr>
      <th>1566</th>
      <td>blood glucose level<br>SITA<br>pharmacodynamic study</td>
      <td></td>
      <td>Despite low levels of SITA, the combination demonstrated a significant reduction in blood glucose level when compared with individual drug and individual extract administered groups during pharmacodynamic study.</td>
    </tr>
    <tr>
      <th>397</th>
      <td>method</td>
      <td></td>
      <td>These data indicated that the accuracy and precision of the method were satisfactory.</td>
    </tr>
    <tr>
      <th>402</th>
      <td>patients with renal dysfunction<br>neonates<br>digoxin</td>
      <td></td>
      <td>Endogenous digoxin substances are present in neonates and patients with renal dysfunction, and these substances may lead to elevated or false-positive digoxin plasma concentration monitoring results.</td>
    </tr>
    <tr>
      <th>2315</th>
      <td>food supplements</td>
      <td></td>
      <td>There are only food supplements available, with insufficiently defined product quality.</td>
    </tr>
    <tr>
      <th>1271</th>
      <td>Banderol<br>Samento</td>
      <td></td>
      <td>Therefore, Samento and Banderol were tested up to a dilution of 1% in the induction assay.</td>
    </tr>
    <tr>
      <th>1181</th>
      <td>Chinese databases<br>MEDLINE<br>CENTRAL<br>EMBASE<br>AMED<br>CINAHL Plus<br>Cochrane Database of Systematic Reviews</td>
      <td></td>
      <td>These included two conventional databases (EMBASE and MEDLINE), five other English databases (AMED, CINAHL Plus, Cochrane Database of Systematic Reviews, CENTRAL, and SciFinder Scholar) four Chinese databases.</td>
    </tr>
    <tr>
      <th>828</th>
      <td>drug-induced cardiopulmonary toxicity</td>
      <td></td>
      <td>This was an important case of drug-induced cardiopulmonary toxicity.</td>
    </tr>
    <tr>
      <th>586</th>
      <td>drug interactions<br>GGT</td>
      <td></td>
      <td>GGT with five major ingredients also possesses chance of drug interactions when co-administering with other drugs.</td>
    </tr>
    <tr>
      <th>960</th>
      <td>study participants</td>
      <td></td>
      <td>In order to compensate for study participants who did not complete both treatment phases, a total of 24 subjects were to be randomised.</td>
    </tr>
    <tr>
      <th>705</th>
      <td>therapies<br>drugs<br>interactions</td>
      <td></td>
      <td>However, a large number of these therapies have been shown that they are not safe and can be harmful due to their interactions with other drugs which are used contemporaneously.</td>
    </tr>
    <tr>
      <th>1298</th>
      <td>0.033<br>1%<br>P-glycoprotein (P-gp)<br>Samento</td>
      <td>P-glycoprotein (P-gp)</td>
      <td>Effects of Samento (0.033–1%) and the positive control rifampicin (20 µM) on the protein expression of P-glycoprotein (P-gp) after four days of exposure.</td>
    </tr>
    <tr>
      <th>1061</th>
      <td>darunavir<br>echinacea<br>CYP3A4</td>
      <td>CYP3A4</td>
      <td>The variability in the effect of echinacea on darunavir pharmacokinetics we observed in this cohort may imply some degree of uncertainty in the CYP3A4 inductive/inhibitory potential of this herbal remedy.</td>
    </tr>
    <tr>
      <th>1339</th>
      <td>drug-metabolizing enzymes (DME)<br>herbs<br>drug transporters</td>
      <td></td>
      <td>Inhibition and/or induction of drug-metabolizing enzymes (DME) and or drug transporters mediated by herbs is the most typical mechanism of herb-drug interactions, which in turn alters the pharmacokinetic disposition of the drug [24,25].</td>
    </tr>
    <tr>
      <th>2275</th>
      <td>Sirolimus</td>
      <td></td>
      <td>Sirolimus is an immunosuppressive drug used to prevent graft rejection.</td>
    </tr>
    <tr>
      <th>1443</th>
      <td>medicinal mushrooms</td>
      <td></td>
      <td>If the control group also received medicinal mushrooms, there should be significant dosage differences of the mushrooms in the treatment group.</td>
    </tr>
    <tr>
      <th>1825</th>
      <td>50% inhibitory concentration<br>aqueous extract of herb<br>CYP2C8</td>
      <td></td>
      <td>Fifty percent inhibitory concentration (IC   where A = log of concentration of aqueous extract of herb in the incubations.</td>
    </tr>
    <tr>
      <th>1222</th>
      <td>herbs<br>drugs</td>
      <td></td>
      <td>Herb–drug interactions strongly challenge the clinical combined application of herbs and drugs.</td>
    </tr>
    <tr>
      <th>1702</th>
      <td>bosutinib<br>S. sphenanthera</td>
      <td></td>
      <td>Conversely, S. sphenanthera at a clinically‐relevant dose results in a predicted three‐fold increase in bosutinib systemic exposure.</td>
    </tr>
    <tr>
      <th>2327</th>
      <td>Seong et al.</td>
      <td></td>
      <td>Seong et al.</td>
    </tr>
    <tr>
      <th>347</th>
      <td>biliary excretion<br>urinary excretion<br>methotrexate</td>
      <td></td>
      <td>Biliary excretion, but not urinary excretion, of methotrexate decreased in the RGE repeated administration group, compared to that in the control group.</td>
    </tr>
    <tr>
      <th>1796</th>
      <td>37 months<br>adjuvant chemotherapy<br>48 women</td>
      <td></td>
      <td>The 48 (80%) women who had received adjuvant chemotherapy were a mean of 37 months (range 4–113) from completion of chemotherapy.</td>
    </tr>
    <tr>
      <th>2393</th>
      <td>Zorbax SB-CN column</td>
      <td></td>
      <td>Urine samples were eluted on a Zorbax SB-CN column (5 μm, 250 × 4.6 mm).</td>
    </tr>
    <tr>
      <th>430</th>
      <td>cytochrome P450</td>
      <td></td>
      <td>The most important class of enzymes involved in human drug metabolism is cytochrome P450 (P450), which occurs as a superfamily of related monooxygenase forms responsible for oxidative metabolism of xenobiotics and endogenous compounds (Nebert et al., 2013).</td>
    </tr>
    <tr>
      <th>2094</th>
      <td>gradient elution program</td>
      <td></td>
      <td>The gradient elution program was as follows: 0–8.5 min, 97% A; 8.7–11 min, 60% A; 11.5–13.5 min, 10% A; 14–15 min, 97% A.</td>
    </tr>
    <tr>
      <th>2328</th>
      <td>tea consumption<br>EFSA<br>HILI</td>
      <td></td>
      <td>A scientific opinion of EFSA [196] from 2018 states that the common food consumption is safe, as there are only few cases of HILI associated with tea consumption despite the widespread use.</td>
    </tr>
    <tr>
      <th>1711</th>
      <td>NADPH</td>
      <td></td>
      <td>The reaction was initiated by the addition of NADPH and terminated by placing the tubes on a cooling block (Selleckchem, Houston, TX, USA).</td>
    </tr>
    <tr>
      <th>1396</th>
      <td>lactate</td>
      <td></td>
      <td>Resting lactate level was measured at baseline and after 12 weeks, and results are presented in Figure 2.</td>
    </tr>
    <tr>
      <th>1160</th>
      <td>herbal products<br>CBZ<br>food<br>pharmacokinetic properties<br>drugs</td>
      <td></td>
      <td>Despite its clinical popularity, CBZ possesses several pharmacokinetic properties which make it prone to interaction with coadministered substances, including drugs, herbal products, and food [7].</td>
    </tr>
    <tr>
      <th>1464</th>
      <td>etoposide<br>doxorubicin<br>5-FU<br>cyclophosphamide<br>cisplatin<br>carboplatin<br>UFT</td>
      <td></td>
      <td>Some Yunzhi–drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49].</td>
    </tr>
    <tr>
      <th>251</th>
      <td>author</td>
      <td></td>
      <td>All authors reviewed the manuscript.</td>
    </tr>
    <tr>
      <th>1474</th>
      <td>gut dysbiosis<br>Warburg-related proteins<br>paclitaxel</td>
      <td></td>
      <td>Notably, a recent study found that such synergistic effect may be due to the inhibition of tumor metabolism via down-regulating Warburg-related proteins and restoration of the gut dysbiosis induced by paclitaxel [97].</td>
    </tr>
    <tr>
      <th>2082</th>
      <td>prostatitis<br>urinary tract infections<br>ex D. Don<br>antibacterial agents<br>P. capitatum<br>pyelonephritis</td>
      <td></td>
      <td>ex D. Don (P. capitatum), a Chinese herbal plant, is often used alone or in combination with antibacterial agents to treat urinary tract infections, pyelonephritis, and prostatitis in China (Chinese Pharmacopoeia Commission, 2010; Liao et al., 2011).</td>
    </tr>
    <tr>
      <th>256</th>
      <td>docetaxel<br>E. purpurea</td>
      <td></td>
      <td>The commercially available E. purpurea extract did not significantly alter the pharmacokinetics of docetaxel.</td>
    </tr>
    <tr>
      <th>279</th>
      <td>docetaxel</td>
      <td></td>
      <td>The individual differences in docetaxel AUC0–∞ are depicted in Figure 3.</td>
    </tr>
    <tr>
      <th>1032</th>
      <td>volatile compounds<br>essential oil</td>
      <td></td>
      <td>Volatile compounds identified in the essential oil of herbal mixture.</td>
    </tr>
    <tr>
      <th>1421</th>
      <td>xenosensor<br>promotor<br>genes<br>PXR<br>xenobiotic receptor<br>PXRRE<br>nucleus</td>
      <td>PXR<br>PXR response elements (PXRRE)</td>
      <td>In the network of genes involved in drug metabolism, the PXR functions as a xenobiotic receptor or “xenosensor,” which, after ligand binding, translocates to the nucleus, where it binds to specific PXR response elements (PXRRE) in the promotor of various genes, modulating their transcription.</td>
    </tr>
    <tr>
      <th>24</th>
      <td>ropinirole<br>carbidopa-levodopa<br>entacapone<br>dopamine</td>
      <td></td>
      <td>Neuronal death in this region results in low dopamine concentrations; therefore, treatment strategies for PD often involve initiating medications (e.g., carbidopa-levodopa, ropinirole, entacapone) that result in increased concentrations of dopamine to improve movement control [8].</td>
    </tr>
    <tr>
      <th>967</th>
      <td>polyphenolic properties<br>herbal agent<br>antioxidant<br>PCOS<br>antioxidant deficiency</td>
      <td></td>
      <td>Therefore, use of an herbal agent with antioxidant and polyphenolic properties without significant side effects helps to treat PCOS as a disease of antioxidant deficiency [13].</td>
    </tr>
    <tr>
      <th>913</th>
      <td>anti-diabetic<br>anti-inflammatory<br>anti-oxidative<br>ginseng</td>
      <td></td>
      <td>The therapeutic benefits of ginseng include anti-diabetic and anti-inflammatory effect and anti-oxidative response on chronic liver disease [3,4,5,6,7,8].</td>
    </tr>
    <tr>
      <th>588</th>
      <td>treatments<br>participant<br>7 ± 1-day washout period</td>
      <td></td>
      <td>Each participant received three treatments with a 7 ± 1-day washout period in-between.</td>
    </tr>
    <tr>
      <th>896</th>
      <td>UGT1A1<br>UGT2B7<br>celastrol</td>
      <td>UGT1A1-mediated 4-MU glucuronidation<br>UGT2B7-catalyzed 4-MU glucuronidation</td>
      <td>Furthermore, inhibition kinetic study (Dixon plot and Lineweaver-Burk plot) demonstrated that celastrol noncompetitively inhibited the UGT1A1-mediated 4-MU glucuronidation, and competitively inhibited UGT2B7-catalyzed 4-MU glucuronidation.</td>
    </tr>
    <tr>
      <th>2296</th>
      <td>knowledge</td>
      <td></td>
      <td>It most often means that we have less knowledge of benefits, as well as risks.</td>
    </tr>
    <tr>
      <th>626</th>
      <td>young individuals</td>
      <td></td>
      <td>This finding also corroborates the results of an earlier study in young individuals.</td>
    </tr>
    <tr>
      <th>1227</th>
      <td>aspirin<br>elimination half-life</td>
      <td></td>
      <td>After administration, aspirin is rapidly hydrolyzed in the body with an elimination half-life of approximatly 15 min [11,12].</td>
    </tr>
    <tr>
      <th>1444</th>
      <td>database searching<br>literature selection</td>
      <td></td>
      <td>Figure 1 summarizes the process of database searching and literature selection.</td>
    </tr>
    <tr>
      <th>1736</th>
      <td>warfarin<br>Danshen<br>Gegen<br>Sprague–Dawley rats</td>
      <td></td>
      <td>Sixty Sprague–Dawley rats were used to investigate the effects of warfarin (0.2 mg/kg), Danshen (240 or 480 mg/kg) and Gegen (240 or 480 mg/kg) both in isolation and combination.</td>
    </tr>
    <tr>
      <th>1085</th>
      <td>CYP2C19</td>
      <td></td>
      <td>does not affect CYP2C19 activity when administered over an 8-day period.</td>
    </tr>
    <tr>
      <th>2278</th>
      <td>sirolimus<br>metabolizing enzymes<br>transporter proteins</td>
      <td></td>
      <td>Previous studies have shown the interactions between sirolimus and drugs that affect the activities of metabolizing enzymes and transporter proteins.</td>
    </tr>
    <tr>
      <th>637</th>
      <td>botanical supplements<br>conventional medications</td>
      <td></td>
      <td>Therefore, botanical supplements, when taken concomitantly with conventional medications, can give rise to serious herb-drug interactions.</td>
    </tr>
    <tr>
      <th>61</th>
      <td>conventional medicines<br>CAM</td>
      <td></td>
      <td>During the past two decades, the world has witnessed an increased rate of conventional medicines integrated with CAM for treatment.</td>
    </tr>
    <tr>
      <th>822</th>
      <td>serotonin-norepinephrine reuptake inhibitor<br>antidepressant<br>Venlafaxine</td>
      <td></td>
      <td>Venlafaxine is a serotonin-norepinephrine reuptake inhibitor used as an antidepressant.</td>
    </tr>
    <tr>
      <th>810</th>
      <td>drug-drug interactions</td>
      <td></td>
      <td>A good understanding of the mechanisms of drug-drug interactions is essential for assessing and minimizing clinical risks.</td>
    </tr>
    <tr>
      <th>1076</th>
      <td>phenotyping metrics<br>bioequivalence<br>adjusted margins</td>
      <td></td>
      <td>Evaluation of phenotyping metrics followed the standard bioequivalence approach, with adjusted margins.</td>
    </tr>
    <tr>
      <th>2035</th>
      <td>cancer patients<br>breast cancer patients<br>complementary and alternative medicine (CAM)</td>
      <td></td>
      <td>Of all the cancer patients, breast cancer patients, in particular, are more likely to turn to complementary and alternative medicine (CAM) treatment (Wanchai et al., 2010).</td>
    </tr>
    <tr>
      <th>934</th>
      <td>ginsenosides<br>plasma samples<br>centrifugation<br>valsartan<br>blood samples</td>
      <td></td>
      <td>After centrifugation of the blood samples at 16,000× g for 10 min, aliquots (50 μL each) of plasma samples were stored at −80 °C until the analysis of ginsenosides and valsartan.</td>
    </tr>
    <tr>
      <th>248</th>
      <td>CYP3A4<br>nutraceuticals<br>rooibos extracts<br>drugs metabolized by CYP2C8 and CYP3A4<br>CYP2C8</td>
      <td>CYP3A4<br>CYP2C8</td>
      <td>Statistical analyses were performed using GraphPad Prism This in vitro study indicated that combining nutraceuticals containing rooibos extracts with drugs metabolized by CYP2C8 and CYP3A4 could potentially alter the pharmacodynamics and safety of these drugs.</td>
    </tr>
    <tr>
      <th>514</th>
      <td>ionization mode<br>mass transition<br>Q3<br>Q1</td>
      <td></td>
      <td>The ionization mode and mass transition from Q1 to Q3 were selected based on the product ion scan results of authentic standards and previously published reports (Figure 1).</td>
    </tr>
    <tr>
      <th>1252</th>
      <td>CYP2C19<br>Samente<br>CYP3A4<br>Banderol</td>
      <td>CYP3A4<br>CYP2C19</td>
      <td>The highest inhibition was demonstrated for CYP3A4 by Samento (around 40% at a concentration of 1%) and Banderol (around 20% at a concentration of 1%) and for CYP2C19 by Banderol (about 20% at a concentration of 1%).</td>
    </tr>
    <tr>
      <th>1146</th>
      <td>Supporting Information</td>
      <td></td>
      <td>Supporting Information Click here for additional data file.</td>
    </tr>
    <tr>
      <th>442</th>
      <td>Aliquots<br>CAW-R61H<br>OHSU<br>CAW-R61F<br>Portland, OR<br>filtrates</td>
      <td></td>
      <td>Aliquots of the two filtrates were shipped to Oregon Health & Science University (OHSU, Portland, OR), where they were frozen and lyophilized, yielding 21.4% from dried CA for CAW-R61F (extraction lot 1) and 23.9% from dried CA for CAW-R61H (extraction lot 2).</td>
    </tr>
    <tr>
      <th>2276</th>
      <td>immunosuppressive drugs</td>
      <td></td>
      <td>Therapeutic drug monitoring is required as with other immunosuppressive drugs.</td>
    </tr>
    <tr>
      <th>2264</th>
      <td>medicinal herbs</td>
      <td></td>
      <td>Medicinal herbs are rich sources of natural bioactive compounds that could interact with drugs.</td>
    </tr>
    <tr>
      <th>220</th>
      <td>alkyl phenols<br>saponins<br>triterpene glycosides</td>
      <td></td>
      <td>The two major classes of compounds isolated from the roots of KF are alkyl phenols and triterpene glycosides (saponins) as reported earlier (Ali and Khan, 2011).</td>
    </tr>
    <tr>
      <th>385</th>
      <td>supernatant<br>centrifugation<br>analysis</td>
      <td></td>
      <td>After centrifuging at 3500 rpm for 10 min, the supernatant was obtained and frozen at −40 °C until analysis.</td>
    </tr>
    <tr>
      <th>1097</th>
      <td>data extraction<br>reviewers<br>study selection</td>
      <td></td>
      <td>The study selection and data extraction used standard eligibility inclusion criteria as determined by two reviewers.</td>
    </tr>
    <tr>
      <th>2098</th>
      <td>CIP<br>ofloxacin</td>
      <td></td>
      <td>The precursor-product ion transitions of CIP and ofloxacin (internal standard) were 332.1→288.1 and 362.2→318.1, respectively.</td>
    </tr>
    <tr>
      <th>1147</th>
      <td>Curcumin<br>pure powder capsule<br>Quality Supplements and Vitamins</td>
      <td></td>
      <td>Curcumin commercially available as pure powder capsule (95%) was obtained from Quality Supplements and Vitamins (Fort Lauderdale, FL, USA).</td>
    </tr>
    <tr>
      <th>564</th>
      <td>phytochemical profiling<br>drug interacting constituents<br>related herbs<br>therapeutic purposes</td>
      <td></td>
      <td>The advantage of phytochemical profiling is that similar drug interacting constituents could be identified in other related herbs that are used for therapeutic purposes and that necessary mechanistic studies are performed on them.</td>
    </tr>
    <tr>
      <th>1068</th>
      <td>placebo<br>EGb 761® 120 mg<br>EGb 761® 240 mg</td>
      <td></td>
      <td>The following treatments were administered for 8 days each: placebo twice daily (treatment A), EGb 761® 120 mg twice daily (treatment B), and EGb 761® 240 mg in the morning and placebo in the evening (treatment C).</td>
    </tr>
    <tr>
      <th>2065</th>
      <td>protective effect</td>
      <td></td>
      <td>The protective effect is dose-dependent (Rahate and Rajasekaran, 2015).</td>
    </tr>
    <tr>
      <th>308</th>
      <td>product ions<br>EC<br>EGC<br>parent ions<br>C18<br>Atlantis T3<br>Electrospray mode<br>Waters<br>M/Z values</td>
      <td></td>
      <td>The monitored M/Z values of the parent and product ions under the positive electrospray mode of ECG, EGC, EC, and internal standard (IS) injected into MS through the Atlantis T3 (4.6×50 mm ×3 µm) C18 (Waters) column were 443.10 → 123.00, 307.20 → 151.00, 291.20 → 139.00, and 199.00 → 127.03, respectively.</td>
    </tr>
    <tr>
      <th>1320</th>
      <td>geometric mean ratios<br>confidence intervals</td>
      <td></td>
      <td>Geometric mean ratios (GMRs) with 90% confidence intervals (CIs) were calculated after log transformation of within-subject data.</td>
    </tr>
    <tr>
      <th>893</th>
      <td>severe adverse reactions</td>
      <td></td>
      <td>It is noteworthy that no severe adverse reactions were observed in this study.</td>
    </tr>
    <tr>
      <th>450</th>
      <td>P450 enzyme<br>CAW-R61J<br>NADPH</td>
      <td></td>
      <td>Potential TDI of P450 enzyme activity by CAW-R61J was determined using the shift in IC50 values between 30-minute preincubations in the presence and absence of NADPH.</td>
    </tr>
    <tr>
      <th>790</th>
      <td>valerenic acid<br>valerian extract<br>500 mg</td>
      <td></td>
      <td>Daily before going to bed, participants took two tablets, with 500 mg valerian extract each (extraction solvent ethanol 70%, valerenic acid content 5.51 mg/tablet), for 14 subsequent days.</td>
    </tr>
    <tr>
      <th>1117</th>
      <td>warfarin</td>
      <td></td>
      <td>She had no history of warfarin use, but warfarin was detected in her blood serum analysis.</td>
    </tr>
    <tr>
      <th>181</th>
      <td>Levofloxacin</td>
      <td></td>
      <td>Levofloxacin (LVFX) is used to treat numerous bacterial infections belonging to the third-generation fluoroquinolone antibiotic family [8].</td>
    </tr>
    <tr>
      <th>2394</th>
      <td>Asafetida<br>DEX</td>
      <td></td>
      <td>The in vitro formation of DEX metabolites in the presence of Asafetida was compared with the control by using a one-way analysis of variance (ANOVA), and a Post hoc Scheffe’s multiple comparison test with a significant P value ⩽0.05.</td>
    </tr>
    <tr>
      <th>2179</th>
      <td>OCT1<br>OAT3<br>OATP1B1<br>OAT1<br>OATP1B3<br>OCT2</td>
      <td></td>
      <td>[ HEK293 cells transiently overexpressing OAT1, OAT3, OCT1, OCT2, OATP1B1, and OATP1B3 transporters were purchased from Corning-Gentest (Tewksbury, MA, USA).</td>
    </tr>
    <tr>
      <th>2364</th>
      <td>diabetic treatment<br>herb</td>
      <td></td>
      <td>This herb has been in use for diabetic treatment for almost two millennia [72].</td>
    </tr>
    <tr>
      <th>1580</th>
      <td>glucose</td>
      <td></td>
      <td>Glucose level was determined using GOD-POD Erba diagnostic kits.</td>
    </tr>
    <tr>
      <th>2385</th>
      <td>dextrorphan (DOR)<br>CYP2D6<br>DEX</td>
      <td>CYP2D6</td>
      <td>The O-demethylation of DEX to dextrorphan (DOR) is predominantly mediated by CYP2D6 (Barnhart, 1980; Schadel et al., 1995).</td>
    </tr>
    <tr>
      <th>502</th>
      <td>6 °C<br>post-preparative stability<br>QC samples<br>autosampler</td>
      <td></td>
      <td>Post-preparative stability was evaluated by comparing the extracted QC samples maintained in the autosampler at 6 °C for 24 h (compared with the untreated QC samples).</td>
    </tr>
    <tr>
      <th>2389</th>
      <td>betaxolol<br>codeine</td>
      <td></td>
      <td>The internal standards codeine and betaxolol were of USP reference standard.</td>
    </tr>
    <tr>
      <th>1234</th>
      <td>Trizol<br>2 × 10 Total RNA<br>cells</td>
      <td></td>
      <td>Briefly, 2 × 10 Total RNA was extracted from the cells using the Trizol (CW0581, CWbio, Beijing, China).</td>
    </tr>
    <tr>
      <th>2245</th>
      <td>dietary supplements<br>herbal products<br>herbal species</td>
      <td></td>
      <td>This is because many marketed herbal products are made of mixtures of different herbal species and/or dietary supplements whose biological disposition in humans is poorly understood.</td>
    </tr>
    <tr>
      <th>1945</th>
      <td>CYP3A4<br>CYP1A1<br>CYP2D6<br>CYP1B1<br>cytochrome P450<br>CYP1A2</td>
      <td>CYPs 1A1, 1A2, 1B1, 3A4 and 2D6<br>cytochrome P450<br>P450 enzymes</td>
      <td>[15] to screen natural products for cytochrome P450 inhibition potential with a particular emphasis on the P450 enzymes, CYPs 1A1, 1A2, 1B1, 3A4 and 2D6.</td>
    </tr>
    <tr>
      <th>226</th>
      <td>P-value</td>
      <td></td>
      <td>*P < 0.05, **P < 0.01, and ***P < 0.001, determined by One way ANOVA, followed by Dunnett’s multiple comparison tests.</td>
    </tr>
    <tr>
      <th>659</th>
      <td>laboratory tests<br>written informed consent<br>medical history<br>clinical examination<br>participants<br>physician</td>
      <td></td>
      <td>Participants were certified healthy by a physician based on medical history, clinical examination, and laboratory tests and they gave their written informed consent to comply with the study protocol.</td>
    </tr>
    <tr>
      <th>124</th>
      <td>OATs<br>SLC22 family members</td>
      <td></td>
      <td>Currently, there are 29 putative SLC22 family members, 18 of which are believed to be OATs.</td>
    </tr>
    <tr>
      <th>1055</th>
      <td>ritonavir<br>E. purpurea<br>CYP2C8</td>
      <td></td>
      <td>Figure ​Figure11 displays the ritonavir concentration-versus-time profile, and Table ​Table22 lists the pharmacokinetic parameters of ritonavir after multiple-dose administration of darunavir-ritonavir alone or in combination with E. purpurea.</td>
    </tr>
    <tr>
      <th>99</th>
      <td>intestinal absorption<br>test compound<br>herbal extracts<br>bioavailability<br>plasma concentration</td>
      <td></td>
      <td>Since the intestinal absorption and plasma concentration of each test compound are not known and with the knowledge that herbal extracts have different bioavailability [24], the bioavailable concentration was estimated using the % yield (weight extracted powdered material/weight of original starting material) to give the soluble extract available in the GIT tract.</td>
    </tr>
    <tr>
      <th>1828</th>
      <td>FRE<br>herb–drug interactions<br>in vitro<br>GRT<br>CYP2C8</td>
      <td></td>
      <td>In vitro herb–drug interactions studies are mostly conducted for commonly used herbs to evaluate and predict potentially significant in vivo herb–drug interactions and to help design appropriate in vivo herb–drug interaction studies (Fasinu, Bouic, & Rosenkranz, 2012; Awortwe, Bouic, Masimirembwa, & Rosenkranz, 2013).</td>
    </tr>
    <tr>
      <th>2187</th>
      <td>polyethylene tubing<br>jugular vein</td>
      <td></td>
      <td>Rats were cannulated with polyethylene tubing (PE-50, Natsume Co, Tokyo, Japan) in the jugular vein for sampling under anesthesia with isoflurane.</td>
    </tr>
    <tr>
      <th>2402</th>
      <td>Asafetida<br>CYP3A4</td>
      <td>CYP3A4</td>
      <td>In conclusion, the significant Asafetida inhibitory effect on CYP3A4 metabolic activity was an important finding of this study.</td>
    </tr>
    <tr>
      <th>767</th>
      <td>R-warfarin<br>CYP2C8</td>
      <td></td>
      <td>Table 2  Pharmacokinetic parameters of S-warfarin and R-warfarin  \tMean (95% CI)\tGeometric mean ratio (90% CI)  \tWarfarin only\tWarfarin and cranberry\tWarfarin and garlic\tWarfarin and cranberry/warfarin only\tWarfarin and garlic/warfarin only S-warfarin  tmax (h)\t1.4 (1.1–1.6)\t1.9 (1.1–2.7)\t1.3 (1.1–1.6)\tNA\tNA  Cmax (μg mL−1)\t1.8 (1.7–1.9)\t1.7 (1.5–2.0)\t1.9 (1.5–2.2)\t0.94 (0.67–1.29)\t1.06 (0.77–1.47)  t1/2 (h)\t38.6 (35.7–41.5)\t34.9 (31.0–38.8)\t41.2 (35.1–47.3)\t0.94 (0.79–1.12)\t0.99 (0.83–1.18)  AUC (μg mL−1 h)\t60.3 (54.5–66.1)\t63.0 (57.3–68.8)\t65.5 (55.3–75.6)\t1.04 (0.94–1.67)\t1.06 (0.95–1.19)  CL/F (mL h−1)\t213 (193–232)\t204 (183–224)\t202 (175–229)\t0.89 (0.80–0.99)\t1.05 (0.94–1.17)  Fraction unbound (fu)\t0.010 (0.007–0.013)\t0.010 (0.007–0.014)\t0.011 (0.008–0.014)\t1.00 (0.75–1.25)\t1.12 (0.39–1.84)  \t \t \t \t \t  R-warfarin  tmax (h)\t1.4 (1.1–1.6)\t1.9 (1.1–2.7)\t1.8 (0.7–2.9)\tNA\tNA  Cmax (μg mL−1)\t1.8 (1.7–2.0)\t1.7 (1.5–1.9)\t1.9 (1.5–2.2)\t0.90 (0.67–1.21)\t1.02 (0.8–1.4)  t1/2 (h)\t55.6 (46.2–65.0)\t47.7 (41.5–53.9)\t52.6 (47.4–57.9)\t0.93 (0.80–1.08)\t0.98 (0.84–1.14)  AUC (μg mL−1 h)\t108.7 (90.0–127.3)\t105.8 (91.7–119.9)\t105.0 (96.3–113.7)\t1.0 (0.9–1.1)\t0.99 (0.87–1.13)  CL/F (mL h−1)\t123 (106–140)\t124 (109–139)\t121 (112–131)\t0.87 (0.75–0.99)\t0.96 (0.84–1.11)  Fraction unbound (fu)\t0.006 (0.004–0.007)\t0.005 (0.004–0.007)\t0.006 (0.004–0.007)\t0.95 (0.72–1.18)\t1.04 (0.80–1.29) Open in a separate window Abbreviations: AUC, area under the plasma concentration–time curve; CI, confidence interval; CL, clearance; CL/F, apparent clearance; Cmax, maximum concentration; F, bioavailability; NA, not applicable; tmax, time to Cmax.</td>
    </tr>
    <tr>
      <th>401</th>
      <td>Western drugs</td>
      <td></td>
      <td>Most of these reports and studies are on combinations with Western drugs.</td>
    </tr>
    <tr>
      <th>723</th>
      <td>congenital kidney disease<br>polycystic kidney disease<br>drug-induced renal failure<br>acute kidney injury</td>
      <td></td>
      <td>The others (13.23%) consisted of congenital kidney disease, polycystic kidney disease, drug-induced renal failure, and acute kidney injury.</td>
    </tr>
    <tr>
      <th>619</th>
      <td>CYP2C8</td>
      <td></td>
      <td>[45] Go to: RESULTS General Experimental Observations  All subjects completed the study and no serious adverse events occurred during the course of the investigation.</td>
    </tr>
    <tr>
      <th>1090</th>
      <td>PK-PD parameters<br>warfarin<br>randomized controlled trials (RCTs)<br>clinical data<br>herbal medicines</td>
      <td></td>
      <td>The aim of this article was to systematically review clinical data, including PK-PD parameters, from randomized controlled trials (RCTs) and to discuss interactions between herbal medicines and warfarin.</td>
    </tr>
    <tr>
      <th>829</th>
      <td>DIP</td>
      <td></td>
      <td>Although DIP can occur from hours to months after the beginning of treatment, Another typical feature of DIP is its reversibility after drug discontinuation.</td>
    </tr>
    <tr>
      <th>191</th>
      <td>LVFX<br>method<br>complex matrices</td>
      <td></td>
      <td>Based on our findings, the developed method is acceptable and accurate for analyzing LVFX in complex matrices.</td>
    </tr>
    <tr>
      <th>676</th>
      <td>quinine</td>
      <td></td>
      <td>The AUC0–∞ of quinine was slightly reduced by about 9 %.</td>
    </tr>
    <tr>
      <th>1079</th>
      <td>EGb 761</td>
      <td></td>
      <td>Administration of EGb 761® 120 mg b.i.d.</td>
    </tr>
    <tr>
      <th>155</th>
      <td>smooth muscle antibody<br>Antinuclear antibody</td>
      <td></td>
      <td>Antinuclear antibody (ANA) was 1 : 40 and smooth muscle antibody was modestly elevated at 1 : 80.</td>
    </tr>
    <tr>
      <th>288</th>
      <td>alkylamide<br>DTAI<br>E. purpurea</td>
      <td></td>
      <td>For example, alkylamide content is known to vary considerably across different parts of E. purpurea plants [20], and DTAI are more abundant in roots than in leaves.</td>
    </tr>
    <tr>
      <th>1818</th>
      <td>CYP isoenzymes<br>tropical medicinal herbs</td>
      <td>CYP isoenzymes</td>
      <td>Little is known of the effect of most tropical medicinal herbs on the metabolic capacity of CYP isoenzymes.</td>
    </tr>
    <tr>
      <th>1763</th>
      <td>warfarin<br>Gegen<br>Danshen</td>
      <td></td>
      <td>Although there were no clinical reports in the literature pertaining to the interactions between Gegen and warfarin, the results of several case reports indicated that Danshen can interact with warfarin in humans [20–22].</td>
    </tr>
    <tr>
      <th>1647</th>
      <td>Gouqizi</td>
      <td></td>
      <td>In China, Gouqizi is a popular component of the daily diet, making the prohibition of its consumption in patients taking warfarin difficult to implement.</td>
    </tr>
    <tr>
      <th>198</th>
      <td>pharmacokinetic level</td>
      <td></td>
      <td>At present, our current studies at the pharmacokinetic level may not be able to explain this problem strongly.</td>
    </tr>
    <tr>
      <th>462</th>
      <td>P</td>
      <td></td>
      <td>***P < 0.0001.</td>
    </tr>
    <tr>
      <th>1607</th>
      <td>plasma sample preparation<br>tissue homogenates</td>
      <td></td>
      <td>Tissue homogenates were treated by the same method as plasma sample preparation except dilution process.</td>
    </tr>
    <tr>
      <th>1211</th>
      <td>hypoglycaemic agents</td>
      <td></td>
      <td>Tabular summary of the pharmacological management of the patients' based on their prescribed hypoglycaemic agents.</td>
    </tr>
    <tr>
      <th>2357</th>
      <td>herbs<br>drugs<br>pharmacodynamic HDI</td>
      <td></td>
      <td>When these herbs and drugs are used together, pharmacodynamic HDI (either additive/synergistic) may occur.</td>
    </tr>
    <tr>
      <th>1265</th>
      <td>pheophorbide A<br>BCRP<br>MDCKII-BCRP cells<br>parental cell line MDCKII<br>flow cytometry</td>
      <td>BCRP</td>
      <td>BCRP inhibition was tested by flow cytometry using pheophorbide A as a specific BCRP substrate in MDCKII-BCRP cells compared to the parental cell line MDCKII as described previously [24].</td>
    </tr>
    <tr>
      <th>1494</th>
      <td>Viscum album extracts<br>other types of cancer<br>breast cancer</td>
      <td></td>
      <td>Clinical studies have reported on the benefits of Viscum album extracts (VAE) not only in breast cancer patients but also for other types of cancer [10–13].</td>
    </tr>
    <tr>
      <th>1080</th>
      <td>EGb 761®<br>240-mg<br>1 week<br>CYPs</td>
      <td>CYPs</td>
      <td>A maximum exposure was realized with a 240-mg EGb 761® daily dose, and exposure duration was sufficient to eventually induce CYPs, as steady state for EGb 761® components was reached, and 1 week is typically sufficient to achieve full induction [35].</td>
    </tr>
    <tr>
      <th>417</th>
      <td>qi<br>food<br>bias of medicine<br>yang<br>yin<br>blood</td>
      <td></td>
      <td>When the bias of medicine is greater than that of food, it will inevitably affect the balance of qi, blood, yin and yang of the human body (Jia et al., 2021).</td>
    </tr>
    <tr>
      <th>1247</th>
      <td>L-MDR1 cells<br>intracellular calcein fluorescence<br>Banderol<br>human P-glycoprotein (P-gp)<br>Samento</td>
      <td>P-gp<br>P-glycoprotein (P-gp)</td>
      <td>Neither Samento nor Banderol increased intracellular calcein fluorescence in L-MDR1 cells over-expressing human P-glycoprotein (P-gp), indicating lack of P-gp inhibition (data not shown).</td>
    </tr>
    <tr>
      <th>2189</th>
      <td>prescription drugs<br>herbal co-medication<br>patient demographics</td>
      <td></td>
      <td>showed that the practice of herbal co-medication with prescription drugs cut across various patient demographics, with 38% of respondents reporting concomitant herbal use [6].</td>
    </tr>
    <tr>
      <th>1659</th>
      <td>antihypertensive<br>delphinidin-3-sambubioside<br>aqueous extracts<br>cyanidin-3-sambubioside<br>Anthocyanins<br>antioxidant<br>hypocholesterolemic<br>HS</td>
      <td></td>
      <td>Anthocyanins, particularly delphinidin-3-sambubioside and cyanidin-3-sambubioside, are generally believed to be the active constituents responsible for the antihypertensive, antioxidant, and hypocholesterolemic effects of HS, possibly because they are found in high relative quantities in aqueous extracts [8, 11, 13, 16].</td>
    </tr>
    <tr>
      <th>375</th>
      <td>pharmacokinetic studies<br>RGE treatment</td>
      <td></td>
      <td>Pharmacokinetic studies started 2 h after the last RGE treatment.</td>
    </tr>
    <tr>
      <th>1534</th>
      <td>rats plasma</td>
      <td></td>
      <td>In selectivity testing, six rats plasma was used.</td>
    </tr>
    <tr>
      <th>1777</th>
      <td>tanshinone components<br>warfarin hydroxylation<br>Danshen</td>
      <td></td>
      <td>This finding is also supported by Yueng’s study, where the major tanshinone components rather than the aqueous extract of Danshen showed effects on warfarin hydroxylation in vitro and in vivo [58].</td>
    </tr>
    <tr>
      <th>1242</th>
      <td>***</td>
      <td></td>
      <td>** and *** denoted result significantly different from that of the control group (p < 0.01 and p < 0.001, respectively).</td>
    </tr>
    <tr>
      <th>1535</th>
      <td>sulfhydryl group<br>capitol<br>2-4-dibromoacetophenone</td>
      <td></td>
      <td>In this experiment, we used 2-4-dibromoacetophenone as a derivatization agent to prevent the sulfhydryl group in captopril from binding to plasma sulfhydryl groups.</td>
    </tr>
    <tr>
      <th>813</th>
      <td>pharmacodynamic interactions</td>
      <td></td>
      <td>At present therefore a relevant risk of pharmacodynamic interactions is not proven by valid clinical observations.</td>
    </tr>
    <tr>
      <th>1111</th>
      <td>case reports</td>
      <td></td>
      <td>Some studies pointed out such limitations, that is, that case reports often result in misleading conclusions for multiple reasons [39, 40].</td>
    </tr>
    <tr>
      <th>2077</th>
      <td>WHO<br>2020<br>GBD Diseases and Injuries<br>Global Health Estimates<br>Communicable diseases</td>
      <td></td>
      <td>Communicable diseases are still leading causes of death and disability globally, according to WHO’s Global Health Estimates 2000–2019 (GBD Diseases and Injuries, 2020).</td>
    </tr>
    <tr>
      <th>1155</th>
      <td>curcumin</td>
      <td></td>
      <td>This effect of curcumin can be attributed due to one or more possible mechanisms as reported earlier.</td>
    </tr>
    <tr>
      <th>2004</th>
      <td>hydrolysis of OS<br>herbal extracts<br>rat plasma<br>herbal components</td>
      <td></td>
      <td>The metabolic inhibition studies performed in rat plasma suggested that all the herbal extracts (500 μg/mL) and all the herbal components (100 μg/mL) could inhibit the hydrolysis of OS in rat plasma, but the % inhibition rate varied between herbs/herbal components.</td>
    </tr>
    <tr>
      <th>628</th>
      <td>CYP2E1<br>allyl sulfide</td>
      <td>CYP2E1</td>
      <td>[42] The difference in extent of inhibition between the two age groups hints at either an age-related diminution in CYP2E1 responsivity or a dissimilarity in allyl sulfide content between the garlic supplements.</td>
    </tr>
    <tr>
      <th>703</th>
      <td>prevalence</td>
      <td></td>
      <td>Data were reported as prevalence (percent) of the occurrence.</td>
    </tr>
    <tr>
      <th>130</th>
      <td>pharmacodynamics<br>St John's wort<br>CYP2C9<br>gliclazide<br>genotype<br>pharmacokinetics</td>
      <td>CYP2C9</td>
      <td>Keywords: pharmacokinetics, pharmacodynamics, gliclazide, St John's wort, CYP2C9, genotype Go to: Introduction  The incidence of type 2 diabetes is increasing in the community.</td>
    </tr>
    <tr>
      <th>2299</th>
      <td>species</td>
      <td></td>
      <td>From the combined literature, a list of the most frequently occurring species was established.</td>
    </tr>
    <tr>
      <th>2229</th>
      <td>CNS benefits<br>kava</td>
      <td></td>
      <td>Despite the general concern about its safety, kava is still popularly consumed for CNS benefits.</td>
    </tr>
    <tr>
      <th>1130</th>
      <td>adverse events<br>Siliphos<br>pill diary</td>
      <td></td>
      <td>Each subject received his/her Siliphos in a blister pack and was asked to complete a pill diary documenting the time of administration, beverage, and approximate volume used to aid swallowing, and adverse events, if applicable.</td>
    </tr>
    <tr>
      <th>939</th>
      <td>valsartan<br>retro-orbital vein</td>
      <td></td>
      <td>Blood samples were collected via the retro-orbital vein at 0.17, 0.33, 0.67, 1.5, 2, 4, 8, 24, and 48 h after valsartan dosing.</td>
    </tr>
    <tr>
      <th>655</th>
      <td>adverse side effects from taking G. kola seeds<br>hypersensitivity to quinine<br>breastfeeding<br>pregnancy</td>
      <td></td>
      <td>Pregnancy, breastfeeding, histories of hypersensitivity to quinine or similar agents, or adverse side effects from taking G. kola seeds were also used as exclusion criteria for the study.</td>
    </tr>
    <tr>
      <th>121</th>
      <td>HDI<br>in vitro-in vivo-extrapolation (IVIVE) Drug-Drug Interaction (DDI) models<br>pharmacological tool</td>
      <td></td>
      <td>Currently, there is no specific pharmacological tool to predict HDI since almost all in vitro-in vivo-extrapolation (IVIVE) Drug-Drug Interaction (DDI) models deal with one inhibitor-drug and one victim-drug.</td>
    </tr>
    <tr>
      <th>1980</th>
      <td>OSA</td>
      <td></td>
      <td>The formation rate of OSA could be significantly suppressed by all the herb/herbal components.</td>
    </tr>
    <tr>
      <th>597</th>
      <td>GGT<br>AAP</td>
      <td></td>
      <td>AAP at 1000 once a day or 1000 mg × 4 times a day was administered in the presence or absence of GGT (7680 mg) daily.</td>
    </tr>
    <tr>
      <th>1634</th>
      <td>FRE<br>GRT</td>
      <td></td>
      <td>1).</td>
    </tr>
    <tr>
      <th>302</th>
      <td>ABCB1<br>p-glycoprotein</td>
      <td>p-glycoprotein (p-gp) encoded by ABCB1</td>
      <td>Previous in vitro studies have reported the inhibitory effect of green tea on p-glycoprotein (p-gp) encoded by ABCB1.</td>
    </tr>
    <tr>
      <th>2038</th>
      <td>Lilyturf<br>Ginger<br>Licorice</td>
      <td></td>
      <td>), Licorice (Glycyrrhiza glabra L.), Ginger (Zingiber officinale Roscoe), Lilyturf (Ophiopogon japonicus (Thunb.)</td>
    </tr>
    <tr>
      <th>693</th>
      <td>placebo<br>1200 mg<br>MOS-HIV</td>
      <td></td>
      <td>With respect to the MOS-HIV, failure differences were found between placebo and 1200 mg, favouring the 1200mg group.</td>
    </tr>
    <tr>
      <th>1931</th>
      <td>5′-methoxydehydropodophyllotoxin<br>deoxydehydropodophyllotoxin<br>cadina-4,10(15)-dien-3-one<br>dehydro-b-peltatin methyl ether<br>4′-demethyldesoxypodophyllotoxin<br>dehydropodophyllotoxin<br>β-Sitosterol</td>
      <td></td>
      <td>β-Sitosterol, cadina-4,10(15)-dien-3-one and a mix of five lignans comprised of dehydropodophyllotoxin, deoxydehydropodophyllotoxin, 4′-demethyldesoxypodophyllotoxin, 5′-methoxydehydropodophyllotoxin, and dehydro-b-peltatin methyl ether were supplied by the Department of Chemistry, University of the West Indies, Mona Campus, Jamaica.</td>
    </tr>
    <tr>
      <th>2291</th>
      <td>Epimedium sagittatum</td>
      <td></td>
      <td>Second, the pretreatment period of Epimedium sagittatum extract might have been too short to identify the possible herbal drug effect.</td>
    </tr>
    <tr>
      <th>2027</th>
      <td>Niubangzi<br>Fructus Arctii<br>Arctium lappa L.</td>
      <td></td>
      <td>Fructus Arctii (Fruit of Arctium lappa L., Niubangzi).</td>
    </tr>
    <tr>
      <th>1096</th>
      <td>herb</td>
      <td></td>
      <td>An herb was defined as a product or an extract originating from a single botanical source.</td>
    </tr>
    <tr>
      <th>407</th>
      <td>digoxin</td>
      <td></td>
      <td>Experiments in mice have shown that the AUC of digoxin is increased by gavage and intravenous injection.</td>
    </tr>
    <tr>
      <th>2192</th>
      <td>P-glycoprotein (P-gp)<br>cytochrome P450 (CYP)<br>grapefruit juice<br>pharmacokinetic profiles<br>felodipine</td>
      <td>P-glycoprotein (P-gp)<br>cytochrome P450 (CYP)</td>
      <td>Since the accidental discovery of the ability of grapefruit juice to alter the pharmacokinetic profiles of felodipine through the inhibition of cytochrome P450 (CYP) and P-glycoprotein (P-gp), more studies have elucidated various mechanisms of HDI [11].</td>
    </tr>
    <tr>
      <th>1233</th>
      <td>notoginsenoside R</td>
      <td></td>
      <td>PNS contents were determined as: notoginsenoside R UPLC-MS/MS analysis was conducted on an Ultimate 3000 UPLC system (Thermo Fisher Scientific, Waltham, MA, USA) equipped with an LTQ-Orbitrap Elite mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA).</td>
    </tr>
    <tr>
      <th>852</th>
      <td>antithrombotic drugs<br>thyroid disease<br>diabetes mellitus<br>menopause<br>endometrial hyperplasia<br>functional foods<br>sex hormone–related cancers<br>selective estrogen receptor modulators<br>sleep inducers<br>thromboembolism<br>migraines<br>clinically significant abnormalities based on mammographies or Pap smears<br>antihyperlipidemic drugs<br>bisphosphonates<br>cardiovascular disease<br>antidepressants<br>drug or alcohol abuse<br>breast cancer<br>calcitonin<br>cerebrovascular disease<br>hysterectomy<br>hypersensitivity to the test drug or its ingredients<br>hypertension<br>herbal medicines<br>female hormone formulations<br>participation in other clinical trials<br>intensive exercises</td>
      <td></td>
      <td>Meanwhile, the exclusion criteria were: 1) women who became menopausal from surgery or chemotherapy; 2) women who underwent hysterectomy; 3) women with a history of endometrial hyperplasia or endometrial, breast, or sex hormone–related cancers; 4) women with uncontrolled hypertension (160/100 mmHg or higher); 5) women with uncontrolled diabetes mellitus (fasting blood sugar 180 mg/dL or higher, or cases of starting or changing medication due to diabetes within 3 mo); 6) uncontrolled thyroid patients; 7) women who have had severe migraines within the last year or who have been diagnosed with thromboembolism, cerebrovascular disease, or serious cardiovascular disease; 8) women with atypical uterine bleeding after 1 yr of menopause; 9) women who have taken sleep inducers, antidepressants, selective estrogen receptor modulators, antihyperlipidemic drugs, antithrombotic drugs (Aspirin, Warfarin, and Clopidogrel), bisphosphonates, or calcitonin within 4 wk; 10) women who have taken plant hormones (isoflavone, flaxseed, pomegranate, horseradish, white sorghum, red shamrock, and red ginseng products) in the form of supplements or medicines within 4 wk; 11) women who have continuously taken functional foods and herbal medicines that could affect bone health, blood lipid lipids (triglyceride and cholesterol), and blood circulation within 4 wk; 12) women who were administered female hormone formulations within 6 mo; 13) women with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels exceeding 3 times the laboratory's normal upper limit; 14) women with creatinine levels exceeding 2 times the laboratory's normal upper limit; 15) women with a history of drug or alcohol abuse; 16) women who have performed intensive exercises (more than 10 h) within 3 mo; 17) women with hypersensitivity to the test drug or its ingredients; 18) women with clinically significant abnormalities based on mammographies or Pap smears (Category 0 or higher than 3 of Breast Imaging Reporting and Data System (BI-RADS)) is confirmed (in the case of BI-RADS Category 0, subject registration is possible after confirming additional test results; in the case of Pap smear, atypical squamous cell of undetermined significance can be registered); 19) women who have participated in other clinical trials within 1 mo of the start of the current study or who are planning to participate in another clinical trial during the study period; and, 20) in cases where the researchers decided that the subject is unsuitable to participate in this study.</td>
    </tr>
    <tr>
      <th>2175</th>
      <td>Prof. Yeong Bae Seo<br>Seoul, Korea<br>Seoul National University<br>Natural Products Research Institute</td>
      <td></td>
      <td>Co., Seoul, Korea) and their identity was kindly confirmed by Prof. Yeong Bae Seo (a specialist in plant classification, Natural Products Research Institute, Seoul National University, Seoul, Korea).</td>
    </tr>
    <tr>
      <th>1641</th>
      <td>anticoagulant therapy<br>alcohol<br>thrombin times</td>
      <td></td>
      <td>[7] previously showed that administration of 375 ml wine did not result in thrombin times (TTs) outside the therapeutic range, which suggested that a moderate intake of alcohol occasionally may be acceptable during anticoagulant therapy.</td>
    </tr>
    <tr>
      <th>539</th>
      <td>M.P.</td>
      <td></td>
      <td>and M.P.</td>
    </tr>
    <tr>
      <th>431</th>
      <td>perpetrator drug<br>victim drug<br>Metabolic drug interactions</td>
      <td></td>
      <td>Metabolic drug interactions normally occur between two or more drugs such that the addition of the perpetrator drug alters the systemic levels of the victim drug (Lin and Lu, 1998; Bohnert et al., 2016).</td>
    </tr>
    <tr>
      <th>458</th>
      <td>S.D.<br>Mean</td>
      <td></td>
      <td>Mean\tS.D.</td>
    </tr>
    <tr>
      <th>1484</th>
      <td>medicinal mushrooms<br>chemotherapeutic drugs</td>
      <td></td>
      <td>In summary, the aforementioned outcomes suggest that medicinal mushrooms have great potential to ameliorate the adverse effects of chemotherapeutic drugs in clinical settings.</td>
    </tr>
    <tr>
      <th>1752</th>
      <td>solvent A</td>
      <td></td>
      <td>The linear gradient elution was carried out as follows with a total running time of 90 min: solvent A was kept at 5 % for the first 5 min, and then increased to 10, 17, 35 and 90 % in the next 13, 12, 10 and 30 min, respectively, then returned to 5 % in 5 min and equilibrated for 15 min before the next injection.</td>
    </tr>
    <tr>
      <th>702</th>
      <td>PDF</td>
      <td></td>
      <td>(PDF) Click here for additional data file.</td>
    </tr>
    <tr>
      <th>1355</th>
      <td>DAS<br>APG</td>
      <td></td>
      <td>Further thorough in vivo studies of the APG–DAS interaction in humans are warranted to support these findings.</td>
    </tr>
    <tr>
      <th>749</th>
      <td>herbal formulas</td>
      <td></td>
      <td>Therefore, we think that a comprehensive management of our patients should also include education about the risk of interactions with herbal formulas.</td>
    </tr>
    <tr>
      <th>925</th>
      <td>OATP<br>valsartan<br>Oatp</td>
      <td>OATP<br>Oatp</td>
      <td>The results suggest that valsartan could be used as a model drug for investigating OATP (in human) or Oatp (in rats)-mediated herb–drug interaction between valsartan and RGE or ginsenosides.</td>
    </tr>
    <tr>
      <th>1857</th>
      <td>ammonium acetate<br>FRE<br>GRT<br>CYP2C8</td>
      <td></td>
      <td>34860-2.5L-R) and ammonium acetate (catalog No.</td>
    </tr>
    <tr>
      <th>727</th>
      <td>age range<br>50–70 years<br>herbal users<br>patients</td>
      <td></td>
      <td>The majority of the patients identified as herbal users were in the age range of 50–70 years, and herbal usage prevalence was high among this age range.</td>
    </tr>
    <tr>
      <th>454</th>
      <td>logEC50<br>CYP2C8</td>
      <td></td>
      <td>2 above (substituting logEC50 for logIC50).</td>
    </tr>
    <tr>
      <th>2322</th>
      <td>bleeding risk<br>ginkgo<br>anticoagulant<br>platelet inhibiting co-medication</td>
      <td></td>
      <td>Based on cases of severe bleeding events associated with ginkgo [169,170], the plant has been suspected to increase bleeding risk of patients with anticoagulant or platelet inhibiting co-medication.</td>
    </tr>
    <tr>
      <th>781</th>
      <td>valerian<br>anticancer drugs</td>
      <td></td>
      <td>Academic Editor: Igho J. Onakpoya In recent popular publications as well as in widely used information websites directed to cancer patients, valerian is claimed to have a potential of adverse interactions with anticancer drugs.</td>
    </tr>
    <tr>
      <th>354</th>
      <td>ginsenosides<br>Rh1<br>rat plasma<br>Re<br>Rg3</td>
      <td></td>
      <td>However, other ginsenosides, such as Rg3, Re, and Rh1, were not detected in rat plasma despite their high content in RGE (Table 1 and Table 2).</td>
    </tr>
    <tr>
      <th>745</th>
      <td>positron emission tomography<br>residual tumor<br>fluorethylenthyrosin<br>18 F</td>
      <td></td>
      <td>Unfortunately, a [18 F]-fluorethylenthyrosin positron emission tomography positive residual tumor was detected 2 months after the end of radiotherapy.</td>
    </tr>
    <tr>
      <th>2142</th>
      <td>RER<br>metabolic rate<br>blood lipid metabolites<br>YM</td>
      <td></td>
      <td>Previous studies in human participants have shown promising effects of YM ingestion on metabolic rate and RER acutely [21], and after 12 weeks of ingestion, on blood lipid metabolites in healthy obese participants [11,21].</td>
    </tr>
    <tr>
      <th>1780</th>
      <td>SAB</td>
      <td></td>
      <td>In our study, although SAB was used as a major component of the Danshen granules, the in vivo effects were very different to those observed in cells because of the poor absorption and bioavailability of SAB.</td>
    </tr>
    <tr>
      <th>400</th>
      <td>existing studies</td>
      <td></td>
      <td>The results of existing studies are controversial and further in-depth studies are required.</td>
    </tr>
    <tr>
      <th>2281</th>
      <td>parsley</td>
      <td></td>
      <td>Parsley is a food, spice, and also a medicinal herb.</td>
    </tr>
    <tr>
      <th>2060</th>
      <td>JEKHT<br>Jaeumkanghwa soup<br>traditional herbs</td>
      <td></td>
      <td>Jaeumkanghwa soup (JEKHT) is a compound composed of 12 traditional herbs (Jung et al., 2010).</td>
    </tr>
    <tr>
      <th>1334</th>
      <td>BCRP/ABCG2<br>APG</td>
      <td>ABCG2<br>BCRP</td>
      <td>The inhibitory potential of APG on BCRP/ABCG2 protein expression was investigated and shown in Figure 5A,B.</td>
    </tr>
    <tr>
      <th>1307</th>
      <td>tablet</td>
      <td></td>
      <td>Its original formulation was in a tablet form.</td>
    </tr>
    <tr>
      <th>1518</th>
      <td>Springer Nature<br>jurisdictional claims<br>institutional affiliations</td>
      <td></td>
      <td>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</td>
    </tr>
    <tr>
      <th>1958</th>
      <td>symptoms</td>
      <td></td>
      <td>Five days after presentation, her symptoms had completely resolved.</td>
    </tr>
    <tr>
      <th>1941</th>
      <td>Waters Alliance 2690 HPLC<br>Mass Lynx V4.1 software<br>Waters LCT Time of Flight Mass Spectrometer<br>Waters Micromass Ltd.</td>
      <td></td>
      <td>High resolution LC-MS was conducted using a Waters LCT Time of Flight Mass Spectrometer (Waters Micromass Ltd., Wilmslow, UK), with a Waters Alliance 2690 HPLC and Mass Lynx V4.1 software using similar HPLC conditions to those described above.</td>
    </tr>
    <tr>
      <th>332</th>
      <td>adverse events</td>
      <td></td>
      <td>All the adverse events were mild in intensity and resolved without any treatment.</td>
    </tr>
    <tr>
      <th>1318</th>
      <td>4-hydroxybupropion<br>bupropion</td>
      <td></td>
      <td>Geometric means were calculated for the AUC(0,∞), Cmax and so on of bupropion and 4-hydroxybupropion.</td>
    </tr>
    <tr>
      <th>750</th>
      <td>whole blood<br>normal saline<br>6 min<br>0.5 mL<br>37 °C</td>
      <td></td>
      <td>Briefly, whole blood (0.5 mL) was diluted twofold with freshly prepared normal saline and incubated at 37 °C for at least 6 min.</td>
    </tr>
    <tr>
      <th>1014</th>
      <td>polyphenols</td>
      <td></td>
      <td>In fact, polyphenols determine the antioxidant activity, and this positive relationship renders a trend in many medicinal plants [36].</td>
    </tr>
    <tr>
      <th>1648</th>
      <td>warfarin<br>atrial fibrillation<br>China</td>
      <td></td>
      <td>Due to public concern regarding the risk of bleeding during treatment with warfarin, as well as the uneasy relationship between allopathic doctors and their patients, no more than 10% of patients with atrial fibrillation take warfarin in China [5].</td>
    </tr>
    <tr>
      <th>2312</th>
      <td>liver injury<br>500 mg leaf powder<br>laxative</td>
      <td></td>
      <td>Another patient experienced liver injury after taking 500 mg leaf powder every 2–3 days as a laxative [117].</td>
    </tr>
    <tr>
      <th>843</th>
      <td>medicamentos cardíacos</td>
      <td></td>
      <td>A maioria dos medicamentos cardíacos foi, portanto, descontinuada.</td>
    </tr>
    <tr>
      <th>425</th>
      <td>TCM formulations</td>
      <td></td>
      <td>The composition of TCM formulations is complex.</td>
    </tr>
    <tr>
      <th>2321</th>
      <td>ginkgolic acid</td>
      <td></td>
      <td>For the refined quantified dry extract, the ginkgolic acid content is limited to 5 ppm [154].</td>
    </tr>
    <tr>
      <th>1538</th>
      <td>Ammonia</td>
      <td></td>
      <td>Ammonia was used during derivatization since the reaction is optimal at basic pH.</td>
    </tr>
    <tr>
      <th>1613</th>
      <td>feces<br>urine</td>
      <td></td>
      <td>Urine and feces were collected 0–6 h, 6–18 h and 18–28 h after administration.</td>
    </tr>
    <tr>
      <th>1031</th>
      <td>Polycystic ovary syndrome (PCOS)</td>
      <td></td>
      <td>Polycystic ovary syndrome (PCOS) patients’ flow diagram.</td>
    </tr>
    <tr>
      <th>1994</th>
      <td>co-administration<br>rat urine samples<br>RS<br>OSA/OS ratio<br>CYP2C8</td>
      <td></td>
      <td>This can further be verified by the lowered OSA/OS ratio in rat urine samples after co-administration with RS (Fig.</td>
    </tr>
    <tr>
      <th>1754</th>
      <td>VKOR<br>platelet aggregation<br>Gegen<br>Danshen<br>TM</td>
      <td>VKOR<br>TM</td>
      <td>Danshen and Gegen elicit their effects by improving microcirculation and inhibiting platelet aggregation [24, 32], whereas warfarin exerts its anticoagulant effect by inhibiting the activity of VKOR and inducing TM.</td>
    </tr>
    <tr>
      <th>1486</th>
      <td>Table S4</td>
      <td></td>
      <td>Table S4.</td>
    </tr>
    <tr>
      <th>959</th>
      <td>visit</td>
      <td></td>
      <td>For each visit, a deviation of ±1 day was permitted.</td>
    </tr>
    <tr>
      <th>152</th>
      <td>Park</td>
      <td></td>
      <td>Park et al.</td>
    </tr>
    <tr>
      <th>280</th>
      <td>CYP3A4<br>midazolam<br>E. purpurea</td>
      <td>CYP3A4</td>
      <td>Compared with the clinical studies in which significant induction of CYP3A4 by E. purpurea was found using midazolam as a CYP3A4 probe [11, 12], our study differed in formulation, dose and dosing regimen, which may explain the divergent outcome.</td>
    </tr>
    <tr>
      <th>2311</th>
      <td>opioids</td>
      <td></td>
      <td>Short-term use of opioids for patients who cannot reach pain relief otherwise may occur, e.g., to bridge the time until surgical intervention.</td>
    </tr>
    <tr>
      <th>1602</th>
      <td>metabolites<br>indomethacin<br>feces<br>Officinarum<br>bile</td>
      <td></td>
      <td>A. Officinarum could accelerate the excretions of indomethacin and its three metabolites in the bile and feces of rats in the excretion study.</td>
    </tr>
    <tr>
      <th>457</th>
      <td>dmd.120.090860f1</td>
      <td></td>
      <td>Object name is dmd.120.090860f1.jpg Fig.</td>
    </tr>
    <tr>
      <th>2335</th>
      <td>CYP</td>
      <td></td>
      <td>They favor CYP, as the patient could be unusually susceptible due to the individual genotype [207].</td>
    </tr>
    <tr>
      <th>766</th>
      <td>statistical significance</td>
      <td></td>
      <td>However, this did not reach statistical significance (data not shown).</td>
    </tr>
    <tr>
      <th>2074</th>
      <td>transcription activity</td>
      <td></td>
      <td>Studies have shown that just the monitoring of protein expression levels is insufficient in understanding transcription activity in vitro (Gordân et al., 2009).</td>
    </tr>
    <tr>
      <th>1471</th>
      <td>tumor cell angiogenesis<br>antitumor effect<br>reactive oxygen species production</td>
      <td></td>
      <td>In addition, the enhancement of the antitumor effect was shown to be achieved via the inhibition of tumor cell angiogenesis [104] or increase in the reactive oxygen species production [124].</td>
    </tr>
    <tr>
      <th>1882</th>
      <td>sequentially numbered drug containers</td>
      <td></td>
      <td>Double-blinded treatments were allocated using sequentially numbered drug containers.</td>
    </tr>
    <tr>
      <th>1549</th>
      <td>GLT<br>AC</td>
      <td></td>
      <td>The results suggest that the herb-drug interaction between GLT and AC might occur when they were co-administered.</td>
    </tr>
    <tr>
      <th>1547</th>
      <td>Agilent 1290 series liquid chromatography system</td>
      <td></td>
      <td>The analysis was performed on an Agilent 1290 series liquid chromatography system (Agilent Technologies, Palo Alto, CA, USA).</td>
    </tr>
    <tr>
      <th>1344</th>
      <td>DAS<br>CYP2C8</td>
      <td></td>
      <td>The radical alteration in the pharmacokinetic parameters of DAS 25 mg/kg P.O.</td>
    </tr>
    <tr>
      <th>28</th>
      <td>pharmacogenomic (PGx) data<br>cannabis<br>pharmacodynamic<br>pharmacokinetic</td>
      <td></td>
      <td>The case described herein demonstrates the importance of considering the pharmacokinetic and pharmacodynamic effects of cannabis and an individual’s pharmacogenomic (PGx) data when evaluating a patient’s medication regimen for therapeutic response and/or adverse drug events.</td>
    </tr>
    <tr>
      <th>21</th>
      <td>HTR2A<br>cannabis<br>COMT</td>
      <td></td>
      <td>It was discovered that the patient took cannabis for chronic back pain, and a pharmacogenomics (PGx) test indicated the presence of variants for the COMT and HTR2A genes.</td>
    </tr>
    <tr>
      <th>1730</th>
      <td>MBI</td>
      <td></td>
      <td>MBI, mechanism‐based inhibition Go to: 4.</td>
    </tr>
    <tr>
      <th>1823</th>
      <td>positive ion mode<br>Multiple reaction monitoring</td>
      <td></td>
      <td>Multiple reaction monitoring (MRM) mode using positive ion mode.</td>
    </tr>
    <tr>
      <th>135</th>
      <td>conventional medicines<br>alternative medicines<br>diabetic patients</td>
      <td></td>
      <td>Furthermore, 31% of diabetic patients have been reported to take alternative medicines, most in conjunction with conventional medicines (Ryan et al., 2001).</td>
    </tr>
    <tr>
      <th>1144</th>
      <td>conjugative metabolism<br>drug development</td>
      <td></td>
      <td>Design of drug molecules to avoid oxidative metabolism continues to emphasize the importance of conjugative metabolism in drug development.</td>
    </tr>
    <tr>
      <th>1446</th>
      <td>CD3+<br>platelets<br>antibody production<br>delayed hypersensitivity<br>CD4<br>Bax expression<br>CD4+ T cells<br>NK cells<br>caspase 3<br>T cells<br>cell cycle arrest<br>caspase 8<br>tumor inhibition<br>apoptotic rate<br>bone marrow cells<br>phagocytic activity<br>CD4/CD8<br>intestinal damage</td>
      <td></td>
      <td>Reduce T cell apoptosis and caspase 3 activity through downregulating Bax expression in T cells [170] Increase in efficacy and survival [20], better symptomatic relief [20] increase in T cells count (CD4, CD4/CD8) [20] Better symptomatic relief [141] and increase appetite [144] Less reduction in WBC (CD3+, CD4+ T cells, NK cells) [141, 144], platelets [144] Pharmacodynamic interactions between medicinal mushrooms and cytotoxic drugs in preclinical studies Increase in tumor inhibition effect [83, 84, 98] and survival time [63] Less decrease in WBC [83, 84, 145], platelets [83] and other bone marrow cells [84] Greater recovery rate from intestinal damage caused by 5-FU [173] Increase in survival [67], cytotoxicity and inhibit metastasis [111] Reduce immunosuppression (reduce the decrease in phagocytic activity, antibody production [111], delayed hypersensitivity [111, 112]) Increase in tumor inhibition and apoptotic rate (dose-related or time-dependent) [98–103], similar effect at lower dose of 5-FU [105] Induce cell cycle arrest at different phases [99, 101], increase caspase 3 and 8 expression and activity [100].</td>
    </tr>
    <tr>
      <th>1816</th>
      <td>isoenzymes<br>CYP2C8</td>
      <td></td>
      <td>These isoenzymes are responsible for the metabolism of over 70% of prescription and over‐the‐counter medications (Rendic & Guengerich, 2014).</td>
    </tr>
    <tr>
      <th>998</th>
      <td>standard deviation<br>descriptive statistics<br>dispersion<br>frequency<br>measures of central tendency<br>mean<br>percentage</td>
      <td></td>
      <td>Descriptive statistics, including the frequency and percentage, and measures of central tendency and dispersion, including the mean and standard deviation (SD), were also used to describe the study variable.</td>
    </tr>
    <tr>
      <th>472</th>
      <td>dmd.120.090860f3</td>
      <td></td>
      <td>Object name is dmd.120.090860f3.jpg Fig.</td>
    </tr>
    <tr>
      <th>1188</th>
      <td>soybean<br>septilin<br>CBZ<br>Xiao-cha-hu-tang<br>Ispaghula husk</td>
      <td></td>
      <td>Ispaghula husk, septilin, soybean and Xiao-cha-hu-tang reduced the plasma level of CBZ by affecting its gastric absorption.</td>
    </tr>
    <tr>
      <th>761</th>
      <td>pharmacokinetic model<br>INR<br>prothrombin complex activity<br>pharmacodynamic model<br>S-warfarin</td>
      <td></td>
      <td>In brief, a two-compartment pharmacokinetic model was used to describe S-warfarin concentration–time data and an indirect pharmacodynamic model described the relationship between percentage of prothrombin complex activity (PCA; which was derived from the INR data in this study) and S-warfarin concentration.</td>
    </tr>
    <tr>
      <th>1558</th>
      <td>Y.O.<br>S.M.<br>H.W.<br>J.K.<br>M.F.<br>K.S.<br>R.T.</td>
      <td></td>
      <td>S.M., Y.O., R.T., J.K., H.W., M.F., and K.S.</td>
    </tr>
    <tr>
      <th>678</th>
      <td>G. kola<br>quinine<br>trace metals<br>flavonoids</td>
      <td></td>
      <td>[38]  Although, the exact mechanism responsible for the delayed and decreased absorption of quinine in the presence of G. kola in this current study is not known, it is possible that quinine may have interacted through complex formation with the trace metals or flavonoids usually found in G. kola [6, 11] as evidenced from a significant reduction in the Cmax and tmax of quinine but no significant change in parameters which are indicative of interference with elimination.</td>
    </tr>
    <tr>
      <th>6</th>
      <td>lesion<br>chemotherapy<br>pre-aortic seat of the retro-peritoneum space</td>
      <td></td>
      <td>In spite of chemotherapy, the lesion progressed rapidly reaching 16 × 10 cm and extending into the pre-aortic seat of the retro-peritoneum space.</td>
    </tr>
    <tr>
      <th>1722</th>
      <td>lignans<br>clinically-reported parameter values<br>PBPK model<br>pharmacokinetic parameters</td>
      <td></td>
      <td>Prediction differences of pharmacokinetic parameters for the three lignans, expressed as the ratio of PBPK model prediction to clinically‐reported parameter values were also evaluated.</td>
    </tr>
    <tr>
      <th>1819</th>
      <td>mixture</td>
      <td></td>
      <td>Each mixture was filtered, concentrated, and freeze‐dried.</td>
    </tr>
    <tr>
      <th>1418</th>
      <td>tail suspension test<br>SJW extracts<br>antidepressant treatment</td>
      <td></td>
      <td>The tail suspension test, which also measures changes in immobility in rodents after antidepressant treatment, was applied by several investigators (Butterweck, Christoffel, et al., 2003; Machado et al., 2008; Tian et al., 2014) and SJW extracts significantly reduced the time of immobility in this test.</td>
    </tr>
    <tr>
      <th>616</th>
      <td>probe drug administration</td>
      <td></td>
      <td>Adherence to these restrictions was further emphasized five days before each probe drug administration.</td>
    </tr>
    <tr>
      <th>1405</th>
      <td>pregnane X receptor</td>
      <td>pregnane‐X‐receptor (PXR)</td>
      <td>These interactions were caused by pregnane‐X‐receptor (PXR) activation.</td>
    </tr>
    <tr>
      <th>2210</th>
      <td>clinical decisions<br>anecdotal evidence<br>HDIs</td>
      <td></td>
      <td>Anecdotal pieces of evidence like this not only highlight the reality and severity of the consequences of HDIs, they underscore the importance of further studies to guide clinical decisions.</td>
    </tr>
    <tr>
      <th>409</th>
      <td>heart rhythm<br>C. pinnatifida Bunge (Shanzha)<br>digoxin-induced arrhythmias<br>cardiovascular system<br>blood vessels<br>blood pressure<br>flavane polymers<br>flavonoid glycoside</td>
      <td></td>
      <td>used the duration of QRS interval prolongation, ventricular precontraction, ventricular tachycardia, and ventricular fibrillation as markers of arrhythmia to study the effects of C. pinnatifida Bunge (Shanzha) extract on digoxin-induced arrhythmias, and the results showed that the ventricular arrhythmias in the digoxin-induced experimental group of rats all decreased after the administration of C. pinnatifida Bunge (Shanzha) extract, indicating that the flavonoid glycoside and flavane polymers in C. pinnatifida Bunge (Shanzha) extract can antagonize digoxin-induced arrhythmias (Li and Huang, 2016), which may be related to their ability to dilate blood vessels, lower blood pressure, slow down the heart rhythm, and improve the cardiovascular system (Zhang et al., 2021).</td>
    </tr>
    <tr>
      <th>453</th>
      <td>CYP2C8</td>
      <td></td>
      <td>To determine the IC50 values, the concentration-response (percentage control value) curves were fitted to a four-parameter sigmoid (Hill) model, according to eq.</td>
    </tr>
    <tr>
      <th>1387</th>
      <td>knee joint center<br>femoral epicondyles<br>isokinetic dynamometer</td>
      <td></td>
      <td>The subject’s knee joint center, measured using the femoral epicondyles as a joint center reference, was aligned with the axis of the isokinetic dynamometer.</td>
    </tr>
    <tr>
      <th>1769</th>
      <td>genetic factors<br>predictive models<br>physical factors<br>warfarin dose<br>algorithms</td>
      <td></td>
      <td>Algorithms that integrate the relevant genetic and physical factors into comprehensive, individualized predictive models were used to predict warfarin dose [54].</td>
    </tr>
    <tr>
      <th>75</th>
      <td>rs1142345<br>TPMT<br>hypoglycemic effect<br>SNP<br>thiopurine S-methyltransferase</td>
      <td></td>
      <td>The rs1142345 (A>G) SNP in the thiopurine S-methyltransferase (TPMT) gene was significantly associated with the hypoglycemic effect of the drug (P = 0.001, FDR P = 0.043).</td>
    </tr>
    <tr>
      <th>1179</th>
      <td>antiepileptic therapy</td>
      <td></td>
      <td>Patients on antiepileptic therapy are usually on a long-term basis.</td>
    </tr>
    <tr>
      <th>475</th>
      <td>CYP3A4<br>CYP2D6<br>CYP2C19<br>human liver microsomes<br>CYP2C9<br>centelloids</td>
      <td></td>
      <td>Purified centelloids are weak inhibitors in human liver microsomes and human P450 forms expressed by E. coli of CYP2C19, CYP3A4, CYP2D6, and CYP2C9.</td>
    </tr>
    <tr>
      <th>888</th>
      <td>p-value<br>Fisher's exact test</td>
      <td></td>
      <td>p-value by Fisher's exact test.</td>
    </tr>
    <tr>
      <th>1427</th>
      <td>SJW<br>hyperforin<br>PXR<br>OATP2B1</td>
      <td>PXR<br>OATP2B1</td>
      <td>For OATP2B1, we have recently shown that this transporter is not only inhibited by hyperforin but also transports this constituent of SJW (Schäfer, Bock, & Meyer Zu Schwabedissen, 2018), thus influencing the intracellular transactivation of PXR by hyperforin (Schäfer et al., 2019).</td>
    </tr>
    <tr>
      <th>1433</th>
      <td>pharmacoepidemiology<br>herb-drug interactions<br>data mining<br>bioinformatics<br>cancer therapies</td>
      <td></td>
      <td>Based on the high quality clinical data, pharmacoepidemiology methods and bioinformatics or data mining could be adopt for further identification of clinical meaningful herb-drug interactions in cancer therapies.</td>
    </tr>
    <tr>
      <th>439</th>
      <td>Preparation of CAW-R61J<br>C. asiatica<br>Plant Material</td>
      <td></td>
      <td>C. asiatica Plant Material and Preparation of CAW-R61J.</td>
    </tr>
    <tr>
      <th>1295</th>
      <td>rifampicin<br>pregnane X receptor<br>Samento</td>
      <td>pregnane x receptor (PXR)</td>
      <td>(a) Concentration-dependent effect of Samento and the positive control rifampicin (insert) on pregnane x receptor (PXR) activity.</td>
    </tr>
    <tr>
      <th>512</th>
      <td>amlodipine<br>berberine</td>
      <td></td>
      <td>For amlodipine analysis, 50 μL aliquots were mixed with 150 μL acetonitrile containing 1 ng/mL berberine (IS).</td>
    </tr>
    <tr>
      <th>605</th>
      <td>pharmacokinetic parameters<br>AAP<br>Non-compartmental analysis<br>CYP2C8</td>
      <td></td>
      <td>Non-compartmental analysis (NCA) result of pharmacokinetic (PK) parameters of AAP.</td>
    </tr>
    <tr>
      <th>580</th>
      <td>Michelle Skelton<br>Dee Blackhurst<br>Kevin Dzobo<br>Ambroise Wonkam<br>Denis Chopera</td>
      <td></td>
      <td>Denis Chopera, Kevin Dzobo, Ambroise Wonkam, Dee Blackhurst and Michelle Skelton commented.</td>
    </tr>
    <tr>
      <th>1799</th>
      <td>Competing interests</td>
      <td></td>
      <td>Competing interests          The authors have declared no conflicts of interests.</td>
    </tr>
    <tr>
      <th>1844</th>
      <td>2000</td>
      <td></td>
      <td>(2000).</td>
    </tr>
    <tr>
      <th>2228</th>
      <td>kavalactones</td>
      <td></td>
      <td>The pharmacological activities of kava have been attributed to kavalactones, which are concentrated in the rhizomes [96].</td>
    </tr>
    <tr>
      <th>1229</th>
      <td>22 compounds</td>
      <td></td>
      <td>A total of 22 compounds were identified or tentatively identified (Figure 1).</td>
    </tr>
    <tr>
      <th>2277</th>
      <td>Parsley</td>
      <td></td>
      <td>Parsley, Petroselinum crispum, is a food, spice, and also a medicinal herb.</td>
    </tr>
    <tr>
      <th>190</th>
      <td>CYP2C8</td>
      <td></td>
      <td>Group one was administered 42 mg·kg Data are presented as mean ± standard deviation (SD).</td>
    </tr>
    <tr>
      <th>1565</th>
      <td>Eugenia jambolana</td>
      <td></td>
      <td>Eugenia jambolana (EJ) is an Indian traditional herb widely used for the treatment of diabetes mellitus.</td>
    </tr>
    <tr>
      <th>317</th>
      <td>EC<br>ECG<br>EGC<br>LC-MS/MS<br>EGCG</td>
      <td></td>
      <td>Using this LC-MS/MS method, a calibration curve range was generated by 0.1–50 ng/mL for EC and 1–500 ng/mL for EGCG, ECG, and EGC.</td>
    </tr>
    <tr>
      <th>1969</th>
      <td>thiazolyl blue tetrazolium bromide<br>Hygromycin B<br>glycyl-sarcosine</td>
      <td></td>
      <td>Hygromycin B, glycyl-sarcosine (Gly-Sar) and thiazolyl blue tetrazolium bromide (MTT) were purchased from Sigma-Aldrich Chem.</td>
    </tr>
    <tr>
      <th>381</th>
      <td>Dybro et al.</td>
      <td></td>
      <td>2014; Dybro et al.</td>
    </tr>
    <tr>
      <th>71</th>
      <td>clinical study<br>herb products<br>HDIs<br>pharmacogenomics</td>
      <td></td>
      <td>In the following, we reviewed pharmacogenomics studies, mainly from clinic study, on some important herb products that have been reported to have HDIs.</td>
    </tr>
    <tr>
      <th>909</th>
      <td>glucuronidation<br>UGT2B7<br>4-MU<br>Celastrol</td>
      <td>UGT2B7-catalyzed 4-MU glucuronidation</td>
      <td>Inhibition kinetic analysis of celastrol (Cela) towards UGT2B7-catalyzed 4-MU glucuronidation.</td>
    </tr>
    <tr>
      <th>1261</th>
      <td>PXR<br>drug metabolizing enzymes<br>St. John’s Wort<br>drug transporters<br>rifampicin</td>
      <td>PXR</td>
      <td>PXR activating drugs (e.g., rifampicin) or herbal preparations (e.g., St. John’s Wort) consequently induce drug metabolizing enzymes, and drug transporters can deteriorate drug efficacy by reducing the bioavailability or increasing the clearance of concomitantly used drugs, being substrates of such enzymes and/or transporters [16,17].</td>
    </tr>
    <tr>
      <th>474</th>
      <td>triplicate determinations</td>
      <td></td>
      <td>of triplicate determinations.</td>
    </tr>
    <tr>
      <th>493</th>
      <td>fimasartan-amide<br>amlodipine<br>Fimasartan<br>hydrochlorothiazide<br>Agilent 6470 Triple Quadrupole LC-MS/MS system</td>
      <td></td>
      <td>Fimasartan, fimasartan-amide, amlodipine, and hydrochlorothiazide levels in each sample were determined using an Agilent 6470 Triple Quadrupole LC-MS/MS system (Agilent, Wilmington, DE, USA).</td>
    </tr>
    <tr>
      <th>786</th>
      <td>valerian root</td>
      <td></td>
      <td>Recommended daily doses of valerian root extracts are about 600 mg, usually taken as capsules or tablets.</td>
    </tr>
    <tr>
      <th>1964</th>
      <td>single herbs<br>OS<br>Wen Bing formulas</td>
      <td></td>
      <td>To explore more, we would like to investigate the interactions between OS and selected single herbs from these Wen Bing formulas.</td>
    </tr>
    <tr>
      <th>775</th>
      <td>Drug Metabolism and Pharmacokinetics<br>Madison, WI, USA<br>herb–drug interaction<br>warfarin<br>complementary medicines<br>Covance Laboratories Inc.</td>
      <td></td>
      <td>Current address: Drug Metabolism and Pharmacokinetics, Covance Laboratories Inc., Madison, WI, USA Patients commonly take complementary medicines in conjunction with warfarin yet evidence supporting the safety or the risk of a herb–drug interaction is lacking.</td>
    </tr>
    <tr>
      <th>798</th>
      <td>Haloperidol<br>valerian</td>
      <td></td>
      <td>Haloperidol (38 mg/kg bw) was applied intramuscularly once every 4 weeks over 12 weeks beginning after 15 days of treatment with valerian [51].</td>
    </tr>
    <tr>
      <th>2248</th>
      <td>P-gp<br>human small intestinal enterocytes<br>CYP3A4</td>
      <td></td>
      <td>CYP3A4 and P-gp are richly expressed in the human small intestinal enterocytes.</td>
    </tr>
    <tr>
      <th>2396</th>
      <td>DEX<br>DOR<br>Asafetida resin alcoholic extract</td>
      <td></td>
      <td>In the in vitro study, Asafetida resin alcoholic extract inhibited the formation of DOR from DEX in a concentration dependent manner (Fig.</td>
    </tr>
    <tr>
      <th>1596</th>
      <td>9<br>Table 2</td>
      <td></td>
      <td>9, Table 2).</td>
    </tr>
    <tr>
      <th>1923</th>
      <td>Ginkgo biloba<br>Panax ginseng<br>Allium sativum<br>Hypericum perforatum</td>
      <td></td>
      <td>Clinical studies of some of the most commonly researched plants include garlic (Allium sativum), St. John’s wort (Hypericum perforatum), Panax ginseng, and Ginkgo biloba [9].</td>
    </tr>
    <tr>
      <th>1095</th>
      <td>participant</td>
      <td></td>
      <td>Type of participant.</td>
    </tr>
    <tr>
      <th>631</th>
      <td>G. biloba</td>
      <td>CYP</td>
      <td>[18] Taken together these findings indicate that herb-drug interactions attributable to G. biloba are not the result of phytochemical-mediated effects on CYP isoforms.</td>
    </tr>
    <tr>
      <th>1202</th>
      <td>individual herbs</td>
      <td></td>
      <td>Composition of individual herbs in the included herbal formulae.</td>
    </tr>
    <tr>
      <th>2109</th>
      <td>K tissue distribution<br>gallic acid<br>PCA<br>ciprofloxacin<br>CIP<br>PCE</td>
      <td></td>
      <td>CIP significantly increased the K  Tissue distribution profiles of gallic acid (GA) after oral administration of PCE in the absence (A) and presence (B) of ciprofloxacin, as well as the tissue to plasma distribution coefficients [K  The tissue distribution curves of PCA in the absence and| presence of CIP are shown in Figures 8A,B, respectively.</td>
    </tr>
    <tr>
      <th>675</th>
      <td>3-hydroxyquinine</td>
      <td></td>
      <td>The limit of quantitation was 0.37µg/ml and 0.5µg/ml for quinine and for 3-hydroxyquinine respectively.</td>
    </tr>
    <tr>
      <th>384</th>
      <td>MDCKII-BCRP cells</td>
      <td></td>
      <td>; 3.5 μm) at room temperature.</td>
    </tr>
    <tr>
      <th>718</th>
      <td>age group<br>20–60 years<br>CAM<br>nonusers<br>male/female ratio</td>
      <td></td>
      <td>Regarding CAM nonusers, the majority were in the age group of 20–60 years with the male/female ratio of 73/27 percent.</td>
    </tr>
    <tr>
      <th>1680</th>
      <td>ERK pathway<br>stimulation of new vessel formation<br>vasodilation<br>decrease in blood viscosity<br>adipocyte differentiation<br>PI3-K/Akt pathway<br>anthocyanins<br>endothelium-derived relaxant pathways<br>active site<br>reduction of myocardial mass<br>inhibition of calcium influx<br>ACE inhibition<br>cyclooxygenase inhibitory activity</td>
      <td>ACE</td>
      <td>Biological Mechanisms  In vitro and in vivo studies focused on mechanism of action have determined several potential mechanisms of the HS extracts that may explain the hypotensive activity, including (1) vasodilation mediated through endothelium-derived relaxant pathways and inhibition of calcium influx [9, 57], (2) ACE inhibition [9] by the stimulation of new vessel formation and a reduction of myocardial mass [52] or anthocyanins competing with the substrate for the active site [58], (3) decrease in blood viscosity through cyclooxygenase inhibitory activity [44], and (4) inhibition of adipocyte differentiation through the modulation of PI3-K/Akt and ERK pathway [59].</td>
    </tr>
    <tr>
      <th>2115</th>
      <td>liver metabolism<br>renal epithelia<br>biliary excretion<br>intestinal epithelia<br>CIP</td>
      <td></td>
      <td>Since the liver metabolism (approximately 10%) and biliary excretion (approximately 1%) of the drug is relatively low (Vance-Bryan et al., 1990), the reduced circulating CIP in humans was mainly attributed to the change of CIP across the renal and intestinal epithelia.</td>
    </tr>
    <tr>
      <th>1699</th>
      <td>manuscript</td>
      <td></td>
      <td>As a service to our customers we are providing this early version of the manuscript.</td>
    </tr>
    <tr>
      <th>2400</th>
      <td>healthy human volunteers</td>
      <td></td>
      <td>The in vivo study was conducted on healthy human volunteers.</td>
    </tr>
    <tr>
      <th>2195</th>
      <td>echinacea<br>kratom<br>St. John’s wort<br>hydroxycut<br>piperine<br>celery<br>rhodiola<br>moringa<br>valerian<br>terminalia/commiphora ayurvedic mixture<br>ginger<br>ginkgo<br>kava</td>
      <td></td>
      <td>These are celery, echinacea, ginkgo, ginseng, hydroxycut, kava, kratom, moringa, piperine, rhodiola, St. John’s wort, terminalia/commiphora ayurvedic mixture and valerian.</td>
    </tr>
    <tr>
      <th>398</th>
      <td>plasma drug concentration<br>toxic concentration</td>
      <td></td>
      <td>Its effective plasma drug concentration is close to the toxic concentration, and large individual differences in the effects of the drug have been observed.</td>
    </tr>
    <tr>
      <th>2292</th>
      <td>combined extraction solution</td>
      <td></td>
      <td>The combined extraction solution was then evaporated to dryness.</td>
    </tr>
    <tr>
      <th>149</th>
      <td>CYP2C9<br>tolbutamide<br>glipizide<br>CYP2C9*3 allele</td>
      <td>CYP2C9*3 allele</td>
      <td>By contrast, for carriers of the CYP2C9*3 allele, the CL/Fs of glipizide (Kidd et al., 1999) and tolbutamide (Kirchheiner et al., 2002a) were significantly different from wild-type subjects, with ratios of 0.18 and 0.58, respectively.</td>
    </tr>
    <tr>
      <th>1883</th>
      <td>simvastatin<br>simvastatin hydroxy acid<br>lovastatin</td>
      <td></td>
      <td>The mean (SD) plasma concentrations of simvastatin, its metabolite simvastatin hydroxy acid, and internal standard lovastatin are shown in Figure 4.</td>
    </tr>
    <tr>
      <th>2075</th>
      <td>PCA<br>MDR1<br>GA<br>BCRP<br>OAT1/3</td>
      <td>BCRP<br>OAT1/3<br>MDR1</td>
      <td>In the transporter-mediated in vitro HDI, GA and PCA presented inhibitory effects on OAT1/3 and inductive effects on MDR1 and BCRP.</td>
    </tr>
    <tr>
      <th>1273</th>
      <td>RNA<br>cDNA</td>
      <td></td>
      <td>RNA was isolated using the GeneElute Mammalian Total RNA Miniprep Kit and cDNA was synthesized with the RevertAid™ H Minus First Strand cDNA Synthesis Kit according to the manufacturers’ instructions.</td>
    </tr>
    <tr>
      <th>2139</th>
      <td>incremental protocol<br>24% increase<br>low to moderate exercise intensities</td>
      <td></td>
      <td>This increase is comparable with 24% increase found during low to moderate exercise intensities determined using an incremental protocol in our previous study [22].</td>
    </tr>
    <tr>
      <th>214</th>
      <td>FBS<br>non-essential amino acids<br>MDCK-II cells<br>digoxin<br>96-well microplates<br>DMEM</td>
      <td></td>
      <td>Radio labeled digoxin [ Parental and transfected MDCK-II cells were grown in DMEM supplemented with 10% FBS, 1% non-essential amino acids, 1%  The assay for reversible inhibition was conducted in a total volume of 200 μL in 96-well microplates.</td>
    </tr>
    <tr>
      <th>1888</th>
      <td>P-value</td>
      <td></td>
      <td>A difference was considered significant at P < 0.05.</td>
    </tr>
    <tr>
      <th>1051</th>
      <td>darunavir<br>Cτ<br>AUCτ<br>E. purpurea</td>
      <td></td>
      <td>Coadministration of E. purpurea resulted in little change in darunavir pharmacokinetic parameters, with Cτ and AUCτ decreasing by averages of 16% and 10%, respectively.</td>
    </tr>
    <tr>
      <th>1037</th>
      <td>Spain<br>Arkopharma<br>V05895B<br>Madrid</td>
      <td></td>
      <td>V05895B; Arkopharma, Madrid, Spain).</td>
    </tr>
    <tr>
      <th>1644</th>
      <td>Dong quai<br>Ginkgo biloba<br>Danshen</td>
      <td></td>
      <td>or other herbs (Danshen, Ginkgo biloba, Dong quai, etc.).</td>
    </tr>
    <tr>
      <th>2162</th>
      <td>satiety<br>weight-loss supplementation<br>mood state<br>psychomotor effects<br>fat</td>
      <td></td>
      <td>Favorable psychomotor effects on mood state and satiety are often expected outcomes of fat and weight-loss supplementation protocols.</td>
    </tr>
    <tr>
      <th>1311</th>
      <td>over the counter medications<br>prescription medications</td>
      <td></td>
      <td>Subjects were also asked to abstain from taking prescription and over the counter medications for 2 weeks before and during the study period.</td>
    </tr>
    <tr>
      <th>1357</th>
      <td>M.A.A.</td>
      <td></td>
      <td>and M.A.A.</td>
    </tr>
    <tr>
      <th>1383</th>
      <td>angular velocity<br>isokinetic knee extensions<br>leg<br>2 min</td>
      <td></td>
      <td>In the main test session, subjects performed 5 isokinetic knee extensions of the leg at an angular velocity of 60 degrees/second, and subjects recovered passively for 2 min between sets of measurements [26,27].</td>
    </tr>
    <tr>
      <th>43</th>
      <td>PCP</td>
      <td></td>
      <td>However, his PCP determined that additional medication for pain control was warranted.</td>
    </tr>
    <tr>
      <th>642</th>
      <td>phenols<br>benxophenones<br>kolaviron<br>saponins<br>xanthones<br>copper<br>alkaloids<br>aluminum<br>biflavonoid complex<br>magnesium<br>calcium<br>G. kola<br>tannins</td>
      <td></td>
      <td>[4] Studies on phytochemical analysis of G. kola seeds [6–11] reveal benxophenones, xanthones, alkaloids, phenols, tannins and saponins, kolaviron a biflavonoid complex, and metallic ions such as aluminum, magnesium, calcium and copper as major chemical components of G. kola.</td>
    </tr>
    <tr>
      <th>800</th>
      <td>FRE<br>GRT<br>CYP2C8</td>
      <td></td>
      <td>The results were not presented in detail but indicated that the two drugs act independently from each other.</td>
    </tr>
    <tr>
      <th>1540</th>
      <td>PEPT1 transporter<br>GSH level<br>H. sabdariffa extract</td>
      <td>PEPT1 transporter<br>GSH</td>
      <td>Two weeks of coadministration of H. sabdariffa extract is sufficient enough to affect the GSH level or the expression of the PEPT1 transporter.</td>
    </tr>
    <tr>
      <th>1967</th>
      <td>Albuterol<br>Sigma-Aldrich Chemicals</td>
      <td></td>
      <td>Albuterol (as internal standard) was purchased from Sigma-Aldrich Chem.</td>
    </tr>
    <tr>
      <th>286</th>
      <td>alkylamides<br>DTAI</td>
      <td></td>
      <td>In contrast, contents of DTAI or other alkylamides in the extracts used in the midazolam studies [11, 12] were not specified.</td>
    </tr>
    <tr>
      <th>110</th>
      <td>water</td>
      <td></td>
      <td>Extraction was performed using water to mimic the indigenous mode of extraction.</td>
    </tr>
    <tr>
      <th>890</th>
      <td>hot flash<br>headache<br>pruritus</td>
      <td></td>
      <td>In addition, one subject with pruritus and hot flash and another subject with headache fully recovered after discontinuation of administration in the placebo group.</td>
    </tr>
    <tr>
      <th>252</th>
      <td>Echinacea</td>
      <td></td>
      <td>Echinacea was well tolerated, and all participants completed the study.</td>
    </tr>
    <tr>
      <th>572</th>
      <td>HREC REF: 826/2014<br>University of Cape Town Human Research Ethics committee</td>
      <td></td>
      <td>Ethical approval was obtained from the University of Cape Town Human Research Ethics committee with number HREC REF: 826/2014.</td>
    </tr>
    <tr>
      <th>1049</th>
      <td>HIV-1 RNA load</td>
      <td></td>
      <td>No patient reported adverse events during the study, and all maintained an HIV-1 RNA load of <50 copies/ml at the end of the study.</td>
    </tr>
    <tr>
      <th>1539</th>
      <td>formic acid</td>
      <td></td>
      <td>The reaction was then stopped by adding formic acid [17].</td>
    </tr>
    <tr>
      <th>540</th>
      <td>CV<br>mean</td>
      <td></td>
      <td>Data represented as mean and CV from five or six independent experiments.</td>
    </tr>
    <tr>
      <th>1579</th>
      <td>filtrate</td>
      <td></td>
      <td>It was filtered and the filtrate obtained in this step was mixed with the previous filtrate.</td>
    </tr>
    <tr>
      <th>2213</th>
      <td>memory loss<br>cardiovascular disorders<br>cognition decline<br>general well-being<br>anxiety and mood disorders<br>fatigue<br>ginkgo</td>
      <td></td>
      <td>Several controlled clinical studies, as shown by review and meta-analysis of published data, suggest that the use of ginkgo is associated with clinically significant improvement in symptoms of cognition decline and memory loss, anxiety and mood disorders, fatigue and general well-being, as well as cardiovascular disorders [59-61].</td>
    </tr>
    <tr>
      <th>1890</th>
      <td>herbal medicines<br>bioavailability</td>
      <td></td>
      <td>Herb-drug interactions incidence was predicted to increase due to herbal medicines' worldwide popularity with the development of several herbal formulations with improved bioavailability.</td>
    </tr>
    <tr>
      <th>1015</th>
      <td>SOD<br>GPx<br>CAT<br>MDA</td>
      <td></td>
      <td>particularly illustrated an increase in the SOD, CAT, and GPx levels, while the MDA level more significantly decreased compared to other groups using only one herb [17].</td>
    </tr>
    <tr>
      <th>1700</th>
      <td>imatinib<br>Schisandra lignans</td>
      <td></td>
      <td>Interaction between imatinib and Schisandra lignans was unlikely to be of clinical importance.</td>
    </tr>
    <tr>
      <th>1654</th>
      <td>Conflict of interests</td>
      <td></td>
      <td>Go to: Conflict of interests  There is no conflict of interests.</td>
    </tr>
    <tr>
      <th>2124</th>
      <td>potential conflict of interest</td>
      <td></td>
      <td>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</td>
    </tr>
    <tr>
      <th>592</th>
      <td>1000 mg<br>common cold<br>AAP</td>
      <td></td>
      <td>To mimic the recommended dose based on the status of patients, AAP dose is suggested from 1000 mg to the maximum dose of 1000 mg × 4 times (8 tablets) per day for treatment of the common cold [22,23].</td>
    </tr>
    <tr>
      <th>682</th>
      <td>CL/F<br>quinine<br>T1/2<br>G. kola</td>
      <td></td>
      <td>Moreover, parameters such as T1/2 and CL/F of quinine that relates to elimination in both study groups were also not altered significantly in the presence of G. kola.</td>
    </tr>
    <tr>
      <th>2244</th>
      <td>herbal products</td>
      <td></td>
      <td>This is important because the vast majority of herbal products are orally administered.</td>
    </tr>
    <tr>
      <th>1585</th>
      <td>inflammatory response<br>oxidative stress<br>liver damage<br>diabetes</td>
      <td></td>
      <td>The underlying mechanism of diabetes that contributes to liver damage is the combination of increased oxidative stress and an aberrant inflammatory response.</td>
    </tr>
    <tr>
      <th>2353</th>
      <td>Diabetes</td>
      <td></td>
      <td>Diabetes is a complex condition with a variety of causes and pathophysiologies.</td>
    </tr>
    <tr>
      <th>2050</th>
      <td>Viscum album L.<br>Mistletoe</td>
      <td></td>
      <td>Mistletoe (Viscum album L.) derived medicinal preparations are widely used and registered as medicines in many European countries.</td>
    </tr>
    <tr>
      <th>1142</th>
      <td>raloxifene<br>silibinin</td>
      <td></td>
      <td>Alternate study designs, including silibinin predosing and multiple dosing of raloxifene, could provide further insight into interaction potential.</td>
    </tr>
    <tr>
      <th>1429</th>
      <td>low‐hyperforin SJW extract<br>pharmacokinetic interaction study<br>clinically relevant interactions<br>Zahner et al., 2019</td>
      <td></td>
      <td>This statement was provided even before another comprehensive pharmacokinetic interaction study was published, where no clinically relevant interactions were found for seven test drugs in concomitant application with a low‐hyperforin SJW extract (Zahner et al., 2019).</td>
    </tr>
    <tr>
      <th>981</th>
      <td>hesperidin<br>antioxidants<br>SOD<br>CAT<br>C. sinensis<br>MDA</td>
      <td></td>
      <td>Moreover, hesperidin in C. sinensis increases the levels of antioxidants including SOD and CAT, and decreases the MDA level [19].</td>
    </tr>
    <tr>
      <th>1225</th>
      <td>HepaRG cell line<br>liver-specific enzymes</td>
      <td></td>
      <td>HepaRG cell line, derived from a hepatocellular carcinoma, could express a large panel of liver-specific enzymes [5,6,7].</td>
    </tr>
    <tr>
      <th>1379</th>
      <td>lactate level<br>QMS</td>
      <td></td>
      <td>In ANOVA results, QMS (p = 0.001) and lactate level (p = 0.038) showed significant interactions.</td>
    </tr>
    <tr>
      <th>202</th>
      <td>anticancer<br>anti-inflammatory<br>KF<br>antioxidant<br>anti-osteoporosis</td>
      <td></td>
      <td>Furthermore, the extract and constituents of KF have been shown to possess anticancer, antioxidant, anti-osteoporosis, and anti-inflammatory properties (Nadia et al., 2012; Fathilah et al., 2013).</td>
    </tr>
    <tr>
      <th>196</th>
      <td>LVFX<br>Polygonum capitatum</td>
      <td></td>
      <td>Polygonum capitatum may inhibit the entrance of LVFX into blood, thereby directly affecting its distribution rate in the tissue.</td>
    </tr>
    <tr>
      <th>2220</th>
      <td>subtherapeutic serum levels<br>seizure<br>toxicological autopsy</td>
      <td></td>
      <td>He was reported to have experienced a seizure before his death, and the toxicological autopsy results revealed subtherapeutic serum levels for both drugs.</td>
    </tr>
  </tbody>
</table>

</body>
</html>
